Insulin and leptin action: roles in diabetes and obesity. by Bedford, D.C.
INSULIN AND LEPTIN ACTION: 
ROLES IN DIABETES AND OBESITY.
A thesis submitted to the University of London 
for the degree of Doctor of Philosophy
by
David Charles Bedford.
Department of Medicine 
University College London 
Rayne Institute 
5 University Street
London, WC1E 6JJ. November 2004.
l
UMI Number: U591650
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U591650
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
ABSTRACT.
Obesity is a major risk factor for insulin resistance and therefore type 2 
diabetes. However, the precise mechanisms whereby obesity causes insulin resistance 
are complex and not completely understood. The adipocyte derived hormone leptin and 
the pancreatic derived hormone insulin act as satiety factors to the central nervous 
system, regulating long-term energy homeostasis. In addition both hormones have been 
shown to act in the central nervous system (CNS) to acutely regulate peripheral glucose 
homeostasis. Leptin and insulin have also been shown to regulate pancreatic islet 
function.
A growing amount of evidence suggests there is considerable overlap in the 
pathways by which these hormones act to mediate their physiological effects. The insulin 
receptor substrate-2 (IRS-2) protein is a critical mediator of cellular responses to insulin, 
especially those associated with somatic growth and carbohydrate metabolism. It has 
been suggested that IRS-2 signalling pathways act as a potential point of convergence for 
insulin and leptin signalling.
Much of our current understanding of both the cellular and molecular effects of 
leptin and insulin has been derived from studies of murine models of obesity and 
diabetes. In this thesis I have exploited three such models to generate mice with defective 
1) IRS-2 function (IRS-2 KO) and leptin production (ob/ob) and 2) IRS-2 function and 
leptin receptor (db/db) function. I have also produced mice which lack IRS-2 and STAT- 
3 specifically in their P-cells and hypothalamus. As insulin resistance and leptin 
resistance coexist in obese subjects, it was hoped that such murine models would give 
some insights into the contribution of these processes to the obesity phenotype and its 
associated insulin resistance and type 2 diabetes. In particular it was hoped to address the 
hypothesis that a linear relationship exists between IRS-2 and STAT-3 in mediating the 
effects of insulin and leptin action, with IRS-2 being upstream of the events that lead to 
the phosphorylation of STAT-3.
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Considering either systemic or tissue-specific approaches, it was evident that 
insults to leptin signalling in combination with Irs-2 deletion results in additive effects 
upon growth, adiposity, glucose homeostasis and islet function. These additive effects 
would indicate that IRS-2 and STAT-3 mediate these effects by acting in separate 
signalling pathways, as opposed to converging upon a linear pathway. However cross­
talk between these parallel pathways is likely to be critical for the maintenance of insulin 
and leptin sensitivity in target tissues.
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CHAPTER 1
INTRODUCTION.
1.1 Obesity and type 2 diabetes: a worldwide epidemic
Obesity and its associated pathologies are major causes of ill health and death 
worldwide (1). The incidence of obesity is increasing in both developed and developing 
countries. For example in the UK currently over two thirds of men and half of women 
are overweight or obese (2). Obesity increases the risk of insulin resistance, type II 
diabetes mellitus, cardiovascular disease, osteoarthritis and some types of cancers, 
resulting in increased mortality at any given age. Indeed, the increasing prevalence of 
type 2 diabetes associated with obesity in UK teenagers further highlights this as a 
major cause of morbidity with significant implications for future health-care provision 
(3, 4). However, despite significant progress in our understanding of the mechanisms 
by which energy homeostasis is regulated, the precise pathophysiological relationships 
between obesity, insulin resistance and type 2  diabetes are not completely understood.
1.2 Overview of insulin resistance, type 2 diabetes and obesity
Type 2 diabetes is a complex metabolic disorder characterised by a triad of 1) 
resistance to insulin action on glucose uptake in peripheral tissues, especially skeletal 
muscle and adipocytes, 2 ) impaired insulin action to inhibit hepatic glucose production 
and 3) dysregulated insulin secretion. Insulin resistance is one of the earliest 
abnormalities in the clinical history of type 2  diabetes, and is also seen in non-diabetic 
relatives of diabetic subjects (5). However, initially, insulin resistance does not cause 
overt hyperglycaemia because normally p-cells are capable of secreting sufficient 
amounts of insulin to offset the defects in insulin action. This P-cell compensation in 
the face of insulin resistance occurs due to both an increase in the production of insulin 
by individual P-cells but also an overall increase in P-cell mass (6 , 7). However, once
16
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Figure 1.1 Pathogenesis o f type 2 diabetes
The presence o f insulin resistance places an increased demand upon the pancreatic IT- 
cell to compensate by secreting more insulin. Both genetic and environmental factors 
may limit compensation leading to relative p-cell failure and type 2 diabetes mellitus.
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this compensation fails, glucose intolerance supervenes. Hence the development of 
overt type 2  diabetes requires the presence of two defects; insulin resistance and P-cell 
failure (Fig 1.1). Insulin resistance is thus a fundamental factor in the aetiology of type 
2 diabetes and is linked to a wide array of other pathophysiological conditions 
including hypertension, hyperlipidemia, atherosclerosis, and polycystic ovarian disease 
(8).
The mechanisms resulting in insulin resistance are complex and appear to 
arise from a combination of both genetic and environmental factors (9). It can arise 
from defects in insulin signal transduction, changes in the expression of proteins or 
genes that are targets of insulin action, cross talk from other hormonal systems, or 
metabolic abnormalities. In most cases type 2 diabetes is a polygenic disease with 
complex inheritance patterns. A strong genetic component is suggested by the 
concordance between monozygotic twins and increased prevalence in first-degree 
relatives of affected individuals (10). Environmental factors, especially diet, physical 
activity and age, interact with genetic predisposition to affect disease prevalence (5).
Obesity is a major risk factor for insulin resistance and therefore type 2 
diabetes. The precise mechanisms whereby obesity causes insulin resistance are 
complex and not completely understood. However, a number of pathophysiological 
processes are thought to be involved. The elevated free fatty acids (FFA) levels and 
their metabolites seen in obesity impair insulin action in skeletal muscle by acting 
negatively upon elements of the insulin-signalling pathway (11). Increased adipose 
tissue production of cytokines, such as tumour necrosis factor-a, inhibits insulin 
signalling. Similarly reduced expression of the adipocyte hormones adiponectin and 
leptin (see below) are associated with insulin resistance. It is apparent that the excess 
FFAs seen in obesity may also impair pancreatic islet function and thus contribute to 
the a-cell defect seen in type 2  diabetes (1 2 , 13).
It is therefore clear that an understanding of the mechanisms that regulate 
glucose homeostasis, insulin sensitivity and whole body energy storage will have an 
important role in our understanding of the pathophysiology of type 2  diabetes.
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1.3 Acute regulation o f peripheral glucose homeostasis by insulin
1.3.1 Pancreatic islet function and glucose uptake
The brain and central nervous system require glucose as the sole or primary 
source of energy. While hypoglycaemia may produce cellular death, chronic 
hyperglycaemia also can result in organ damage. Therefore, plasma glucose levels are 
tightly regulated between 4 and 7 mM in normal individuals (5). This narrow range, is 
governed by, a balance between glucose absorption from the gut, production by the 
liver and uptake by peripheral tissues and organs. The balance between the utilization 
and production of glucose is maintained at equilibrium by the opposing actions of 
insulin and glucagon (Fig 1.2). In response to a meal, blood glucose levels increase and 
insulin is released from the P-cells within the islets of Langerhans, stimulating glucose 
transport into muscle and fat via GLUT4 glucose transporter mechanisms, whilst 
inhibiting hepatic glucose production (8 ). Similarly, when glucose levels fall, glucagon, 
released from the a-cells, promotes the release of stored and newly synthesised glucose
into the bloodstream. Insulin and glucagon therefore act in concert to ensure that
glucose homeostasis is maintained throughout a wide variety of physiological states.
1.3.2 Insulin and gene expression
In addition to these acute effects upon glucose uptake, insulin also regulates 
metabolism at the level of gene transcription and translation, regulating such processes 
as gluconeogenesis and lipogenesis. For example, at the transcriptional level, acute 
insulin treatment decreases the messenger RNAs encoding gluconeogenic enzymes, 
such as phosphoenolpyruvate carboxykinase and increases the mRNAs encoding 
lipogenic enzymes via the action of the transcription factor, sterol regulatory element 
binding protein (SREBP-lc) (14). Central administration of insulinomimetics and 
insulin receptor anti-sense has also indicated that insulin can act centrally to regulate 
gene expression in peripheral tissues (15).
19
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Figure 1.2 Regulation o f plasma blood glucose by opposing actions o f insulin and 
glucagon
Blood glucose levels are maintained between 4 and 7mM in normal individuals by the 
opposing actions of insulin and glucagon. When blood glucose levels increase, insulin 
is secreted from p-cells in the pancreas, promoting the uptake of blood glucose into 
peripheral metabolic tissues such as muscle and fat, whilst inhibiting hepatic glucose 
output. Similarly, when blood glucose levels are low, glucagon is released from a-cells 
in the pancreas and stimulates the secretion of newly synthesized glucose from the liver 
into the bloodstream.
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1.4 Central nervous system regulation o f energy homeostasis
In contrast to these relatively acute effects of insulin upon peripheral 
metabolism described above it is well-established that physiological systems regulate 
longer-term aspects of energy homeostasis such as the control of food intake and the 
maintenance of body fat stores (16). The impressive stability of body adiposity over 
long periods of time, despite often marked variation in daily food intake and energy 
expenditure, led Kennedy to propose that a signal generated in proportion to body fat 
stores acts in the brain to promote energy homeostasis (17).
1.4.1 Hypothalamic circuits regulating food intake and adiposity
The hypothalamus is thought to be the major region of the CNS regulating and 
integrating food intake and energy homeostasis. Areas of the hypothalamus involved in 
control of food intake were initially identified in lesioning experiments. Lesions of the 
lateral hypothalamus (LHA) result in hypophagia, weight loss and eventual death, 
while lesions of the arcuate nucleus (ARC), ventromedial hypothalamus (VMH), 
dorsomedial hypothalamus (DMH) and paraventricular nucleus (PVN) result in 
hyperphagia and weight gain (18). Subsequent work has identified various 
neuropeptides present in these hypothalamic nuclei, along with their sites of synthesis, 
release and their receptor fields. It has now become apparent that the hypothalamic 
nuclei form a complex neural network involved in the regulation of food intake and 
energy expenditure. It has also become clear that there is a complex interplay between 
these circuits and peripheral signals (16).
1.4.2 Arcuate nucleus (ARC)
The arcuate nucleus is located at the base of the hypothalamus on either side 
of the third ventricle. The ARC effectively lies outside the blood brain barrier and thus, 
ARC neurones are accessible to circulating hormones and nutrients. Two adjacent 
groups of neurons in the ARC, the agouti-related protein (AgRP)/neuropeptide Y 
(NPY) neurones (orexigenic) and the proopiomelanocortin (POMC)/ cocaine-
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amphetamine-regulated transcript (CART) neurones (anorectic), act as the primary site 
in the brain for receiving the humoral signals that reflect body energy status (Fig 1.3). 
Projections between ARC AgRP/NPY and POMC/CART allow cross talk and hence a 
co-ordinated response. These neurons are often referred to as “first order neurons” 
because of their direct contact with peripheral signals. From the ARC, neurons project 
to “second order neurons” in the PVN, VMH, DMH, and LHA (19). Second order 
neurons project to the nucleus of the solitary tract (NTS) in the brainstem and the 
dorso-motor nucleus of the vagus (DMV). The communication between hypothalamic 
pathways and the caudal brainstem, in response to peripheral satiety signals, is essential 
for the long-term regulation of energy homeostasis.
1.5 Peripheral signals of long-term energy balance
The neuronal and molecular hypothalamic circuits described in brief above 
are now known to represent a major component of the brain centres that Kennedy 
proposed as responding to humoral adiposity signals. However, in contrast to the 
complexity and significant numbers of factors involved in hypothalamic function, the 
search for peripherally produced adiposity signals has to date revealed only a few key 
molecules. The pancreatic hormone insulin, which enters the brain from the circulation 
and acts there to reduce energy intake was the first hormonal signal implicated in the 
control of body weight by the CNS (20). However, it was the subsequent identification 
of the adipocyte hormone leptin (21) and the delineation of its role in the CNS 
regulation of energy homeostasis that provided the impetus for many of the recent 
advances in our understanding of these pathways and mechanisms. The interactions 
between the peripheral and central mechanisms regulating energy homeostasis are 
summarised in Figure 1.3.
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Figure 1.3 Representation of how insulin and leptin act as adiposity signals to the 
CNS and regulate energy homeostasis
Both insulin and leptin act upon the first order neurons, stimulating the anorectic Proopiomelanocortin 
(POMC)/Cocaine-amphetamine-regulated transcript (CART) neurones and inhibiting the orexigenic 
Agouti-related protein (AgRP)/ Neuropeptide Y (NPY) neurones. Projections between ARC AgRP/NPY 
and POMC/CART allow cross talk and hence a co-ordinated response that signals to second order 
neurones, which then relay signals to the caudal brainstem. It is also known that hormones, such as 
cholecystokinin (CCK), are released from the gut in response to food intake and act in the CNS to rely 
satiety. Both adiposity and satiety signals act within the CNS to regulate whole body energy 
homeostasis. Figure adapted with permission from (19).
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1.5.1 Leptin: an adiposity signal acting in the CNS
The adipocyte-derived hormone leptin is the best-characterised peripheral 
adiposity signal. Its expression and circulating concentration reflect nutritional status 
(21, 22). Leptin synthesis and release is proportional to fat mass but is also regulated in 
the short term by food intake and is reduced following fasting (23). In both rodents and 
humans, leptin deficiency or defects in the leptin receptor result in hyperphagia, 
obesity, reduced energy expenditure and infertility (21). These abnormalities seen in 
the obese, leptin-deficient ob/ob mouse and also leptin-deficient humans can be 
reversed by peripheral administration of leptin (24, 25). Both NPY/AgRP and 
POMC/CART neurones express the long-form of the leptin receptor (26) and leptin is 
known to regulate the expression of these peptides. Fasting increases expression of 
NPY and AgRP, whilst CART and POMC expression are reduced and these changes in 
expression can be prevented by administration of leptin (27, 28). Electrophysiological 
recordings have demonstrated that leptin acutely modulates the activity of both NPY 
and POMC neurones, hyperpolarizing the NPY neurones and depolarising the POMC 
neurones (29).
1.5.2 Insulin: actions in the CNS
Insulin is another important adiposity signal to the brain but in contrast to 
leptin its role in the central regulation of energy homeostasis has been less intensively 
studied (19). Insulin receptors are expressed in the hypothalamus particularly in the 
ARC and PVN (30). Early studies demonstrated a role for intracerebroventricularly 
administered insulin in the control of food intake and body weight (20). Recently, 
deletion of the insulin receptor in the murine brain has been shown to cause mild 
hyperphagia and adiposity in female mice and diet-sensitive obesity in both sexes (31). 
Central administration of insulinomimetics and insulin receptor anti-sense also support 
a role for CNS insulin signalling in the regulation of energy homeostasis (15, 32). In 
addition to suppressing food intake and reducing body weight, hypothalamic 
administration of insulin has been shown to regulate NPY and AgRP expression (19). 
It has therefore been suggested that insulin and leptin target the same neurones in the 
hypothalamus, ie NPY/AgRP and POMC/CART neurones.
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In addition to its role as a peripheral signal, acting in the hypothalamus to 
regulate long-term energy homeostasis, there is evidence that leptin may act in the CNS 
to acutely regulate peripheral glucose homeostasis. For example intracerebroventricular 
administration of leptin has been shown to modulate hepatic glucose fluxes (3 3 ). 
Central administration of leptin has also been shown to regulate fatty acid oxidation in 
skeletal muscle acting via AMP-activated protein kinase (AMPK) (34). AMPK is 
activated following an increase in the AMP:ATP ratio within the cell that occurs 
following a decrease in ATP levels (35). Minokoshi et al demonstrated that leptin 
directly stimulates phosphorylation and activation of the oc2 catalytic subunit of AMPK 
(a2 AMPK) in skeletal muscle. It was also noted that early activation of AMPK occurs 
by leptin acting directly on muscle, whereas later activation requires leptin to function 
through the hypothalamic-sympathetic nervous system axis (34).
1.6 Insulin and leptin signal transduction pathways
Our understanding of the underlying cellular and molecular mechanisms by 
which insulin and leptin mediate their physiological effects have increased significantly 
in recent years. In particular, studies have delineated much of the signalling pathways 
that are stimulated by these hormones and have started to demonstrate similarities and 
differences between the signalling mechanisms involved.
1.6.1 Insulin receptor signalling cascade
Insulin action on glucose uptake in muscle and fat results from a cascade of 
signalling events emanating from the insulin receptor and culminating in translocation 
of the major insulin responsive glucose transporter, GLUT-4, from intracellular vesicles 
to the plasma membrane (36, 37), (summarised in Fig 1.4). Insulin binds to its cell 
surface transmembrane receptor stimulating receptor autophosphorylation and 
activation of the intrinsic kinase activity. Resulting in tyrosine phosphorylation of 
several cytosolic docking proteins called insulin receptor substrate (IRS) proteins. 
There are at least four closely related insulin receptor substrate proteins. Findings from 
transgenic mouse models have revealed distinct physiological roles for the four major
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IRS proteins (38). Mice lacking IRS1 display profound growth retardation and insulin 
resistance, but do not develop diabetes due to (3 cell compensation (39). IRS-3 and 
IRS-4 null mice have minimal metabolic, endocrine and growth phenotypes (reviewed 
in (38)). In contrast, mice lacking IRS2 have mild growth defects but develop diabetes 
due to P cell failure in the face of peripheral insulin resistance. Once phosphorylated 
IRS proteins bind to various effector molecules including the regulatory subunit (P85a) 
of phosphoinositide 3-kinase (PI3K), via Src homology 2 (SH2) domains.
The primary function of the PI3K enzyme in insulin signalling appears to be 
the transduction of tyrosine phosphorylation into a signal leading to activation of 
serine/threonine kinases. P85a dimerizes the pi 10 catalytic subunit of the PI3K 
enzyme. Deletion of P85a in mice resulted in increased insulin sensitivity and 
hypoglycaemia due to increased glucose transport in skeletal muscle and adipocytes 
(40). The lipid products of PI3K and in particular PIP3, are thought to be involved in 
recruitment and perhaps activation of enzymes and proteins containing pleckstrin- 
homology (PH) domains which are able to bind phospholipids. The 3- 
Phosphoinositide-dependent kinase-1 (PDK-1) is one such kinase and activates a family 
of serine/threonine kinases grouped under the acronym of AGC kinases (41), these 
include p70s6k, Akt, and SgK isoforms. It has been shown that autophosphorylation of 
PDK-1 on Ser-241 residue is required for full kinase activity (42). Interestingly the 
global deletion of PDK-1 in mice results in embryonic lethality, while hypomorphic 
alleles are associated with decreased cell size (43).
The Akt kinase (also known as PKB) was initially thought to play a major role 
in insulin signalling because of its rapid insulin-dependent activation (44) and ability to 
mimic many of insulin’s actions when overexpressed (45). It is now accepted that Akt 
activates a number of downstream targets to mediate insulin effects upon cell growth 
and metabolism. Activation of Akt requires phosphorylation of Thr-308 in the 
activation loop and Ser-473 in the C- terminal hydrophobic motif.
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Figure 1.4 Simplified insulin signalling cascade
Insulin binds to its transmembrane receptor, stimulating receptor autophosphorylation and activation o f  
the intrinsic kinase activity, resulting in tyrosine phosphorylation o f several cytosolic docking proteins 
called insulin receptor substrate (IRS) proteins. Cellular responses to insulin, especially those that are 
associated with somatic growth and carbohydrate metabolism, are largely mediated through IRS-1 and 
IRS-2. Once phosphorylated IRS proteins bind to various effector molecules including the regulatory 
subunit of phosphoinositide 3-kinase (PI3K) via Src homology 2 (SH2) domains. The lipid products of 
the PI3K enzyme, particularly PIP3 recruit and activate enzymes containing Pleckstrin-homology (PH) 
domains. These include Akt (also known as PKB), which requires phosphorylation at Ser473 to become 
fully active. Akt is capable o f regulating glucose transport, glycogen synthesis by inhibiting the activity 
o f the Glycogen Synthase Kinase enzyme by phosphorylating residues Ser-9 (GSK-3/3) and Ser-21 (GSK- 
3a). In addition, Akt can regulate protein synthesis by inhibiting the activities o f Tuberous Sclerosis-1 
and 2 (TSC1-TSC2) enzymes and thereby opposing the stimulatory actions of AMP-activated Protein 
Kinase (AMPK). It is also known that the mitogenic effects o f insulin are mediated by the MAP-kinase 
signalling pathway. Indeed, it is likely that there is much crosstalk between the metabolic and mitogenic 
limbs o f insulin signalling.
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PDK-1 can only phosphorylate Akt in the presence of PIP3. A model has been 
proposed in which binding of PIP3 to the PH domain of Akt causes a conformational 
change that relieves autoinhibition of the enzyme, allowing PDK-1 access to Thr-308 
(46). The kinase responsible for Ser-473 phosphorylation is poorly characterised, but 
has been tentatively termed PDK-2, as it is also PI3K-dependent.
Glycogen synthase kinase 3 (GSK-3) is an important downstream effector of 
Akt signalling. Insulin stimulation leads to inhibition of GSK3 isoforms by inducing 
the phosphorylation of GSK3a on Ser-21 and GSK3P on Ser-9. Insulin stimulated 
phosphorylation at these sites can be blocked by inhibitors of PI3K signalling, such as 
wortmannin, in a dose-dependent manner, implying that PI3K activity is required for 
this process (47-49). In addition to regulating glycogen synthesis, Akt has also been 
implicated in the regulation of glucose transport, regulating the trafficking of GLUT 4 
vesicles (50).
In addition, Akt can regulate protein synthesis by inhibiting the activities of 
Tuberous Sclerosis-1 and 2 (TSC1-TSC2) enzymes and thereby opposing the 
stimulatory actions of AMP-activated Protein Kinase (AMPK) (51). TSC-1 and TSC-2 
have an inhibitory role on the mammalian Target of Rapamycin (mTOR), which 
mediates protein synthesis by its stimulatory effects upon elongation factor-4E binding 
protein (4E-BP1) and the p70 ribosomal s6  protein kinase (p70s6k) (51). The p70s6k 
protein is responsible for phosphorylation of the 40 S ribosomal protein S6  and thereby 
regulates the translation of several hundred mRNAs. These mRNAs largely encode 
proteins necessary for the assembly of the translational machinery, including ribosomes 
and elongation factors (52). Insulin-stimulated activation of the PDK/Akt signalling 
pathway has been implicated in the activation of the p70 ribosomal s6  protein kinase 
(p70s6k). However, the initial step in p70s6k activation appears to involve a 
phosphorylation-induced conformational change in the C-terminus of the kinase 
domain, revealing additional phosphorylation sites. The activation of MAP-kinase has 
been implicated in this initial phosphorylation event (53).
Other effector molecules that bind to IRS proteins include the Grb2/SOS 
complex, which bind p21ras to activate the Mitogen Activated Protein Kinase (MAPK) 
cascade (Erkl/Erk2). Activation of the MAPK cascade leads to phosphorylation and
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activation of various transcription factors (ie. elkl, c-fos) which then mediate the 
mitogenic effects of insulin.
1.6.2 Leptin receptor signalling cascade
The leptin receptor was first isolated from the mouse choroid plexus using an 
expression cloning strategy (54). It does not have homology to the insulin receptor but 
belongs to the cytokine receptor family and consists of a single membrane spanning 
domain. Alternative splicing of the LepR gene results in the expression of at least six 
leptin receptor isoforms, Ob-Ra, OB-Rb, Ob-Rc, Ob-Rd, Ob-Re and Ob-Rf (Fig 1.5). 
These isoforms are expressed in a tissue-specific manner, having an identical 
extracellular ligand-binding domain at the amino terminus but differ from one another 
at the carboxy terminus. Five isoforms, Ob-Ra, Ob-Rb, Ob-Rc, Ob-Rd, and Ob-Rf 
have transmembrane domains; with the Ob-Rb (the long receptor isoform) believed to 
be the primary receptor that mediates leptin-induced signal transduction (55). 
However, several studies have reported that short isoforms of the receptor are capable 
of mediating signal transduction (56-58) (see below). Upon leptin binding the receptor 
recruits and activates a member of the janus kinase (Jak) family, primarily Jak2 (59). 
Once activated, Jak molecules phosphorylate the intracellular domain of the leptin 
receptor, creating a binding site for the signal transducers and activators of transcription 
(STAT) molecules. In response to leptin stimulation, activated STAT-3 translocates to 
the nucleus where it functions as a transcription factor (59). Intracellular negative 
feedback to this signalling system is provided by a family of suppressor of cytokine 
signalling (SOCS) molecules that are synthesized in response to STAT-3 activation 
following leptin stimulation. Leptin receptor activation is also known to activate ERK- 
regulated pathways (59) (Fig 1.5).
The fact that STAT-3 can also be activated by a number of cytokines, 
suggests that it may not play a primary role in leptin function. However, the importance 
of STAT-3 signalling in relation to leptin’s effects upon energy balance in vivo, in mice 
was demonstrated by the ablation of tyrosine phosphorylation at Tyr1138, by the 
replacement of the Tyr1138 residue with a serine residue on the leptin receptor (Y1138S 
mutant mice).
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Figure 1.5 Leptin signalling cascade
There are at least six leptin receptor isoforms, Ob-Ra, OB-Rb, Ob-Rc, Ob-Rd, Ob-Re and 
Ob-Rf. The long form the Ob-Rb receptor contains intracellular motifs required for activation of 
signal transducer and activator of transcription 3 (STAT-3) molecules. Upon leptin binding the 
receptor recruits and activates a member of the janus kinase (Jak) family, primarily Jak-2 (59) 
Activated, Jak molecules phosphorylate the intracellular domain o f the leptin receptor, at Tyrosine 
residues 985 and 1138. Phosphorylation at Tyr985 leads to activation o f ERK signalling pathway via 
recruitment o f SH2-containing tyrosine phosphatase (SHP-2), whilst phosphorylation at Tyrll38 
leads to recruitment and activation of STAT-3 molecules. In response to leptin stimulation, activated 
STAT-3 translocates to the nucleus where it acts as a transcription factor, activating leptin-dependent 
gene transcription (59). Negative feedback to leptin signalling is achieved by the Suppressor of 
Cytokine Signalling 3 (SOCS3) molecules binding to phosphorylated Tyr985 residues on the leptin 
receptor.
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Phosphorylation at this site is known to be essential for the recruitment and activation 
of STAT-3 (60-62). Interestingly, like mice lacking the leptin receptor (db/db mice), 
Y1138S mutant mice are hyperphagic and obese (63).
However whereas db/db mice are infertile, short and diabetic, Y1138S mutant 
mice are fertile, long and less hyperglycaemic (63). Moreover, hypothalamic 
expression of neuropeptide Y (NPY) is elevated in db/db mice but not Y1138S mutant 
mice. In contrast, the hypothalamic melanocortin system is suppressed in both db/db 
and Y1138S mutant mice (63). These findings suggest that LRb-STAT-3 signalling 
mediates the effects of leptin on melanocortin production and body energy homeostasis, 
whereas distinct LRb signals regulate NPY and the control of fertility, growth and 
glucose homeostasis. Interestingly, mice lacking STAT-3 expression specifically in the 
liver, show insulin resistance associated with increased hepatic expression of 
gluconeogenic genes (64). Thus highlighting an important role for STAT-3 in the 
regulation of hepatic gluconeogenic gene expression and carbohydrate metabolism 
(64). Indeed restoration of STAT-3 expression in these mice, using adenovirus- 
mediated gene transfer, corrected the metabolic abnormalities and the alterations in 
hepatic expression of gluconeogenic genes (64).
1.6.3 Signals generated by the short-isoforms of the leptin receptor:
The soluble leptin receptor isoform (ObRe) does not play a direct role in 
leptin signalling but is likely to be important in determining the amount of circulating 
free leptin (65). Indeed, the proportion of leptin circulating in the free and protein- 
bound form may be an important physiological determinant of leptin action (66). 
Considering the other leptin receptor isoforms, whereas the ObRb long-isoform 
contains an intracellular domain of approximately 306 amino acids, the short-isoforms 
contain an intracellular domain ranging between 32-40 amino acids. However common 
between these receptor isoforms is an identical 29 amino acid sequence, containing a 
“Box 1” Janus-family tyrosine kinase (JAK) binding domain in the juxtamembrane 
region (as shown in Fig 1.5). In addition to this “Box 1” JAK-binding domain, the 
ObRb isoform also contains a “Box 2” motif. As described above this region has been
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shown to be essential for leptin to recruit and activate the STAT-3 transcription factor 
(59).
Interestingly, expression of ObRb is highest in the hypothalamus (67), yet, it 
is also found in many peripheral tissues at lower levels (68, 69). In contrast, the ObRa 
isoform is expressed fairly ubiquitously and represents the major isoform of many 
peripheral tissues (67, 70). However, it should be noted that examination of ObR 
isoform expression by RT-PCR has often been inconsistent (71).
Although the ObRb long-isoform receptor has been proposed as the 
“signalling isoform”, there is clear evidence that the short receptor isoforms are capable 
of initiating signal transduction, even showing divergent signalling capacities (57, 58, 
72). Indeed the mechanism underlying the stimulation of PI3K by leptin often involves 
phosphorylation of the IRS proteins. In some cells (57, 72-74), but not all (75) leptin 
can induce phosphorylation of IRS proteins, often via the activation of JAK proteins. 
For example, tyrosine phosphorylation of IRS-1 was increased by leptin in HEK293 
cells coexpressing the long or short form of leptin receptor, with JAK2 and IRS-1 (57). 
It has also been demonstrated that leptin increased PI3K activity in C2C12 cells via a 
JAK2- and IRS-2-dependent mechanism (72). Indeed, the activation of PI3K by either 
long or short form leptin receptor mechanisms may be an important potential point of 
crosstalk between the insulin and leptin signalling pathways (see below).
7.7 Murine models of obesity and type 2 diabetes: insights into leptin and 
insulin signalling
Much of our current understanding of both the cellular and molecular 
activities of leptin and insulin has been derived from studies of murine models of 
obesity and diabetes. These models include spontaneously occurring mutants as well as 
a variety of models generated either by transgenic or gene-targeting approaches. The 
use of such models has been reviewed extensively elsewhere (38, 76) and for the 
purposes of this thesis, only models utilised in the current studies will be described in 
detail.
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1.7.1 Ob and db mice: spontaneous mouse mutants of leptin action
Recessive mutations in the mouse obese (ob) and diabetes {db) genes result in 
obesity and later develop diabetes in a syndrome that resembles morbid human obesity 
(77, 78). ob/ob mice maintained on the C57B1/6J genetic background arise due to a 
non-sense mutation in the leptin gene, which results in a truncated protein that is 
degraded in the adipocyte (21). Similarly, a spontaneous G to T point mutation in the 
genomic ObRb sequence in db/db mice, results in the generation of a donor splice site 
that converts a 106 nucleotide region to a novel exon retained in the ObRb transcript 
(79). This splice variant creates a premature stop codon resulting in a truncated protein 
resembling the ObRa receptor isoform and hence loss of Jak-STAT box binding motifs.
Both ob/ob and db/db mice have similar phenotypes, each weighing up to 
three times more than normal mice (even when fed the same diet) and both exhibit a 
five-fold increase in body fat content. The ob/ob mice show many of the abnormalities 
seen in starved animals, including decreased body temperature, hyperphagia, decreased 
energy expenditure (including activity), decreased immune function, and infertility 
(77). Administration of leptin to ob/ob mice corrects all of these abnormalities, 
implying that ob/ob mice exist in a state of “perceived starvation” and that the resulting 
biological response in the presence of food leads to obesity, db/db are resistant to the 
effects of leptin implicating the long-form of the receptor in mediating the 
physiological actions of this hormone.
Initial findings in ob/ob mice implicated leptin as a satiety factor that 
potentially could act as an anti-obesity drug. However the fact that most cases of 
obesity are associated with high circulating leptin levels indicated that leptin resistance 
contributes significantly to the obese phenotype. Indeed the role of leptin is now 
considered to be far more complex, acting as a messenger between the CNS and 
periphery to report whole-body energy status. More recently leptin receptors have been 
deleted specifically in POMC neurons in mice. These mice were mildly obese, 
hyperleptinemic, and had altered expression of hypothalamic neuropeptides (80). This 
finding highlights the importance of leptin receptors in POMC neurons. However the
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milder obesity suggests that leptin action in other neuronal populations is essential for 
complete regulation of body weight homeostasis.
1.7.2 fi-HypSTA T3KO mice
The importance of leptin signalling in the regulation of energy homeostasis 
has been further demonstrated by the deletion of STAT-3 specifically in the P-cell of 
mice (|3-HypSTAT3KO) (81, 82). Deletion was achieved by using a transgene 
expressing Cre-recombinase driven by the rat insulin promoter. These mice were 
glucose intolerant as early as five weeks of age as a result of a deficiency in early-phase 
insulin secretion. In addition (3-HypSTAT-3KO mice also displayed impaired islet 
morphology, with a-cells frequently appearing in central regions of the islets (81, 82). 
Unexpectedly, these mice also exhibited partial leptin resistance, becoming 
hyperphagic and obese at eight weeks of age or older. This impairment to appetite 
control is believed to result from the expression of the rat insulin II promoter (RlP)-cre 
transgene in the hypothalamus, leading to deletion of STAT-3 in hypothalamic regions 
implicated in the control of food intake (81, 82).
1.7.3 Insulin receptor substrate (IRS) 2 knockout mice
Another murine model that results in the development of an insulin resistant 
metabolic phenotype is the insulin receptor substrate 2 knockout mouse (83). These 
mice were generated by standard murine gene targeting strategies and lack expression 
of lrs-2 in all tissues. Irs-2 null mice exhibit mild peripheral insulin resistance and (3- 
cell deficiency at birth but have adequate compensatory insulin secretion for several 
weeks. However, subsequent relative (3-cell failure in the face of continued peripheral 
insulin resistance causes overt fasting hyperglycaemia without ketoacidosis, the 
common characteristic of human type 2 diabetes (5). As well as developing a diabetic 
phenotype, global deletion of lrs-2 also results in an increase in food intake, this being 
particularly evident in female mice. Deletion of lrs-2 also causes an increase in fat 
stores despite elevated plasma leptin levels. These findings not only suggest the
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presence of CNS leptin resistance but also suggest that insulin action in the CNS or that 
components of the insulin signalling pathways are also necessary for intact neuronal 
responsiveness to leptin. Indeed, STAT-3 phosphorylation in response to leptin is 
defective in lrs-2 null mice suggesting some signalling convergence between leptin and 
insulin (84). Such findings support the notion that lrs-2 may act as a convergence point 
for insulin and leptin signalling in the CNS. The demonstration of a role for insulin 
signalling pathways in the central regulation of energy homeostasis has also been 
supported by deletion of the insulin receptor in the brain of mice (31), which also 
resulted in mice with pathological expansion of fat stores despite elevated leptin levels. 
Furthermore, both lrs-2 null mice and brain-specific insulin receptor null mice have 
defects in reproductive function (84). Infertility is a significant feature of the phenotype 
of ob/ob and db/db mice as described above. Taken together, these findings have 
therefore added increased evidence for convergence in the physiological roles of insulin 
and leptin upon the central regulation of energy homeostasis.
1.7.4 P-HyplRS2KO mice
Recently, our laboratory and others have attempted to address the importance 
of P-cell autonomous IRS-2 dependent signalling by generating mice lacking IRS-2 
specifically in (3-cells. Firstly, mice were generated in which both alleles of the lrs-2 
gene were floxed (flanked by LoxP DNA recombination sites). Once generated these 
mice were bred with the rat insulin II promoter (RlP)-cre transgenic mice (as described 
above for P-HypSTAT3 KO mice). This transgenic mouse had previously been used to 
delete a number of floxed alleles in the pancreatic p-cell (85, 86). However early 
analysis of these mice revealed that they had an obvious hypothalamic phenotype. 
Further examination of the distribution Cre-recombinase was determined using ZEG 
fluorescent indicator mice and showed that in addition to the P-cell, Cre was also 
expressed in a population of neurons within the hypothalamus (87-89). It was noted 
that p-HypIRS2KO mice progressively developed glucose intolerance and pancreatic 
morphometric analysis showed that by 12 weeks of age they had a 40% reduction in 
islet mass and number compared to controls mice (87). In contrast to lrs-2 null mice, P-
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HypIRS2KO mice did not develop marked fasting blood glucose levels, P-cell failure 
and a progressive diabetic phenotype.
These findings demonstrate that intrinsic P-cell IRS-2 signalling pathways are 
important for islet function and in particular the development and maintenance of p-cell 
mass. Although P-cell-specific deletion of IR or IGF-1R in mice did not result in such 
a profound defect in p-cell mass, their combined p-cell-specific deletion has not been 
reported. It follows that IRS-2 could either mediate the combined effects of these 
receptors upon islet function or the actions of other, as yet uncharacterised receptors 
upon P-cell mass (87). Moreover the resulting obesity phenotype in these mice 
implicates IRS-2 signalling pathways as being important in hypothalamic function.
1,8 Peripheral metabolic actions of leptin and insulin
It is evident from such physiological studies that insulin and leptin have 
complex and often convergent physiological roles in the regulation of whole body 
energy homeostasis (19). For example, both leptin and insulin have been implicated in 
regulating p-cell function. Leptin has been shown to modulate insulin secretion 
reducing its release (90, 91). Insulin signalling mechanisms have been shown to 
regulate insulin production and secretion and regulate p-cell development and growth 
(85, 92). Cross talk between insulin and leptin is complex with their relative sensitivity 
in one metabolic tissue having dramatic effects upon their sensitivity in other tissues. 
More recently it has been suggested that insulin and leptin utilise common signal 
transduction processes to mediate their physiological effects (16, 19).
I will now review the evidence for insulin and leptin interaction in each of the 
major peripheral metabolic tissues. I will then describe some of signalling 
intermediates that have been shown to mediate insulin and leptin action, highlighting, 
the potential for direct interaction between insulin and leptin signalling.
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1.8.1 Skeletal muscle
The accumulation of lipid deposits in non-adipose tissues, termed 
“lipotoxicity”, is suggested to be a major cause of insulin resistance and other 
complications associated with obesity. Leptin has a protective effect against 
lipotoxicity in non-adipose tissues (93, 94). Leptin may regulate lipid metabolism by 
promoting the oxidation of fatty acids, rather than their storage (94).
Both in vitro and in vivo studies have highlighted the importance of leptin in 
promoting muscle fatty acid (FA) oxidation (93, 95). In contrast, exposure to insulin 
had the opposite effect upon muscle FA metabolism, reducing FA oxidation and 
promoting Triacylglyceride (TAG) synthesis. Interestingly, when both hormones were 
added together, leptin could attenuate insulin’s antioxidative and lipogenic effects upon 
lipid utilization (95, 96). How leptin exerts its effects upon lipid metabolism is still not 
fully understood. As described above the AMP-activated protein kinase (AMPK) has 
been identified as a principle mediator of leptin’s effects on fatty-acid metabolism in 
muscle. However the activation of AMPK can occur through both direct and indirect 
actions of leptin upon skeletal muscle, suggesting a complex role for AMPK in 
mediating the effects of leptin on fatty-acid metabolism.
In humans, skeletal muscle is the primary site of insulin-dependent glucose 
disposal (97). Resistance of skeletal muscle to insulin-dependent glucose uptake and 
phosphorylation is an early step in the development of type 2 diabetes (98). 
Surprisingly, conditional deletion of the insulin receptor in the muscle of mice (Muscle 
Insulin Receptor Knockout (MIRKO)) led to impaired insulin signalling and decreased 
insulin-dependent glucose transport but did not result in systemic insulin resistance 
(99). Two alternative pathways of glucose uptake that compensate for the decreased 
insulin receptor signalling are thought to prevent the development of systemic insulin 
resistance. These are Igflr (100) and contraction-activated signalling (101), the latter 
acting again through AMPK.
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1.8.2 Adipose tissue
Adipose tissue had traditionally been considered to function as an energy 
store, for times of energy depletion (ie. during times of starvation). However, the 
identification that a number of hormonal substances (including leptin) were synthesised 
and secreted mainly from adipocytes, suggested that adipose tissue represented an 
important endocrine organ, being capable of regulating a number of physiological and 
pathophysiological conditions, such as satiety, energy expenditure, insulin sensitivity, 
glucose homeostasis (102).
As described above it is clear that leptin deficiency in the ob/ob mouse, which 
results in massive obesity, is associated with insulin resistance. However, it has also 
been shown that in two distinct lipodystrophic murine models, leptin deficiency 
resulting from a lack of white adipose tissue can also lead to severe insulin resistance 
(103, 104).
The insulin-regulated transcription factor Sterol regulatory element binding 
protein-lc (SREBP-lc), is known to activate the transcription of multiple genes, 
including those encoding enzymes responsible for the synthesis of cholesterol and fatty 
acids in cells (105). In aP2-SREBP-lc (1-436) mice, a transgene expresses a truncated 
dominant-positive fragment of SREBP-lc (amino acids 1-436) under control of the fat- 
specific aP2 promoter. Unexpectedly, this truncated form of the SREBP-lc interferes 
with adipose tissue differentiation, creating a syndrome similar to that of congenital 
lipodystrophy in humans. The lack of white adipose tissue in these animals leads to a 
marked reduction in circulating leptin levels, leading to hyperphagia, hyperglycaemia 
and insulin resistance (14). Moreover, these lipodystrophic mice contained fatty livers, 
similar to those seen in ob/ob mice. Interestingly, such abnormalities in the liver and 
plasma of these lipodystrophic mice, like those of the ob/ob mice, can be reversed by 
the peripheral administration of recombinant leptin (106). Indeed, restoration of 
physiologic leptin levels over a 12-day period led to a decline in plasma insulin and 
glucose levels to normal, and the excess hepatic fat largely disappeared (106). Similar 
findings have been found in human subjects with lipodystrophy.
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The adipose hormone adiponectin has recently been implicated in the 
regulation of insulin sensitivity. Indeed both the mRNA expression of adiponectin and 
its plasma levels are significantly reduced in obese/diabetic mice and humans (107, 
108). It has also been demonstrated that these reduced expression levels of adiponectin 
coincide with insulin resistance in murine models of altered insulin sensitivity. 
Furthermore, treatment with physiological doses of adiponectin improved insulin 
resistance in mouse models of lipoatrophy and obesity (109). Such observations 
suggest that leptin or other adipose tissues products such as adiponectin or the hormone 
resistin may play roles in the regulation of insulin sensitivity, potentially acting in 
peripheral tissues or the CNS.
Despite adipose tissue accounting for only -10% of glucose uptake (110, 
111), it is a major site of insulin action. Insulin is known to act upon adipocytes to 
promote adipogenesis, stimulate glucose uptake and lipid synthesis, and inhibit 
lipolysis (112). In particular it is believed that insulin can act upon adipose tissue to 
regulate both the production and secretion of leptin (113).
Specific deletion of the insulin receptor in both white and brown fat (Fat 
Insulin Receptor Knockout (FIRKO)) in mice, resulted in a -50% reduction in fat pad 
mass and a -30% decrease in whole body triglyceride content, with normal circulating 
lipids, free fatty acids and glycerol levels. Moreover, FIRKO mice are resistant to 
gaining weight during aging or following induction of a hypothalamic lesion leading to 
hyperphagia. Consequently these mice display normal glucose tolerance and fail to 
develop impaired glucose tolerance despite hyperphagia (114). A further observation 
of FIRKO mice is that they exhibit inappropriately high leptin levels for their reduced 
fat mass.
The importance of insulin signalling in adipose tissue was further 
demonstrated by the generation of mice with combined global deletions for IRS-1 and 
IRS-3. These mice developed early-onset severe lipoatrophy associated with marked 
hyperglycaemia, hyperinsulinaemia and insulin resistance (115). These findings 
indicate that IRS-1 and IRS-3 have important complementary roles in adipogenesis. 
Interestingly, adenovirus-mediated expression of leptin in the livers of these mice
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reversed the hyperglycaemia and hyperinsulinaemia, highlighting the complex interplay 
between leptin and insulin sensitivity.
1.8.3 Liver
The liver plays a central role in the control of glucose homeostasis and is 
subject to complex regulation by insulin and leptin (116-118). Insulin acts upon the 
liver to suppress glucose output by inhibiting glycolysis and gluconeogenesis. Insulin 
resistance in the liver and, in particular, the loss of the ability to suppress hepatic 
glucose output are closely linked to fasting hyperglycaemia in type 2 diabetes. Liver- 
specific deletion of the insulin receptor in mice (LIRKO mice) results in severe insulin 
resistance and overt glucose intolerance as early as two months of age (118). The 
ability of insulin to inhibit gluconeogenesis could be due to a direct effect of insulin on 
the liver, or could arise due to secondary effects of insulin action on muscle and fat, 
leading to a reduction in the supply of gluconeogenic precursors. The observation that 
LIRKO mice are resistant to the actions of exogenous insulin to suppress hepatic 
glucose production, whilst presumably suppressing lipolysis and the release of 
gluconeogenic precursors from muscle and fat, indicates that the direct effects of 
insulin on the liver are important in regulating gluconeogenesis in wild-type animals.
Assessment of insulin signalling in the livers of ob/ob mice demonstrated a 
significant reduction in the expression of both IRS-1 (29%) and IRS-2 (72%). 
Moreover this reduction led to a differential decrease in hepatic IRS-1 and IRS-2 
phosphorylation, binding of the p85a regulatory subunit of PI3-Kinase, and the 
activation of PI3-Kinase in the livers of ob/ob mice (119).
As described above, mice with too little fat (lipodystrophy) or too much fat 
{ob/ob), display insulin resistance. In both these disorders, the liver overproduces 
glucose as a result of resistance to the actions of insulin to inhibit hepatic 
gluconeogenesis. Shimomura et al, utilised aP2-SREBP-lc and ob/ob mice to examine 
hepatic gene expression and explore how hepatic insulin signalling is effected by these 
insulin resistant states. The livers of both aP2-SREBP-lc and ob/ob mice exhibit both 
decreased IRS-2 mRNA expression and insulin stimulated Akt activity. Despite the 
decrease in IRS-2 expression and decreased levels of phosphorylation of Akt, insulin
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continues to increase the mRNA for SREBP-lc in the liver, suggesting that insulin 
activates SREBP-lc by an IRS-2 independent pathway. Furthermore, this alternative 
pathway allows insulin to continue to stimulate SREBP-lc activity and lipogenesis in 
the livers of insulin-resistant animals. Increased lipogenesis, in addition to the 
inappropriate gluconeogenesis caused by insulin resistance creates a vicious cycle that 
increases insulin secretion and hence aggravates insulin resistance. More recently, it 
has been reported that SREBP molecules are actually capable of directly repressing the 
transcription of IRS-2 and inhibiting glycogen synthesis (120). Interestingly, the livers 
of lrs-2 null mice are reported to exhibit increased hepatic SREBP-1 gene expression 
(121). Moreover, increased expression was also noted in genes downstream of SREBP- 
1, many of which are involved in fatty acid synthesis (121). These findings provide a 
molecular mechanism for the physiological switching from glycogen synthesis to 
lipogenesis and hepatic insulin resistance that is associated with hepatosteatosis.
The above findings implicate liver as an important site of interaction between 
insulin and leptin action. Dysregulation of insulin or leptin signalling endogenous to 
the liver can lead to dramatic alteration in peripheral insulin sensitivity.
1.8.4 Pancreatic 0-cells
Both ob/ob and db/db mice exhibit hyperinsulinaemia even prior to 
development of their obese and diabetic phenotypes (122-124) suggesting that 
functional leptin signalling is important in the regulation of insulin sensitivity. The 
observation that mRNA of the long isoform (ObRb) of the leptin receptor was 
expressed in high abundance in the pancreatic islets of rodents (125), indicated that 
leptin might actually contribute to islet function. Interestingly functional leptin 
receptor expression (including ObRb) has also been demonstrated in p-cells derived 
from human pancreatic islets (126).
More recently both in vitro and in vivo assays of P-cell function have 
suggested that leptin may regulate insulin release, acting to suppress insulin secretion 
(90, 91, 127). However the exact effects of leptin upon insulin secretion are unclear at 
present, as most studies have yielded conflicting results (113). The inhibitory actions
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of leptin upon insulin secretion appear to be determined by body fat stores. As 
previously mentioned, insulin can stimulate both leptin biosynthesis and secretion from 
white adipose tissue. This effect creates an endocrine adipo-insular feedback loop 
between the P-cell and fat tissue (Fig 1.6).
The adipo-insular axis is thought to play an important role during the 
development of type 2 diabetes in obese patients. During the development of this 
disease, hyperinsulinaemia is thought to represent a compensatory response of the 
pancreatic P-cells to peripheral insulin resistance (128, 129), and hyperglycaemia a 
consequence of pancreatic P-cell failure.
However, it has also been demonstrated that hyperinsulinaemia often precedes 
the development of insulin resistance, suggesting that obesity-induced insulin resistance 
might not fully explain the development of type 2 diabetes. For example, in obese 
subjects, resistance to the actions of leptin on the pancreatic P-cell could result in 
dysregulation of the adipo-insular axis, leading to increased insulin production and 
eventually a state of hyperinsulinaemia. Hyperinsulinaemia could then further promote 
insulin resistance, whilst increasing leptin production and secretion from adipose tissue. 
Increased circulating levels of leptin would then be likely to enhance leptin resistance 
of the P-cells, creating a vicious cycle that encourages the manifestation of type 2 
diabetes.
It is now clear that insulin also acts on the pancreatic P-cell, with insulin 
receptor signalling being implicated in the regulation of insulin synthesis and secretion 
by the P-cell (85). The studies described above on lrs-2 null mice have shown that Irs- 
2 is required for the p-cell compensatory response to insulin resistance and may 
mediate the effects of insulin-like growth factor 1 upon islet function (92). 
Furthermore, it has been demonstrated that mice with P-cell specific deletion of the 
insulin receptor have defects in insulin secretion and develop glucose intolerance (85).
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Figure 1.6 Dysregulation o f the adipo-insular axis and pathogenesis o f type 2 
diabetes
A). In leptin-sensitive individuals, leptin is secreted from adipocytes and acts upon the pancreatic P-cells 
to suppress insulin secretion, regulating glucose homeostasis in accordance with body fa t stores. B) In 
leptin-resistant obese individuals, diminished leptin signalling in pancreatic P-cells leads to 
hyperinsulinaemia. Elevated insulin levels promote both insulin resistance and increased leptin 
biosynthesis and secretion from adipose tissue, which may further desensitize leptin signalling in the 
endocrine pancreas and increase leptin resistance. Hypersecretion o f insulin could eventually result in 
P-cell failure and the manifestation of type 2 diabetes.
43
Leptin signal transduction elements such as STAT-3 have also been shown to 
be activated in pancreatic islet cell lines in response to insulin. The recent deletion of 
STAT-3 specifically in the (3-cell of mice has demonstrated the importance of this 
transcription factor in (3-cell development and function (81, 82).
1.9 Convergence of insulin and leptin signalling pathways
In addition to the above physiological studies, there are several lines of 
evidence to support the hypothesis of cross-talk between insulin and leptin signalling 
pathways in the control of glucose homeostasis, body adiposity and reproductive 
function. A potential site of intracellular interaction for both insulin and leptin action 
involves the enzyme PI3K. Although generally considered a downstream effector of 
IRS-1 and IRS-2 signalling, studies in hepatocyte cell lines, have demonstrated that 
leptin enhanced insulin-induced association of IRS-1 with PI3K and increased PI3K 
activity per se (73). Assessment of IRS-mediated PI3K signalling in the liver and 
muscle of ob/ob mice indicated that these mice exhibited reduced Irs-1 and lrs-2 
expression, leading to a differential decrease in IRS/PI3K signalling in these tissues 
(119). Subsequent studies in hepatocytes, demonstrated that leptin activates PI3K via 
tyrosine phosphorylation of IRS-1 and IRS-2 leading to activation of downstream 
targets such as PKB and phosphodiesterase 3B (PDE3B) (130). Thus, leptin action in 
hepatocytes appears to involve signalling through IRS-PI3K pathways.
The central actions of leptin may also be mediated through PI3K signalling. 
Electrophysiological experiments investigating the effects of leptin on hypothalamic 
neurons in rat brain slice cultures, showed that leptin caused a population of 
hypothalamic neurons in the arcuate and ventromedial nuclei to hyperpolarize through 
the activation of ATP-sensitive K+ channels (131). The same population of neurons 
were also hyperpolarized by insulin, indicating that the acute cellular effects of insulin 
and leptin might converge. Hence, an intracellular signalling pathway might exist in 
which activation of PI3K is the target not only of insulin signalling, but also of leptin 
signalling (Fig 1.7). In support of this model, the ability of insulin to regulate the firing 
of certain arcuate nucleus neurons is blocked by inhibitors of PI3K (132). Blocking of 
neuronal PI3K signalling, in vivo, using a specific PI3K inhibitor, resulted in complete
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Figure 1.7 Potential cross-talk between insulin and leptin intracellular signalling via 
the enzyme, phosphoinositide 3-kinase (PI3Kinase)
The insulin receptor tyrosine kinase catalyzes the tyrosine phosphorylation o f the 
insulin receptor substrate-2 (IRS-2) protein, which associates with PI3Kinase, resulting 
in activation o f PI3Kinase enzyme activity and downstream signal transduction. It is 
hypothesized that JAK-2 can act through a similar, IRS-dependent mechanism to 
activate P13Kinase. Both the leptin and insulin receptors interact with numerous other 
signal transduction pathways that are not shown but could be involved in the 
regulation o f energy homeostasis (Adapted from (16)).
45
prevention of leptin-induced anorexia, as compared with control animals given a 
vehicle injection (132). It is evident that reduced PI3K signalling is a key factor that 
underlies insulin resistance in the periphery. Similar mechanisms could be mirrored in 
the brain, where resistance to both leptin and insulin at the level of PI3K might 
contribute to the onset of both obesity and diabetes.
A further potential site of convergence of leptin and insulin action in the 
regulation of glucose and energy homeostasis is the AMP-activated protein kinase 
(AMPK). This family of heterotrimeric enzymes are activated by cellular 5’ AMP 
levels and the LKB1 tumour-suppressor protein. Physiological stimuli that activate 
AMPK include skeletal muscle contraction and the peptide hormones leptin (see above) 
and adiponectin (34, 133). The findings that the system is activated by exercise, and by 
adipocytokines involved in the control of appetite, body weight and insulin sensitivity 
point to its potential importance in energy homeostasis and as a point of convergence of 
insulin and leptin action.
Numerous in vitro studies have demonstrated the suppressor of signalling 3 
(Socs3) is a negative regulator of leptin signalling (134, 135). Peripheral leptin 
administration to mice rapidly induces Socs3 mRNA in hypothalamic regions (135). It 
has been proposed that Socs3 binds to the activated leptin receptor via its Src 
homology-2 (SH2) domain and inhibits Jak tyrosine kinase activity through its N- 
terminal kinase inhibitory region, which functions as a pseudo-substrate (135-137). 
Evidence from in vitro studies has suggested that Socs3 achieves feedback inhibition by 
binding to Tyr985 of the leptin receptor. Moreover, deletion of Socs3 expression in the 
brains of mice, results in elevated leptin sensitivity and resistance to diet-induced 
obesity (138). This finding demonstrates the ability of Socs3 to negatively regulate 
leptin signalling in vivo and indicates that suppression of Socs3 in the brain could be of 
therapeutic value for leptin resistance in obesity. Interestingly, Socs3 has also been 
implicated as a physiological regulator of insulin signalling in adipocytes. Findings 
from 3T3-L1 adipocytes deficient for Socs3 showed these adipocytes had an increased 
IRS-associated PI3K activity (139). In addition lack of Socs3 substantially limited the 
inhibitory effects of tumour necrosis factor-a to suppress IRS-1 and IRS-2 tyrosine 
phosphorylation, PI3K activity, and glucose uptake in adipocytes (139). Such 
observations would suggest that endogenous Socs3 expression is a determinant of basal
46
insulin signalling in adipocytes and therefore may play an important role in mediating 
cytokine-induced insulin resistance in the adipocyte. Taken together these findings 
both in vitro and in vivo highlight the importance of Socs3 and implicated it as a 
potential mediator of both insulin and leptin signalling.
1.10 Summary
Insulin and leptin have complex and convergent physiological roles in the 
regulation of whole body energy homeostasis (19). Leptin is thought to predominantly 
work in the central nervous system to regulate adiposity through the control of food 
intake and energy expenditure. Insulin is primarily considered to act in insulin-sensitive 
peripheral tissues such as skeletal muscle, adipose tissue and liver, regulating glucose 
and lipid metabolism.
In addition to these roles both hormones have been implicated in regulating 
additional physiological processes. For example, insulin also serves as an adiposity 
signal acting upon the same CNS mechanisms as leptin (16). Both leptin and insulin 
have been implicated in regulating p-cell function. Leptin has been shown to modulate 
insulin secretion reducing its release (90, 91). Insulin signalling mechanisms have been 
shown to regulate insulin production and secretion and regulate P-cell development and 
growth (85, 92).
The interactions of insulin and leptin are often complex and involve a number 
of different physiological systems in different tissues. The murine models described 
above have given some insights into the overlapping roles of these two hormone- 
signalling pathways. Cross-talk between insulin and leptin can occur at an organ to 
organ level, for example, it is known that the livers of ob/ob mice exhibit reduced lrs-2 
gene expression (119). Similar to ob/ob mice, lrs-2 null mice are infertile, hyperphagic 
and develop obesity associated with hyperleptinemia and leptin resistance. No such 
phenotype has been noted in animals null for any of the other IRS proteins (39).
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Moreover it has been suggested that insulin and leptin utilise common signal 
transduction processes to mediate their physiological effects. For example, in mice with 
targeted disruption of Irs2, leptin-stimulated STAT-3 phosphorylation is impaired (84). 
Similarly, blockade of PI3K activity abrogrates leptin-mediated hyperpolarization and 
inhibition of LRb/NPY/AgRP hypothalamic neurons (74, 131). Furthermore, leptin 
stimulates IRS-2-associated PI3K activity in the hypothalamus and pharmacological 
blockade of PI3K activity in the hypothalamus blocks the anorectic effect of leptin in 
vivo (132). Importantly, inhibition of PI3K does not alter the anorectic effect of 
melanocortin agonists that operate downstream of LRb expressing neurons, suggesting 
that this effect of PI3K blockade is specific for LRb expressing neurons. More recently 
it has been demonstrated that PI3K activity is also required for leptin-regulated 
sympathetic nervous system function (140).
Moreover, as in vivo (132), it has recently been observed that LRb stimulation 
mediates the tyrosine phosphorylation of IRS proteins and activation of the PI3K 
pathway in cultured cells. This signal is mediated by Jak2 independently of tyrosine 
phosphorylation sites on LRb (141).
The recruitment of IRS proteins/PI3K by Jak2 is less robust than by the insulin 
receptor, however. Indeed, animals with decreased expression of neuronal insulin 
receptors (Neuronal Insulin Receptor Knockout (NIRKO) mice) display a modest 
obesity phenotype, similar to that seen in lrs-2 null mice (31). Also, insulin activates 
the IRS-2/PI3K pathway in the hypothalamus and PI3K activity is also required for the 
anorectic activity of insulin in the brain (132).
Furthermore, as described above the deletion of either IRS-2 or STAT-3 
function specifically in the p-cell and hypothalamus has demonstrated the importance 
of these intrinsic pathways to regulate the development and maintenance of P-cell mass, 
whilst highlighting the importance of insulin and leptin sensitivity in p-cell function 
(81, 82, 88, 89).
Therefore it has been suggested that IRS2/STAT-3 signalling pathways 
potentially act as one site of convergence for insulin and leptin action. Studies have 
suggested that a linear relationship exists between IRS-2 and STAT-3, with IRS-2 
being upstream of the events that lead to the phosphorylation of STAT-3. This would 
lead to the model outlined in figure 1.8.
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Figure 1.8: Insulin receptor substrate-2 may act as a potential site o f convergence for  
insulin and leptin signalling pathways
1RS-2/P13K signals may regulate the activation o f STATS, thereby mediating the 
effects o f insulin and leptin upon energy homeostasis
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To address the interaction between insulin and leptin signalling and in 
particular to;
1). Examine the physiological interplay at the whole organism level.
2). The interaction at the signalling level in specific tissues.
I have undertaken the following lines of investigation.
1). Generation of mice lacking systemic Irs-2 gene function in combination with loss 
of either leptin production (ob/ob) or leptin action (db/db):
To examine the possible interaction between insulin and leptin signalling 
pathways in whole animal physiology, I have combined Irs-2 null mice with mice 
defective for either leptin production (ob/ob) or action (db/db). In addition to these two 
double knockout mouse models, mice will have been derived that contain various 
combinations of these genes. The study of these mice will provide insights into any 
gene dosage effects to whole animal physiology. Once generated I have studied these 
various genotypes for the following parameters;
• Body and tissue weights.
• Glucose metabolism.
• Pancreatic (3-cell function.
• Assessment of insulin signalling pathways in peripheral metabolic tissues.
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2). Generation of mice lacking Irs-2 and Stat-3 gene function specifically in the f$- 
cell and hypothalamus of mice:
To address the roles of IRS-2 and STAT-3 in the (3-cell and hypothalamus, I 
have generated mice with a combined deletion for IRS-2 and STAT-3 in only their 13- 
cells and hypothalamus ((3-HypIRS2+STAT3KO mice). Assessment of the above 
parameters in (3-HypIRS2+STAT3KO mice would provide insight into the relationship 
between these proteins within insulin and leptin signalling specifically in the |3-cell and 
hypothalamus. This would potentially investigate directly the intrinsic role of these 
molecules in these specific tissues.
Insulin resistance and leptin resistance coexist in obese subjects. Studies on 
such murine models may give insights into the contribution of these processes to the 
obese phenotype and its association with insulin resistance and type 2 diabetes.
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CHAPTER 2
METHODS & MATERIALS
2.1 Animals
All animal procedures were approved by the British Home Office Animals 
Scientific Procedures Act 1986 (Project Licence no. 70/5179, personal licence 
no.70/17202). Animals were maintained under a controlled environment (temperature 
21-23 °C, 12 hour light-dark cycle, lights on at 07:00) with ad libitum access to food 
(RM1 diet SDS UK Ltd) and water.
The Irs-2+l' mice had previously generated using standard gene targeting 
strategies (83). The ob/ob mice and db/db mice were purchased from Harlan UK. The 
ob/ob mouse on the C57B1/6J background has a non-sense mutation in the leptin gene, 
which results in a truncated protein that is degraded in the adipocye (21). db/db mice on 
a C57B1/KS background have a premature stop codon in the ObRb long form of the 
receptor resulting in a truncated protein resembling the ObRa receptor isoform, with 
loss of Jak STAT box binding motifs. Unfortunately, genetic background is known to 
influence the course of disease in db/db mice. However, maintainance upon the 
C57BL/KS background allows a number of features to be observed, particularly those 
associated with glucose metabolism. To backcross the db/db mice on to a pure 
C57B1/6J genetic background was deemed to be an inefficient use of funding and time.
Both RIP-CreIRS21ox+/+ and RIP-CreSTAT-31ox+/+ mice were generated in 
the laboratory of Professor D.Withers and maintained upon a C57BL/6J genetic 
background. The rat insulin II promoter (RIP-cre) mice were obtained from the 
Jackson laboratories (http://www.jax.org/) (86). The STAT-31ox+/+ mice were 
obtained from Professor V.Poli from the Univeristy of Dundee (now University of 
Turin). The IRS-21ox+/+ mice were generated within the laboratory of Professor 
D.Withers.
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2.2 Generation o f mice with impaired insulin and leptin function
2.2.1 Generation ofIrs-2+/' ob+/'mice
Irs-2 and ob/ob mouse lines were both maintained on a C57B1/6J genetic 
background to facilitate a comparative analysis. To obtain mice that were compound 
heterozygotes for alleles of Irs-2 and ob (Irs-2+/' ob+/), Irs-2+/' and ob+/' animals were 
intercrossed. Irs-2+/'ob+/' animals were viable and obtained with expected mendelian 
frequency (12.5 %). lrs-2+/'ob+/' mice were fertile and intercrossed to obtain progeny 
of all combinations of deletion of Irs-2 and ob.
2.2.2 Generation o f Irs-2+/'db+/' mice
The db/db mice were maintained on a C57BL/KS background. To obtain Irs-2+/' 
db+A mice, Irs-2+A and db+l' mice were intercrossed. Irs-2+/~db+,~ mice were viable and 
obtained at the expected mendelian frequency (12.5%). Irs-2+/~db+l' mice were fertile 
and intercrossed to obtain progeny of all combinations of deletion of Irs-2 and db. The 
Irs-2 null and db/db phenotypes were indistinguishable on the mixed C57BL/KS/ 
C57B1/6 background compared to mice on their respective pure genetic background.
2.2.3 Generation o f /3-HypIRS2+STA T3KO mice
In order to obtain P-HypIRS2+STAT3KO mice, P-HypIRS2KO and p- 
HypSTAT3KO mice were inter-crossed. This produced P-HypIRS2Iox/++STAT3 
lox/+KO mice, these mice were floxed for one allele at both the Irs-2 and stat-3 gene loci 
and carried the RIP-Cre transgene. These mice were then intercrossed with each other 
to obtain p-HypIRS2+STAT3KO mice.
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2.3 Genotyping Strategies
Mice were tail tipped upon weaning (18-21 days of age) using ethyl chloride 
spray as local anaesthesia. Polymerase chain reaction (PCR) genotyping was then 
carried out upon DNA extracted from the tail tip in order to determine the genotype of 
the mouse.
2.3.1 DNA extraction
Each tail tip was placed in a 1.5 ml eppendorf tube and 100 pi of digestion 
buffer added (6.7 mM Tris-HCl, pH 8.8, 1.66 mM (NH4)2S04, 0.67 mM MgCl2, 0.5 % 
Triton X-100, autoclaved H20  and 1 % p-mercaptoethanol) and heated to 95 °C for 10 
minutes in a heating block. Proteinase K was then added at a final concentration of 1 
mg/ml (5 pi of 20 mg/ml stock) and the tails incubated overnight at 55 °C. Each sample 
was then heated to 95 °C for a further 10 minutes to heat inactivate the proteinase K.
Samples were then centrifuged for 5 minutes at 12, 000 rpm and the supernatant used
for subsequent PCR genotyping.
2.3.2 PCR genotyping strategies
PCR was used to confirm the genotypes of mice. The details of various PCR 
strategies for detecting the genotypic status are outlined below. Detection of PCR 
products was by TAE buffered electrophoresis, resolving on 2% agarose TAE gels. A 
complete list of primer sequences needed for these genotyping strategies are provided 
in appendix II.
50 x Tris-Acetate-EDTA (TAE) buffer (per litre):
Tris-base 242 g
Glacial acetic acid 57.1 ml
0.5M EDTA pH8.0 100 ml
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2% agarose TAE gel:
2 g of routine agarose in 100 ml 1 x TAE buffer.
Irs-2 Genotyping Strategy:
The Irs-2 genotyping was carried out using a set of three primers and the PCR 
reaction conditions detailed below. In the case of wild-type samples, the successful 
annealing of primers Irs-2 upper and Irs-2 lower to both alleles of the Irs-2 gene 
resulted in a single 530 base-pair product. The Irs-2 gene targeting strategy results in 
removal of the coding sequence and thus the internal binding site for the Irs-2 lower 
primer and the introduction of a neomycin cassette, which binds the Irs neo primer, 
resulting in the production of a larger 660 base-pair PCR product (Fig 2.1a) Hence, if 
deletion of the Irs-2 gene was homozygous (occurring on both alleles) then only a 660 
base-pair product would be visualized on a 2% TAE gel. In contrast if the Irs-2 gene 
was heterozygous (deleted on one allele) then both the 530 and 660 base-pair products 
would be present.
PCR REACTION MIX: PCR PROFILE:
DNA l.Opl 94°C for 1 min
RedTaq Polymerase (250 units) 0.5pl Then 30 cycles of;
IRS-2 upper (lOpM) 0.5pl 94°C for 30 secs
IRS-2 lower (lOpM) 0.5pl 65°C for 30 secs
IRS-2 neo (lOpM) l.Opl 72°C for lmin, 30 secs.
RedTaq buffer (1 Ox) 2.5pl Followed by;
dNTPs mix (5mM) l.Opl 72°C for 10 mins
H20 18.0pl stored at 4 °C.
25.0pl
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ob genotyping strategy:
Determination of the genotypic status of the ob gene locus required the use of 
a set of four primers and optimised reaction conditions detailed below. The ob/ob mice 
arise as a result of a nonsense mutation that leads to the expression of a truncated leptin 
gene product. The PCR strategy used makes use of this nonsense mutation by use of 
two primers OB-WT and OB-MUT. These primers only differ in their outmost 3’ 
bases, which are complimentary to position 369 in Lep-cDNA and when annealed form 
a 155 base-pair product with the OB-F primer. In wild-type alleles this base is a “C” 
but is a “T” in the ob/ob allele. Hence two PCR reactions are run in parallel one 
containing the OB-WT primer the other the OB-MUT primer. The presence of the 
APC-F and APC-R primers acts as an internal control, always resulting in a 223 base- 
pair product. If wild-type then both the 223 and 155 base-pair products will be 
produced by the PCR mix containing the OB-WT primer but only the 223 base-pair 
product will be produced by the PCR reaction containing the OB-MUT primer. The 
opposite applies given a homozygous sample and heterozygous samples result in the 
production of both size products in both PCR reactions (Fig 2.1b).
PCR REACTION MIX No. 1:
DNA l.Opl
RedTaq Polymerase (250 units) 0.5pl
APC-Fow (lOpM) l.Opl
APC-Rev (lOpM) l.Opl
OB-Fow (lOpM) l.Opl
OB-WT (lOpM) l.Opl
RedTaq buffer (1 Ox) 2.5pl
dNTPs mix (5mM) 1 .Opl
H20  16.0ul
25.Opl
PCR REACTION MIX No.2:
As for reaction mix No. 1 but exchange 
1 .Opl of Primer -  OB-WT for OB-MUT.
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PCR PROFILE:
94°C for 1 min 
Then 30 cycles of
1). 94°C for 30 secs
2). 67°C for 30 secs
3). 72°C for lmin and 30 secs.
Followed by;
72°C for 10 mins 
stored at 4 °C.
db genotyping strategy:
The PCR protocol was designed to take advantage of the unique restriction cut 
site found in the db/db mutation site. This region of mutant DNA was amplified using 
the primers db-F and db-R and reaction conditions as below and restricted using the 
Rsa I restriction enzyme. Determination of db genotype was confirmed by running 
digested samples on a 3% TAE gel under TAE buffer. The PCR yields a 109 base-pair 
product, once digested the presence of a single 85 base-pair product denotes a wild- 
type, whereas homozygous mutated alleles are denoted by the presence of a single 58 
base-pair product. When both of these digest fragments are present the sample is 
heterozygous for the db mutation (summarised in Fig 2.1c).
PCR MIX (per 25ul reaction): PCR PROFILE:
DNA l.Opl 95°C for 3 mins
RedTaq Polymerase (250 units) 0.5pl Then 35 cycles of;
db - Fow (lOpM) 0.5pl 95°C for 1 min
db - Rev (lOpM) 0.5pl 58°C for 1 min
RedTaq buffer (1 Ox) 2.5 pi 72°C for 1 min.
dNTPs mix (5mM) l.Opl Followed by;
H20 19.0pl 72°C for 10 mins
25 .Opl stored at 4 °C.
Each PCR product was then digested using the following reaction mix, 
incubating at 37 °C for 2 hrs.
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Rsa I restriction enzyme (Reaction mix):
PCR Product 10 (J.1
Rsa I enzyme 0.3 pi
NEB Buffer #1 (lOx) 2.0 pi
Sterile-filtered H20  7.7 pi
20pl.
J3-Hyp IRS2+STAT-3KO genotyping strategy:
Genotyping of |3-HypIRS2+STAT3KO mice required three additional PCR 
protocols, which are outlined below.
1). IRS-21ox PCR:
This was carried out to determine the status of loxP sites at the Irs-2 locus (ie. 
were both alleles of Irs-2 flanked by loxP sites).
PCR MIX (per 25ul reaction): PCR PROFILE:
DNA l.Opl 95°C for 5 mins
RedTaq Polymerase (250 units) 0.5pil Then 35 cycles of;
LoxP - Fow (lOpM) 0.5pil 95°C for 30 secs
LoxP - Rev (lOpM) 0.5pl 60°C for 30 secs
RedTaq buffer (lOx) 2.5pl 72°C for 1 min.
dNTPs mix (5mM) l.Opl Followed by;
H20 19.0pl 72°C for 10 mins
25.Opl stored at 4 °C.
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a), Irs-2 genotyping analysis:
WT HET HOMO
660bp
530bp
b). ob genotyping analysis:
WT HET HOMO
223bp
155bp
1 2  1 2  1 :
1=OB-WT primer reaction.
2=OB-MUT primer reaction.
c). db genotyping analysis:
WT HET HOMO
85bp
58bp
Figure 2.1 Analysis of PCR products obtained from the genotyping of Irs-2, ob/ob 
and db/db mice.
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2). STAT-31ox PCR:
As with the IRS-21ox PCR, the purpose of this PCR was to determine the
status of loxP sites at the stat-3 locus.
PCR REACTION MIX: PCR PROFILE:
DNA l.Opl 94°C for 4 min
RedTaq Polymerase (250 units) 0.5 pi Then 30 cycles of;
APRF-11 UP(10pM ) l.Opl 94°C for 1 min
APRF-11 DOWN (lOpM) l.Opl 60°C for 2 min
APRF-14 DOWN (lOpM) l.Opl 72°C for 3 min
RedTaq buffer (lOx) 2.5pl Followed by;
dNTPs mix (5mM) l.Opl 72°C for 10 mins
H20 17.0ul stored at 4 °C.
25.Opl
3). RIP-Cre PCR:
The following PCR reaction was carried out 
RIP-Cre transgene.
PCR REACTION MIX:
DNA l.Opl
RedTaq Polymerase (250 units) 0.5pl 
Cre 1084 (lOpM) l.Opl
Cre 1085 (lOpM) l.Opl
IL2 F (lOpM) l.Opl
IL2 R (lOpM) l.Opl
RedTaq buffer (1 Ox) 2.5pl
dNTPs mix (5mM) l.Opl
H20  17.0ul
25.Opl
to determine the presence of the
PCR PROFILE:
94°C for 3 min 
Then 30 cycles of; 
94°C for 30 secs 
60°C for 30 secs 
72°C for 1 min 
Followed by;
72°C for 10 mins 
stored at 4 °C.
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2.4 Investigation of serial body weights of progeny from Irs-2*1'ob*1'and Irs-2*1'
db*1' intercross
All body weights were recorded during the early light phase between 10:00am 
and 12:00pm using a Sartorius Master Pro LA balance (Sartoruis, Goettingen, 
Germany) recording to the nearest 0.01 g. Mice were weighed daily from day 10 until 
day 21 to enable tracking of each individual pup within a litter. Following weaning and 
ear-marking at day 21, mice resulting from the lrs-2+/'ob+/~ intercross were weighed 
weekly until 12 weeks of age. In contrast, offspring resulting from the Irs-2+/'db+/' 
intercross were weighed weekly until 8 weeks of age.
2.5 Metabolic studies
2.5.1 Determination of fasting blood glucose levels
Mice were fasted for 15 hours overnight and blood glucose levels were 
determined during the early light phase (8:00 -  10:00) via tail vein bleeds after local 
anaesthesia using a Glucometer Elite glucometer (Bayer).
2.5.2 Determination of glucose homeostasis using intra-peritoneal glucose-
tolerance tests
Mice were fasted for 15 hours and blood glucose levels determined as 
described in section 3.2.2. Mice were then injected with 2 g kg’!of D-glucose 
intraperitoneally (i.p) and blood glucose measured at 15, 30, 60 and 120 minutes post­
injection.
2.5.3 Determination of fasting insulin and leptin levels
Mice were fasted overnight for 15 hr and then terminally anaesthetized (25 % 
Midazolam, 25 % Hypnorm, 50 % water for injection) and cardiac puncture performed. 
Blood samples were centrifuged at 13,000 rpm for 20 minutes at 4 °C, serum was then 
immediately removed and frozen at -80 °C until assayed. Fasting insulin levels were
61
measured using a commercially available ultra sensitive Rat insulin ELISA kit (Crystal 
Chem Inc, cat# 90060) including mouse insulin standards (Crystal Chem Inc, cat# 
90090). Fasting leptin levels were also determined using a commercially available 
mouse leptin ELISA kit (Crystal Chem Inc, cat# 90030). All samples were assayed in 
duplicate. The mouse insulin standard (lyophilised) was reconstituted in lOOpl of 
distilled water. This stock solution was 12.8 ng/ml and was serially diluted 1:1 with the 
sample diluent (provided in the rat insulin ELISA kit) to produce mouse insulin 
standards at the following concentrations; 0, 0.1, 0.2, 0.4, 0.8, 1.6, 3.2 and 6.4ng/ml.
2.6 Investigation of Pancreatic Islet morphology
2.6 .1  H a e m a to x y lin  a n d  e o s in  s ta in in g
Four week old, fasted mice were terminally anaesthetised as described in 
section 2.5.3. The pancreas was then removed, cleared of fat and fixed in Bouin’s 
fixative solution (see below) for 2 hours. Following fixation samples were stored in 75 
% ethanol prior to being processed and paraffin embedded (using automatic embedder).
Bouin’s Fixative solution:
375 ml saturated picric acid
125 ml stock formaldehyde (37% w/w)
25 ml glacial acetic acid 
500ml
For haematoxylin and eosin staining 5 p,m sections were then cut onto glass 
slides, which were then deparaffinised and rehydrated by carrying out the following 
series of washes;
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2 x 5  minutes 
1x5  minutes 
1x5  minutes 
1x5 minutes 
1x5 minutes
Xylene
100 % Ethanol 
95 % Ethanol 
80 % Ethanol 
deionised H2O
Deparaffinised slides were blotted of excess water and then stained for 5 
minutes with haematoxylin stain. Stained slides were then rinsed with and submerged 
in tap water for 5 minutes, to allow staining to develop. Slides were then destained by 
agitation in acid ethanol, rinsed with tap water ( 2x1  minutes), and finally in deionised 
water ( 1 x 2  minute). Slides were then stained with eosin (1 x 30 seconds) and washed 
2 x 3  minutes in 95 % ethanol, 2 x 3  minutes 100 % ethanol. Slides were blotted of 
excess ethanol before submerging in xylene ( 1 x 5  minutes). Slides were then allowed 
to air-dry before mounting coverslips, using DPX medium. Stained sections were then 
viewed using light microscopy.
2.6.2 Immunofluorescence staining for insulin
For insulin staining 5 pm sections were cut onto poly-lysine coated slides. 
Slides were deparaffinised by successive 5 minute washes in 100 % xylene, 100 % 
ethanol, 70 % ethanol, 50 % ethanol respectively, followed by 2 x 2 minute washes in 1 
x phosphate buffer saline (PBS). Prior to staining slides were placed into a beaker of 
pre-boiled 0.01 M sodium citrate pH 6.0 and heated for 8 mins at the lowest microwave 
setting. Slides were allowed to cool before being blocked for 30 mins in 1ml of 1 x 
PBS + 2% chicken serum inside a moisture chamber. Slides were then washed three 
times with 1 x PBS + 0.05% Tween-20. Following washing slides were further blocked 
by incubating for 30 mins in 100 pi of 2 % chicken serum dissolved in 1 x PBS + 2 % 
BSA. This helps to reduce non-specific binding of the secondary antibody, which is 
raised in chicken against mouse IgG. Slides were then incubated for 2 hours, at room 
temperature, in 200 pi of insulin monoclonal antibody (1:500) (sigma 1-2018) dissolved 
in 1 x PBS + 2 % BSA + 2 % chicken serum. After incubation in primary antibody 
slides had excess fluid removed by gentle tapping onto tissue paper, before being 
washed three times in 1 x PBS + 0.05 % Tween-20 for 2 mins. Slides were then placed 
back into the moisture chamber and incubated in secondary antibody (Alexa-Fluor
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5948, Molecular probes A-21200) at 5 p-g/ml in 1 x PBS + 0.05 % Tween-20, for 2 
hours at room temperature. Slides were then washed once with 1 x PBS + 0.05 % 
Tween-20, before mounting.
2.6.3 Quantification of relative islet density and relative islet area
Relative islet density and relative islet area was determined by morphometric 
analysis of four whole pancreatic sections (5 pM) immunostained for insulin, from four 
animals per genotype.
2.7 Insulin treatment of Irs-2'1'ob'1' double-knockout mice
Double-knockout mice were administered daily injections of insulin (Lantus -  
Glargine lOOiu/ml cartridges, Aventis) just prior to the start of their 12 hr dark-cycle 
(17:00 -  18:00) over a period of 6 weeks. Injections were administered subcutaneous 
using an insulin pen (Aventis), carrying a 6mm needle (Disetronic medical systems 
Ltd). The amount of insulin given was determined by measurements of body weight 
and urine glucose and ketone content, taken once in the early light phase (08:00 -  
09:00) and again just prior to time of injection. In addition cages were supplemented 
with wet chow-diet for the first two weeks of injections to encourage the double­
knockouts to feed and hence reducing the risk of hypoinsulinemia.
2.8 Generation of recombinant GST-fusion proteins for the production of IRS-1 
and IRS-2 polyclonal antibodies
Constructs had previously been designed in the laboratory for the expression of 
Glutathione-S-transferase (GST)-fusion proteins containing either the residues 735-900 
of murine IRS-1 or residues 619-746 of murine IRS-2, subcloning into the pGEX6pl 
GST-expression vector system (Amersham Biosciences cat# 27-4597-01).
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2,8.1 Optimisation of induction conditions for IRS-1 and IRS-2 GST-fusion 
proteins
Plasmid constructs were transformed into BL-21 bacterial cells and incubated 
upon L-agar plates containing 50 pg/ml ampicillin. In addition the pGEX vector alone 
was also transformed to use as a positive control during the purification strategy.
L-aear plates (per litre = 40 plates):
Tryptone lOg
Yeast Extract 5g
NaCl 10g
Agar 15g
Make up to 1 litre with distilled water and sterilise by autoclaving. Plates 
should be stored at 4 °C. Plates were briefly incubated at 37 °C prior to use to allow 
surface moisture to dry.
Transformants were then selected and grown in 10 ml L-broth overnight at 37 
°C with agitation. Three 50 ml induction cultures were set-up by adding 500D1 of 
overnight culture into each 50 ml L-broth culture. These 50 ml cultures were grown 
until mid log-phase (ie. OD600 = 0.6), when a 1 ml pre-induction control sample was 
taken and clarified by centrifugation (13,000 rpm for 1 min at 4 °C). The cultures were 
then induced by the addition of either; 0.1 mM, 0.5 mM or 1.0 mM isopropyl b-D- 
thiogalactoside (IPTG). IPTG induces expression of the GST-fusion proteins by 
relieving repression of the lacZ promoter. Cultures were incubated at 37 °C for three 
hours with agitation, taking a 2 ml sample pellet at each hour time point. Sample 
pellets were reconstituted in 100 pi of 1 x PBS, of which 5pi was denatured in 5 pi 
SDS-sample buffer by boiling at 95 °C for 5 mins. Samples were then resolved by 12% 
SDS-polyacrylamide gel electrophoresis and protein content was assessed by 
Coomassie staining.
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Coomassie Blue Stain (1 litre): 
Coomassie Blue R-250 (0.025%) 
Methanol (40%)
Acetic acid (7%)
0.25g
400ml
70ml
Destain (1 litre): 
Methanol (5%) 
Acetic acid (7%) 70ml
50ml
2.8.2 Large-scale purification of GST-IRS1 and GST-IRS2 fusion proteins
2.8.2.1 Lysis ofBL-21 bacterial cells for GST-fusion protein purification
Using these optimal induction conditions of 1.0 mM IPTG at 37°C for 2 hours, 
1 litre cultures of BL-21 bacterial cells containing either GST-IRS1 or GST-IRS2 fusion 
protein constructs were induced. The resulting bacterial pellets were sonicated in 20 ml 
of ice-cold 1 x GST lysis buffer (recipe below). Lysates were clarified by centrifugation 
at 3,500 rpm for 10 mins at 4°C and then further cleared by passing through a glass-wool 
mesh.
1 XGST lvsis Buffer:
1 x PBS
ImM EDTA pH8.0 
ImM Dithiothreitol (DTT)
ImM Sodium Fluoride 
ImM Sodium Orthovanadate 
Nonidet P-40
Protease inhibitor tablets (Roche)
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2.8.1.2 Purification o f GST-IRS1 and GST-IRS2
Purification of both the induced GST-IRS1 and GST-IRS2 fusion proteins was 
achieved by applying the ~15mls of lysate that was retained from lysis to Redipack GST- 
purification columns (2 ml columns with 20 mg protein capacity, Amersham cat# 27- 
4570-02).
The Redipack columns were equilibrated by washing with 5 x column volumes 
of 20% ethanol, followed by 5 x column volumes of 1 x PBS. The ~15mls of induced 
lysate (either GST-IRS1 or GST-IRS2) was then applied to the Redipack columns, 
collecting the flow-through for subsequent analysis. Redipack columns were then 
washed with 10 x column volumes of 1 x PBS, again collecting the flow-through for 
subsequent analysis. The GST-fusion proteins were then eluted by addition of lOmM 
glutathione to the columns. Eluted protein was collected in 500 pi fractions, of which a 
50 pi fraction was taken for further analysis.
2.8.2.3 Analysis o f large-scale GST-IRS1 and GST-IRS2 purifications
In order to determine the concentration of eluted fractions and generally assess 
the efficiency of purification a Bio-Rad protein assay (BioRad cat#500-0006) was carried 
out.
The Bio-Rad assay is a colorimetric assay for the measurement of total protein 
concentration, adapted from the method of Bradford (142). The Bio-Rad assay is based 
on the colour change of coomassie brilliant blue G-250 dye, in response to various 
concentrations of protein. The dye binds primarily basic, (especially arginine) and 
aromatic amino acid residues.
2.8.3 Desalting of GST-IRS1 and GST-IRS2 purified fusion proteins
HiTrap desalting columns (Amersham, Cat# 17-1408-01) were used following 
the manufacturers recommended protocol. GST-fusion proteins were eluted using 1 x 
PBS + 20 % glycerol, in preparation for injections into sheep.
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2.8.4 Evaluation o f anti-IRS-1 (S918A) and anti-IRS-2 (S919A) antisera
The anti-IRS-1 (S918A) and anti-IRS-2 (S919A) sheep polyclonal antisera were 
evaluated by testing their ability to immunoprecipitate native IRS-1 and IRS-2 proteins in 
brain lysates (Fig 2.2). Tissue lysates were prepared and immuoprecipitated with either 
anti-IRS-1 (S918A) or anti-IRS-2 (S919A) antisera were carried out as described in 
below.
WT KO WT KO WT KO WT KO
2 5 0  _ •  
1 6 0
105
IP =
WB =
S918A anti-IRS-1 
UBI anti-IRS-1
S919A anti-IRS-2 
UBI anti-IRS-2
Figure 2.2: Western blot analysis o f immunoprecipitations fo r IRS-1 and IRS-2 in 
brain lysates, using S918A anti-IRS-1 and S919A anti-IRS-2 sheep polyclonal 
antibodies.
Brain lysates were obtained from 2 x wild-type and 2 x Irs-2~f~ mice. Brain lysates (2mg 
in total) were then immunoprecipitated with 10pi o f either S918A or S919A antisera. 
Immunoprecipitates were resolved by 6% SDS-PAGE, transferred and blotted for IRS-2 
using the UBI anti-IRS-2 (Upstate, cat# 06-508 (1:1,000) also see Table 2.1).
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2.9 Signalling analysis o f peripheral tissues
2.9.1 Harvesting of tissues in the fasted state
Mice were fasted overnight for 15 h and then terminally anaesthetized (25 % 
Midazolam, 25 % Hypnorm, 50 % water for injection) samples of liver, quadriceps 
muscles, fat were then rapidly dissected and snap frozen in liquid nitrogen for 
subsequent signalling analysis.
2.9.2 Insulin-stimulated signalling analysis
Mice were fasted overnight then terminally anaesthetised during the early 
light phase (08:00 -  09:00). The inferior vena cava was then cannulated and 5 units of 
human insulin injected. Five minutes post-injection, liver, quadriceps muscles and fat 
were rapidly dissected and snap frozen in liquid nitrogen.
Liver, muscle and fat tissues were homogenized at 4 °C in 3 ml of 1 x Lysis 
buffer (1% Triton-XlOO, 10 mM Tris, 5 mM EDTA (disodium salt), 50 mM NaCl, 
30mM Disodium pyrophosphate, 50 mM NaF, 0.1 mM Sodium orthovanodate, 10 
pg/ml Leupeptin, 10 pg/ml Aprotinin and 10 pg/ml Pepstatin). Homogenates were 
allowed to solubilize for 30 minutes at 4 °C and clarified by centrifugation at 14,000 
rpm for 20 minutes. Supernatants were assayed for their protein concentration using 
the Bradford reaction assay (BioRad). Lysates were used in either 
immunoprecipitations or western blotting to analyse a number of signalling proteins.
2.9.3 Immunoprecipitation of IRS1 and IRS2
For the immunoprecipitation of IRS-1, 10 pi of anti-IRS 1 (S918A) sheep 
polyclonal antibody was incubated with 2 mg of lysate at 4 °C on a rotary mixer 
overnight. Similarly for IRS-2 immunoprecipitations the same conditions were used but 
using 10 pi of the anti-IRS-2 (S919A) sheep polyclonal antibody. Following overnight 
incubation with antibody, samples had 20 pi total bead volume of pre-washed protein- 
G agarose (Roche; Cat#l243233) added to them and were incubated for a further hour
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at 4 °C, again with agitation. Immunoprecipitations were then clarified by gentle 
centrifugation and washed twice with 750 pi of 1 x lysis buffer. Samples were then 
denatured in 20 pi of 2x SDS-sample buffer at 100 °C for 5 mins. Samples were then 
clarified by centrifugation and analysed by western blotting.
2.9.4 Western blotting
Lysates were resolved on 10% SDS-PAGE, loading 100 pg of total lysate per 
lane. Gels were usually run at 120 volts for 90 minutes before transferring onto PVDF 
membrane at 100 volts for 2 hours. The blots were then blocked for 45 mins in 1 x 
PBS + 0.1% Tween + 5 % milk and then incubated overnight at 4 °C with primary 
antibody (1:1,000) diluted in 1 x PBS + 0.1% Tween + 5 % milk. All antibodies used 
are detailed in table 2.1). The primary antibodies used for detection of proteins 
involved in insulin signalling are detailed below. The Blots were washed for 3 x 5 min 
in 1 x PBS + 0.1% Tween and then incubated with HRP-conjugated Goat anti-Rabbit 
secondary antibody (1:10,000) (Dako Ltd). Blots were given a final set of 3 x 5 min 
washes with 1 x PBS + 0.1% Tween, before detection using Enhanced 
Chemiluminesence (ECL kit, Amersham Pharmacia cat# RPN 2106).
2.10 Data handling and statistics
All data was expressed as an average ± s.e.m for all data points, unless 
otherwise indicated. Results are representative of at least four animals per genotype, 
except where indicated. Statistical analyses were carried out using two-tailed student’s 
unpaired t test, with significance being rejected at p > 0.05. Standard error of the mean 
was determined using Prism Version 4.0.
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ANTIBODY Supplier Species Catalogue #
Species
Cross-Reactivity Antigen
Detection on western blot 
(1 x band unless stated)
Anti-IRS2 University of Dundee Sheep polyclonal S919A H,M,R GST-fusion protein Used for immuno-precipitation
Anti-IRS2 Upstate cell signaling solutions Rabbit polyclonal #06-506 H,M,R GST-fusion protein 160-180 KDa
Anti-PI3 Kinase, p85 Upstate cell signaling solutions Rabbit polyclonal #06-195 H,M,R,Mo GST-fusion protein 85 KDa
Anti-phospho-PDK1 s“ 24' New England Biolabs Rabbit polyclonal #3061S H,M,R Phospho-peptide 58 to 68 KDa
Anti-totai PDK1 New England Biolabs Rabbit polyclonal #3062 H,M,R Peptide 58 to 68 KDa
Anti-phospho-AktSer473 New England Biolabs Rabbit polyclonal #9271S H,M,R,C,Hm Phospho-peptide 60 KDa
Anti-total Akt New England Biolabs Rabbit polyclonal #9272 H,M,R,C,Dr,Hm Peptide 60 KDa
Anti-phospho-MAPK71"202^ ’"204 New England Biolabs Rabbit polyclonal #9101S H,M,R,C,Hm,Z Phospho-peptide 2 x bands at 42 and 44 KDa
Anti-total MAPK New England Biolabs Rabbit polyclonal #9102 H,M,R,Hm,Z Peptide 2 x bands at 42 and 44 KDa
Ant-phospho-p70s6kThr389 New England Biolabs Rabbit polyclonal #9205S H,M,R Phospho-peptide 75-80 KDa
Anti-total-p70s6k (C-18) Santa cruz biotechnology inc Rabbit polyclonal SC-230 M,R,H,C,X Peptide 70 KDa
Anti-phospho GSK-3a/pSer9/21 New England Biolabs Rabbit polyclonal #9331S H,M,R,Z Phospho-peptide 46 KDa GSK-3|3 and 51 Kda GSK-3
Anti-total GSK-30 New England Biolabs Rabbit polyclonal #9332 H,M,R,X,Z Peptide 46 KDa
Anti-Cyclin D1 (DCS6)* BD Biosciences (Clonetech) Mouse monoclonal 556470 H.M.R Peptide 36 KDa
Anti-Cyclin D2 (DCS 3.1)* BD Biosciences (Clonetech) Mouse monoclonal 554200 H,M,R Peptide 35 KDa
Anti-Cyclin D3 (DCS 22)* BD Biosciences (Clonetech) Mouse monoclonal 554195 H,M,R Peptide 30 - 35 KDa
Species codes: C = Chicken; Dr = Drosophila; H = Human; Hm = Hamster; M = Mouse; Mo = Monkey; R = Rat; X = Xenopus; Z = Zebra fish 
* These antibodies were a research gift from Dr Michelle Garrett but newer clones my be purchased from BD Biosciences.
Table 2.1: Summary o f primary antibodies usedfor insulin signalling analysis in peripheral tissues o f wild-type, Irs-2’'', ob/ob and double knockout mice 
(see chapter 6). It should be noted that the anti-phospho-PDKlSer24 recognises three bands running between 58-68 KDa.
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CHAPTER 3
Analysis of body weight and anatomy in offspring derived from 
Irs-2+/~ob+/~ and Irs-2+/~db+/~ intercrosses.
3.1 Generation and genotypic frequencies of Irs-2+/'ob+/' offspring
lrs-2 and ob/ob mice were maintained on the same C57B1/6J genetic 
background to facilitate analysis. To obtain all genetic combinations of the Irs2 and ob 
genes, double heterozygote male and female mice were intercrossed. However, since 
ob/ob mice and female Irs-2'A mice are infertile, initially single heterozygote males and 
females were mated to produce double heterozygote animals. Double heterozygote mice 
were fertile and produced litters of comparable size to wild-type matings (data not 
shown). There also appeared to be no difficulties in maternal care for litters.
The intercross of Irs-2+/'ob+/' mice produced 1221 offspring representing all 9 
possible genotypes. PCR genotyping conducted at 3 weeks of age indicated that the 
frequency of these genotypes was generally in accordance with the expected Mendelian 
ratios (Table 3.1).
3.2 Growth characteristics of progeny of Irs-2+/'ob+/' intercross
Growth curves were generated based on daily weights from ten days after birth 
to twenty-one days and weekly weights thereafter until twelve weeks of age, for both 
male and female offspring resulting from the intercross of Irs-2+/'ob+/ mice (Fig 3.1).
The growth of the Irs-2'1', ob/ob and wild-type mice was consistent with 
previous reports (83, 143). Compound heterozygote mice (Irs-2+/'ob+/') had similar 
growth profiles to wild-type mice but usually weighed 1-2 grams more and this weight 
difference was significant by eight weeks of age (Fig 3.2c-d). Mice lacking single alleles 
of either Irs-2 (Irs-2+/'ob+/+) or ob (Irs-2+/+ ob+/') had no obvious change in growth 
pattern over the 12-week period and mirrored the wild-type weight profile (data not 
shown).
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NUMBERS % OFFSPRING
GENOTYPES FEMALE MALE TOTAL ACTUAL EXPECTED
WILD-TYPE 50 54 104 8.52 6.25
IRS-2+/+OB+/- 87 83 170 13.92 12.50
IRS-2+/-OB+/+ 97 97 194 15.89 12.50
IRS-2+/-OB+/- 137 172 309 25.31 25.00
ob/ob 30 37 67 5.49 6.25|
/RS-2 KO 26 36 62 5.08 6.25
IRS-2+/-OB-/- 70 86 156 12.78 12.50
I R S - 2 ^ 0 B + A ^ ^ ^ ^ 53 51 104 8.52 ^ ^ ^ 1 £ 5 0mm
TOTAL 1221 100
Table 3.1 Genetic frequencies o f all 9 possible genotypes resulting from the intercross 
o f Irs-2+/~ob+/~ mice. Animals were PCR genotyped at three weeks o f age.
Irs-2+/'ob'1' mice were obese like the ob/ob mice, also weighing over double that of the 
wild-type mice by eight weeks of age. In contrast, mice lacking both Irs-2 and ob genes 
(Irs-T^'ob'^, termed; double knockouts) were markedly growth retarded (Fig 3.2) only 
growing to a mean peak body weight of 11 grams by six weeks of age (Fig 3.1). 
Therefore double knockout mice displayed a 50% reduction in body weight compared to 
wild-type mice of the same age. After six to eight weeks these double knockout mice 
gradually lost weight and became increasingly frail. In contrast, this striking impairment 
of growth was not seen in the Irs-2'Aob+/'mice. These mice were of comparable weight to 
the I r s - t ' up to twelve weeks of age although there was a non-significant reduction in 
body weight from approximately six weeks of age. This finding suggested that the 
presence of a single allele of the ob gene was sufficient to rescue the phenotype seen in 
the double knockout mice.
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a). Male IRS2/0B Body weight curve
o>
u>
1
■O
t§
2 4 6 8 12
Age (weeks)
—  IRS-2+/-0B+/-
—  IRS-2-/-0B+/- 
 1RS-2+/-0B-/-
—  Double Knockout
—  OB/OB
—  IRS-2 KO
— -  Wild-type
b). Female IRS2/OB Body weight curve
O)
4 8 122 6
IRS-2+/-OB+/- 
IRS-2-/-OB+/- 
IRS-2+/-0B-/- 
Double Knockout 
OB/OB 
IRS-2 KO 
Wild-type
Age (weeks)
Figure 3.1 Growth curves showing mean weights±s.e.m o f a), male and b). female 
offspring resulting from the Irs-2+/~obw' intercross at the indicated ages (weeks).
Results are representative o f at least 8 animals per genotype.
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The body weights measured for both four and eight-week-old mice of each sex 
reflect this growth pattern (Figure 3.2). Analysis of male and female mice showed that 
the body weights of each of the genotypes were consistent regardless of gender. Only 
Irs-2+/'ob+/~ mice showed any possible signs of sexual dimorphism, with males weighing 
approximately 5 grams more than females at eight weeks of age (Figure 3.2 c-d).
Consideration of all genotypes at four weeks of age, revealed that both ob/ob and 
Irs-2+/'ob'A mice weighed significantly more than wild-type controls (Fig 3.2a-b p < 
0.0001 for males and p < 0.01 and p < 0.05 respectively, for females). It was also noted 
that Irs-21', Irs-2'Aob+/~ and double knockout mice weighed significantly less than wild- 
type littermates ip < 0.01, p < 0.0001 and p < 0.0001 respectively for males and p < 
0.01, p < 0.001 and p < 0.0001 respectively for females). Compound heterozygous mice 
were determined to be of comparable weight to that of wild-type mice for both sexes, at 
four weeks of age.
Both sexes showed a similar pattern of body weight at eight weeks of age (Fig 
3.2c-d). However, the weights of both male and female Irs-2'A mice was more 
comparable with wild-type mice than seen at four weeks of age, p < 0.05 for males and 
no significant difference between female mice. Consistent with four week data ob/ob and 
Irs-2+/'ob A mice weighed more than wild-type controls ip < 0.0001 for both male and 
female mice). Double knockout mice were still much lower in body weight compared to 
wild-type mice ip < 0.0001 for both male and female mice). The striking growth 
retardation seen in the double knockout mice is demonstrated in figure 3.3. The mice 
depicted are eight weeks of age and were weaned from the same litter.
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Figure 3.2 Analysis o f body weights o f male and female offspring from  the Irs-2f'o\f 
intercross at a-b). 4 weeks and c-d). 8 weeks o f age.
Results are representative as mean weights ±  s.e.m of at least 8 animals per genotype. Statistical analysis 
was carried out by means of t-tests comparing all genotypes to their wild-type controls; * , p <  0.05, **, p  <
0.01, ***, p  < 0.001, ****, p  < 0.0001.
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Double-knockout
ob/ob
Figure 3.3 Photograph o f double-knockout with wild-type and ob/ob littermates: Mice 
shown were eight weeks o f age and were born from  the same litter.
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3.3 Generation and genotypic frequencies o f Irs-2+/~db+/~ offspring
In contrast to the I r s - 2 and ob/ob mice, db/db mice were maintained on the 
C57B1/KS genetic background. As with the Irs-2+/~ob+/~ intercross single heterozygote 
male and female (Jrs-2+/'x db+~) mice were mated to produce double heterozygote 
animals (Irs-2+/'db+/~). These double heterozygotes were then intercrossed to obtain all 
genetic combinations of the Irs2 and db genes. Double heterozygote mice were fertile 
and produced litters of comparable size to wild-type matings (data not shown). There also 
appeared to be no difficulties in maternal care for litters.
The intercross of Irs-2+'db+~ mice produced 286 offspring representing all 9 
possible genotypes. PCR genotyping conducted at three weeks of age indicated that the 
frequency of these genotypes was generally in accordance with the expected Mendelian 
ratios (Table 3.2). However, it was observed that male Irs-2'1' mice were obtained at a 
very low frequency (3 in total, Table 3.2). As male Irs-2"db+~ mice were obtained from 
the intercross of Irs-2+'db+/~ mice (14 in total, Table 3.2) the low numbers of male Irs-2~f~ 
mice obtained is very surprising. Unfortunately there is no explanation for this finding at 
present.
GENOTYPES
NUMBERS % OFFSPRING
FEMALE MALE TOTAL ACTUAL EXPECTED
WILD-TYPE 14 13 27 9.44 6.25
IRS-2+/+db+/~ 21 16 37 12.94 12.50
IRS-2+/-db+/+ 20 26 46 16.08 12.50
IRS-2+/-db+/ - 26 41 67 23.43 25.00
db/db 6 14 20 6.99 6.2d
|IRS-2 KO 10 3 13 4.5^ 6 .2
IRS-2+/-db -/- 13 16 29 10.14 12.50
15 ^ ^ 1 ^ 4 ^ ^ ^ I Z S O
1 TOTAL 1 286 100| 1001
Table 3.2 Genetic frequencies o f all 9 possible genotypes resulting from the intercross 
o f Irs-2+/~db+/' mice. Animals were PCR genotyped at three weeks o f age.
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3.4 Body weight analysis o f offspring from Irs-2+/'db+/'intercross
Body weight analysis of offspring resulting from the Irs-2+/'db +/'intercross 
showed a similar pattern to that seen in the Irs-2+Aob+A intercross (Fig 3.4). Again the 
lrs-2'Adb'A double knockouts resulting from this cross were growth retarded, weighing 
40% of that of wild-type littermates at four weeks of age (Fig 3.5 a-b). Compound 
heterozygous mice, Irs-2+Adb+A mice exhibited a similar growth profile to that of wild- 
type littermates but weighed significantly more at eight weeks of age (p < 0.01), 
weighing on average 5 grams more. Mice containing a single allele of either the Irs-2 or 
db genes (Irs-2+A and db+A mice) were similar to that of wild-type littermates (data not 
shown). Similar to Irs-2~Aob+A mice, Irs-2 Adb+Amice weighed more than their double 
knockout littermates, again being comparable to Irs-ZA mice at eight weeks of age.
The body weights of Irs-2 A and db/db mice resembled that of their equivalents 
from the Irs-2+Aob+A intercross (Fig 3.4). In contrast, Irs-2+Adb A mice did not appear to 
gain as much weight over the eight week period as db/db mice and were significantly 
smaller than their equivalents from the Irs-2+Aob+A intercross (Fig 3.6). The difference 
between the body weights of Irs-2+Adb~A mice and Irs-2+Aob~A mice at 8 weeks of age was 
significant (Fig 3.6, p < 0.0001). This difference in body weight between lrs-2+Adb’A and 
Irs-2+Aob A mice is an interesting observation but could be a consequence of the db/db 
mice being derived from a different genetic background. However the similarity of 
growth profiles for the other equivalent genotypes from these two intercrosses, would 
suggest that there is a true difference in the level of weight gain observed in Irs-2+Adb A 
compared to Irs-2*Aob A.
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Results are representative o f at least 8 animals per genotype; **, p <  0.01, * * * *  p  < 0.0001.
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Figure 3.5 Analysis o f body weights o f male and female offspring from the Irs-2+/'db+ 
intercross at a-b). 4 weeks and c-d). 8 weeks o f age.
Results are representative as mean weights + . s. e.m o f at least 4 animals per genotype. Statistical analysis 
was carried out by means oft-tests; * p  < 0.05, *** , p  < 0.001, * * * * , p  < 0.0001, of all genotypes versus 
wild-types.
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IRS-2+/-ob-/- IRS-2+/-db-/-
Genotypes
Figure 3.6 Comparison o f Irs-2**'db'*' and I
age.
Results are representative as mean weights +  s. e.m of at least 26 animals per genotype. Statistical analysis 
was carried out by means of t-test for Irs-2+/'db~/~ versus Irs-2+/'ob'A * * * *  p < 0.0001.
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3.5 Tissue weight analysis o f offspring resulting from both the Irs-2+Aob+A and Irs-2+/'
db+A intercrosses
The various offspring resulting from the two intercrosses were dissected at four 
weeks of age, brain and peripheral tissue weights were assessed. The weights of 
gonadal fat pads, muscle groups (gastronemius soleus and quadricep muscles pooled), 
liver and spleen taken from the various genotypes are presented as a percentage of total 
body weight in figures 3.7, 3.8, 3.9 and 3.10 respectively. Similarly, brain weight is 
presented as total brain weight and as a percentage of total body weight in figure 3.11. In 
the interest of the reader, average body weights and average percentage tissue weights of 
all genotypes (except those mice containing a single copy of either gene) are presented in 
for both intercrosses in Table 3.3.
Analysis of peripheral tissue weights relative to total body weight, demonstrated 
that weights were similar between equivalent genotypes from the two intercrosses. 
Considering the weight of gonadal fat pads it was evident that either leptin or leptin long- 
form receptor deficiency, in Irs-2+Aob~A, ob/ob, Irs-2+Adb'A, db/db mice, resulted in a 
significant increase in relative gonadal fat pad weight compared to wild-type littermates. 
In contrast, the relative weight of gonadal fat pads was not increased to such levels in the 
double knockout mice (Fig 3.7). Indeed upon dissection it was noted that many double 
knockout mice were almost deplete of any white adipose tissue. Catabolism and 
development can both effect adipogenesis, the contribution of these parameters to the 
lack of white adipose tissue observed in double knockout mice will be discussed in 
chapter five. Interestingly, both Irs-2~Aob~A and Irs-2'Adb A double knockouts displayed 
marked sexual dimorphism with regards to gonadal fat pad weight, with male fat pads 
tending to weigh more than females (Fig 3.7). This sexual dimorphism was also evident 
in the Irs-2+Aob'A genotype, where the weight of male fat pads as a percentage of total 
body weight, were significantly increased compared to females (**p < 0.01). Although 
this trend appeared to be the same in their equivalent genotype (Irs-2+Adb'A), the increase 
seen in males was not determined to be significant.
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Figure 3.7 Gonadal fa t mass o f offspring from  both Irs-2+/'ob+/~ and Irs-2+/~db+/' 
intercrosses at 4 weeks o f age.
Gonadal fa t weights were expressed as means ofpercentage total body weight ±_ s. e.m of at least 4 animals 
per genotype, except where indicatedu n=3, **, p  < 0.01, ***, p  < 0.001, * * * *  p  < 0.0001. Unfortunately, 
as only three male Irs-2 null mice were obtained from the Irs-2+/'db+,~ intercross, no fa t weights were 
obtained for this particular group.
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Figure 3.8 Muscle group mass o f offspring from both Irs-2+/~ob+/' and Irs-2+ db+ 
intercrosses at 4 weeks o f age.
Gastronemius soleus and quadriceps muscle weights were pooled and expressed as means o f percentage 
total body weight +  s. e.m of at least 4 animals per genotype, except where indicated, * n=3, * p  < 0.05, **,
p  <  0.01, * * * , p  < 0.001, ****, p  < 0.0001.
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Analysis of total gonadal fat pad weight for other genotypes at four weeks of age, 
indicated that they were similar in weight to wild-type littermates and did not exhibit 
sexual dimorphism (Fig 3.7).
Muscle weight was determined by the combined weight of the quadricep and 
gastronemius soleus muscle groups from both hind legs of four-week-old mice. The 
combined weight of these muscle groups did not vary dramatically between sexes, when 
expressed as a percentage of total body weight (Fig 3.8). However, it was observed that 
leptin deficient animals exhibited a significant decrease in relative muscle weight 
compared to wild-type mice (Figure 3.8a; Irs-2+Aob'A, p < 0.01 and ob/ob, p < 0.0001 vs 
wild-type controls). A significant decrease in relative muscle weight was also noted in 
male Irs-2'Aob'A double knockout mice (p < 0.01). Double knockout female mice tended 
to have a decreased relative muscle weight compared to wild-type controls but this was 
not proven to be significant. Interestingly, Irs-2+Aob+A, Irs-2'Aob+A and Irs-2'A mice had 
relative muscle weights comparable to wild-type controls, with only male Irs-2'Aob+A 
mice showing a significant decrease relative to male wild-type littermates (Fig 3.8a; p < 
0.05). The body weights of Irs-2+Aob'A and ob/ob mice, although significant at four 
weeks of age, are not dramatically greater than wild-type littermates (Fig 3.2a-b). It is 
therefore unlikely that the significant decreases in relative muscle weight observed in 
these genotypes at four weeks of age are a direct consequence of their larger habitus. 
Moreover, male double knockout mice also exhibited a significant decrease in relative 
muscle weight at four weeks, despite being strikingly growth retarded at this age (Fig 
3.2a-b). These findings are consistent with previous reports, implicating functional leptin 
gene expression as being critical for the maintenance of muscle mass in mice (144). 
Indeed analysis of offspring from the Irs-2+Adb+Aintercross showed that leptin long-form 
receptor deficient mice also exhibited a significant reduction in relative muscle weight 
compared to wild-type controls (Fig 3.8b). This was particularly evident in female Irs- 
2+Adb'A and db/db mice (p < 0.0001 versus wild-type controls). Double knockout female 
mice from this intercross also displayed a significant decrease in relative muscle weight 
(Fig 3.8b; p < 0.01). Similarly, male double knockouts tended to have reduced relative 
muscle weight but this was not shown to be significant. Interestingly, female Irs-2+Adb+A, 
Irs-2'Adb+A and Irs-2'1' mice also exhibited significant decreases in relative muscle weight 
(Fig 3.8b). Considering male offspring from the Irs-2+Adb+Aintercross, only male Irs-2+A 
db'A and
85
db/db mice exhibited a decrease in relative muscle weight (Fig 3.8b; p < 0.05). This 
finding provides further evidence that functional leptin action is important for the 
maintenance of muscle mass in mice.
Consistent with previous reports both ob/ob and db/db mice had enlarged livers, 
demonstrating a significant increase in relative liver weight at four weeks of age (Fig 
3.9a-b). It was observed that this increase was more significant in female mice (p < 
O.0O1 compared top  < 0.05 for males). Enlarged livers were also observed in Irs-2+Aob'A 
and Irs-2+Adb~A mice (Fig 3.9a-b; p < 0.001 for females and p <0.05 for males versus sex 
matched wild-type controls). Considering other genotypes it was noted that female Irs-2' 
Aob+Aand Irs-2'1' mice also displayed significant increases in relative liver weight, 
compared to wild-type controls (Fig 3.9a; p < 0.0001 and p < 0.05 respectively). In 
comparison all other genotypes resulting from the two intercrosses had relative liver 
weights comparable to wild-type controls.
Interestingly when spleen weights were expressed as a percentage of total body 
weight, it was observed that Irs-2+Aob'A, ob/ob, Irs-2+Adb'A and db/db mice showed 
significant reductions in relative spleen weights compared to wild-type controls (Fig 
3.10). In comparison the relative weights of spleen in all other genotypes was 
comparable to wild-type mice.
Analysis of total brain weights indicated that mice homozygous for Irs-2 
generally had a significantly reduced total brain weight compared to wild-type littermates 
(Fig 3.11 c-d). Only female Irs-2'A mice resulting from the intercross of Irs-2+Adb+Amice 
showed a non-significant reduction in total brain weight, with all other Irs-2 homozygous 
mice demonstrating an extremely significant reduction in total brain weight (Fig 3.11 c-d, 
p < 0.0001), this was consistent with previous reports (145).
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Figure 3.9 Liver mass o f offspring from  both Irs-2+/'ob+/' and Irs-2+/'db+/' intercrosses 
at 4 weeks o f age.
Results are representative as means o f percentage total body weight ±  s.e.m of at least 4 animals per 
genotype, except where indicated’ u n=3, *, p  < 0.05, *** ,p<  0.001, **** p  < 0.0001.
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Figure 3.10 Spleen mass o f offspring from  both Irs-2+/'ob+/' and Irs-2+/'db+ 
intercrosses at 4 weeks o f age.
Results are representative as means of percentage total body weight ±  s.e.m of at least 4 animals per 
genotype, except where indicated. * n=3, *, p  < 0.05, **, p  < 0.01.
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Figure 3.11 Brain mass o f o ff spring from  both Irs-2+/~ob+/' and Irs -T 'd ff intercrosses 
at 4 weeks o f age.
Results are represented as (a-b) means o f percentage total body weight ±s.e.m  and (c-d) means o f total 
brain weights ±  s.e.m. o f at least 8 animals per genotype for the Irs-2+/ob+/ intercross and at least 4 
animals per genotype for the Irs-2+/'db+/' intercross, except where indicated, * n=3, * p  < 0.05, **, p  < 
0.01, *** p  < 0.001, ****, p  < 0.0001.
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Table 3.3: Summary of Body and tissue weights for various genotypes resulting from the two intercrosses
The mean body weights +/- s. e.m o f  all genotypes (excluding those mice containing the loss o f  one allele o f  either gene) are presented at both four and 
eight weeks o f  age. In addition the mean percentage tissue weights +/- s. e.m are presented fo r  the same genotypes resulting from the two intercrosses. 
Genotypes are presented in the table according to body weight, with genotypes decreasing in body weight as you read the table from left to right.
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3.6. Summary and discussion:
Both lrs-2'A and ob/ob mice are hyperphagic, leading to obesity and eventually 
the development of insulin resistance and type 2 diabetes. It was hypothesised that the 
combined deletion of these genes in mice was likely to produce an exaggerated adiposity 
phenotype prior to the development of diabetes, particularly in female mice in which the 
diabetic Irs-2'A phenotype is mild and obesity predominates. In contrast, Irs-2Aob~A mice 
were dramatically growth retarded. Similarly lrs-2Adb~A double knockout mice also 
displayed severe growth retardation. In addition to growth retardation, both double 
knockout mice failed to thrive. As Irs-2 A, ob/ob and db/db mice are insulin resistant and 
develop type 2 diabetes, it was considered that double knockout mice might be suffering 
from a more severe metabolic phenotype at an earlier age.
Growth retardation was not observed in either Irs~2 Aob+A or Irs-2Adb+A mice, 
where it appeared a single allele of either the ob or db gene was sufficient to restore the 
body weight of these animals to that of Irs-2 A mice. Consistent with previous reports, 
Irs-2A mice resulting from the intercross of Irs-2+Aob+A mice displayed sexual 
dimorphism with regard to body weight. Between eight and twelve weeks of age male 
Irs-2 A mice become more catabolic and start to lose weight. In contrast female Irs-1A 
mice are known to have a relatively normal glucose metabolism between eight and 
twelve weeks and this is reflected in their comparable body weights to wild-type animals 
at this age. Due to the surprisingly low numbers of male Irs-2~A mice derived, this sexual 
dimorphism was hard to assess in the Irs-2+Adb+A intercross. The low number of male 
lrs-2A mice derived from this intercross was surprising given the reasonable numbers of 
male Irs-2Adb+A mice obtained. It would have been interesting to see if more male Irs-2' 
A mice would have been gained from further breeding of this intercross. However, at 
present there is no explanation for the low numbers of male Irs-2'A obtained from this 
intercross.
Mice homozygous for either leptin or the leptin long-form receptor were obese 
as previously described (77, 78). It was also evident that Irs-2+Aob'A and Irs-2+Adb'A mice 
exhibited an obese phenotype. However it was clear that Irs-2+Adb'A mice weighed 
significantly less than Irs-2+Aob'A mice at eight weeks of age. As db+A mice were derived 
from a slightly different genetic background, this may influence our observations. Subtle
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variations in phenotypic traits of mice have been documented when mice have been bred 
upon different genetic backgrounds. However, although ob/ob and db/db mice have 
strikingly similar phenotypes, it should be noted that they are not exactly identical. 
Indeed, as db/db mice do not express the long-form of the leptin receptor, they are highly 
leptin resistant, resulting in an increase in circulating leptin levels. Although the leptin 
long-form receptor is believed to be the main mediator of leptin action, the shorter 
isoforms may not be completely redundant (56-58). If this were true, short-isoform 
receptor expression in db/db mice could facilitate some of leptin’s actions in target 
tissues. In contrast, leptin signalling is completely absent in ob/ob mice, as these mice do 
not express leptin (the ligand). Therefore it is reasonable to assume that there may be 
subtle differences between lrs-2+Aob *' and Irs-2+Adb'A mice.
Interestingly, dissections carried out upon four-week-old double knockout mice 
revealed that they contained significantly reduced gonadal fat-pad mass (white adipose 
tissue). As it is well documented that the insulin receptor substrate proteins have pivotal 
roles in adipogenesis (146), it was considered that the double knockout mice might be 
suffering with a form of lipodystrophy. As both development and catabolism can affect 
adipogenesis it would be essential to determine if and to what extent, the double 
knockout mice were catabolic. However the fact that small traces of white adipose tissue 
could be found around the gonadal region of some double knockout mice, indicated that 
this relative lipodystrophy was probably a result of catabolism. This issue is addressed in 
more detail in chapter five.
As expected, ob/ob and db/db mice both exhibited significant increases in 
relative gonadal fat pad mass compared to wild-type mice. This was also observed in Irs- 
2+Aob'A and Irs-2+Adb'A mice. Considering all other genotypes there was no significant 
change in gonadal fat mass relative to wild-type controls.
Muscle mass was significantly reduced in leptin and leptin-receptor deficient 
genotypes (including male Irs-2'Aob'A and female lrs-2~Adb'A double knockout mice) 
compared to wild-type controls. It is known that ob/ob mice exhibit muscle hypoplasia, 
this being particularly evident in the quadriceps (144). Moreover, leptin administration in 
ob/ob mice over a four week period had no effect on the morphology or function of 
skeletal muscle despite a reduction in body mass (147).
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Increases in liver size (hepatomegaly) can occur due to an increase hepatocyte 
proliferation (hepatocarcinogenesis) (148). However obesity is often accompanied by the 
manifestation of a fatty liver phenotype. Both leptin and leptin long-form receptor 
deficient rodents exhibit fatty livers, which are known to be increased for 
triacylglycerides and free-fatty acids (106, 149).
The observation that ob/ob, Irs-2**'ob'*', db/db and Irs-2*1'db'*' mice exhibited an 
significant increase in liver weight was consistent with such reports (150). Similarly 
female Irs-2 *'and Irs-2'*'ob**' mice also displayed a significant increase in liver size but 
this was not evident in male mice. This finding is consistent with the sexual dimorphism 
seen in the Irs-2'*' genotype and was thought to be indicative of the less severe disorder of 
glucose homeostasis and more pronounced obesity, exhibited by female Irs-2'*' mice 
compared to males. Interestingly the livers of female double knockout mice were 
comparable in weight to that of wild-type controls. It would be interesting to assess if 
liver triacylglyceride and free-fatty acid content were increased in double knockout mice, 
similar to previous reports in ob/ob and db/db mice.
The main function of the spleen is to monitor blood for potentially harmful 
foreign molecules. The blood vessels of the spleen are surrounded by nests of B 
lymphocytes. As blood passes through the spleen, it is monitored by T-cells for the 
presence of foreign bodies. Once detected T-cells present the foreign molecule to B 
lymphocytes and division of the appropriate memory B cell leads to the production of 
antibodies directed against the invading antigen.
Immune responses are intrinsically energy expensive and come at a cost to the 
responding organism (151). Leptin plays an important role in the generation and 
maintenance of immune responses (152, 153). Similar to previous reports, the spleens of 
leptin and leptin long-form receptor deficient animals were significantly smaller 
compared with those of age-matched wild-type mice (154, 155). In contrast spleens of 
Irs-2'*', Irs-2'*'ob**' and Irs-2’*'db**' were comparable in size to those of wild-type 
controls. Similarly IRS-2 has been implicated in immune function but these 
abnormalities are relatively mild compared to the disorders found in ob/ob and db/db 
mice (156).
92
In summary the finding that double knockout mice were growth retarded and 
did not exhibit an obese phenotype was unexpected. Previous studies on Irs-2A mice 
revealed that disorder to glucose homeostasis is less profound in females. Therefore the 
observation that female double knockout mice were also severely growth retarded is 
particularly surprising and would indicate that deletion of Irs-2 in combination with 
leptin or leptin receptor function has an additive effect upon peripheral glucose 
metabolism. To understand why this genotype develops such a profound phenotype that 
is surprisingly not obese, several metabolic studies were carried out to assess glucose 
homeostasis in double knockout mice. These are presented in the next two chapters 
(chapters 4 and 5).
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CHAPTER 4
Metabolic studies of offspring resulting from Irs-2+/~ob+/~ and
Irs-2+/~db+/~ intercrosses.
Irs-2~A, ob/ob and db/db mice all develop obesity, insulin resistance and 
eventually overt type 2 diabetes. The growth retardation and failure to thrive seen in the 
double knockout mice suggested that these mice might be developing a more severe 
metabolic phenotype at an earlier age. In order to determine the extent that these animals 
had lost control of glucose homeostasis, a number of metabolic studies were carried out 
immediately post-weaning and at later ages.
4.1 Fasting blood glucose levels of offspring from the Irs~2+Aob+A intercross at 4
and 8 weeks of age
At four weeks of age, double knockout mice had fasting blood glucose levels in 
excess of 12-17mmol/L and thus were markedly diabetic (Fig 4.1a). In comparison, all 
other genotypes had normal fasting blood glucose levels below 5mmol/L at four weeks of 
age (Fig 4.1a). These included the Irs-2'A mice, in which overt diabetes does not usually 
manifest itself until approximately eight to ten weeks of age. There were no differences at 
this age between fasting glucose levels in male and female animals of all the other 
genotypes.
Fasting blood glucose levels taken at eight weeks of age showed the double 
knockout mice to now have fasting blood glucose exceeding 20mmol/L (Fig 4.1b). In 
addition, Irs-2'Aob+A, Irs-2+Aob'A, Irs-2'A, and ob/ob mice now had high fasting blood 
glucose levels when compared to wild-type animals. These mice had fasting blood 
glucose in the range of 7-15mmol/L suggesting the presence of glucose intolerance. It 
was also observed that the hyperglycemia seen in these genotypes was more pronounced 
in males than females. This finding is consistent with previous reports on the Irs-2'A 
mice, with males developing glucose intolerance earlier than females (83, 84).
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Figure 4.1 Fasting blood glucose o f offspring from  Irs-2+/'ob+/' intercross at a) 4 weeks 
and b) 8 weeks o f age.
Results are expressed as mean fasting blood glucose ±_s.e.m and are representative of 8 animals per sex 
per genotype.
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4.2. Glucose tolerance tests o f off spring from the Irs-2+Aob+A intercross at 4 and 8
weeks of age
The marked fasting hyperglycemia displayed by double knockout mice at four 
weeks of age, suggested that they were glucose intolerant. Glucose tolerance tests were 
performed at four and eight weeks of age to address the glucose tolerance of all 
genotypes resulting from the Irs-2+Aob+Aintercross. Glucose tolerance testing of four- 
week-old mice confirmed that the double knockout mice were extremely glucose 
intolerant, regardless of gender (Fig 4.2). Statistical analysis of mean area under the curve 
+ s.e.m, determined both male and female double knockouts to be significantly glucose 
intolerant compared to wild-type controls (Fig 4.4, p < 0.0001). Comparing other 
genotypes at four weeks of age, only male Irs-2+/'ob'A mice showed any significant 
glucose intolerance relative to wild-type controls (Fig 4.4, p < 0.01). Irs-2'Aob+A, Irs-2+/' 
ob+A, lrs-2~A and ob/ob mice displayed normal glucose tolerance at four weeks of age (Fig 
4.2). Normal glucose tolerance was also seen in the Irs-2+/'and ob+A, mice (data not 
shown).
Further glucose tolerance tests carried out at eight weeks of age showed that 
double knockout mice were now severely glucose intolerant with blood glucose levels 
often failing to return within the range of the glucometer (Fig 4.4, p < 0.0001). 
Moreover, Irs-2'Aob+A, Irs-2+Aob'A, and ob/ob mice all now displayed marked glucose 
intolerance, regardless of gender (Fig 4.3). Analysis of area under the curve showed the 
glucose intolerance in these animals to be significant compared to wild-type controls (Fig 
4.4). Glucose tolerance tests carried out at eight weeks highlighted the sexual 
dimorphism seen in lrs-2'A mice, with males displaying severe glucose intolerance, while 
females were still relatively sensitive to a glucose load (Fig 4.3). Analysis of area under 
the curve for lrs-2'A mice showed male Irs-2'A mice to be significantly more glucose 
intolerant than wild-type controls (Fig 4.4, p < 0.001), whereas female lrs-2'A mice were 
shown to be not significantly different to sex matched wild-type controls (Fig 4.4). 
Interestingly Irs-2+Aob+A mice remained glucose tolerant, with an area under the curve 
comparable to that of wild-type controls for both sexes. Similarly, Irs-2+A and ob+A mice 
displayed, normal glucose tolerance at eight weeks of age (data not shown).
96
o
oo
m
Males
35-
30-
25-
?  20-
E
E 15-
10-
5-
0- i 1----- -  ,,i
15 30 60
—  IRS-2+/-OB+/-
—  IRS-2-/-OB+/- 
 IRS-2+/-OB-/-
—  Double knockout
—  OB/OB
—  IRS-2 KO 
Wild-type
Time
(minutes after injection)
Females
a>(0oo3
(!)
m
35n
30-
25-
?  20- 
|  15- 
IQ-
1200 15 30 60
Time
(minutes after injection)
—  IRS-2+/-OB+/-
—  IRS-2-/-OB+/- 
 IRS-2+/-OB-/-
—  Double knockout
—  OB/OB
—  IRS-2 KO
— Wild-type
Figure 4.2 Glucose tolerance tests o f offspring from  the Irs-2+/'ob+/~ intercross at 4 
weeks o f age.
Results are expressed as mean blood glucose ±  s.e.m and are representative o f 8 animals per sex per 
genotype.
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Figure 4.4 Statistical analysis o f glucose tolerance tests carried out at 4 and 8 weeks o f 
age on offspring from  the Irs-2+/~ob+/~ intercross.
Results are expressed as mean area under the curve + s. e.m from glucose tolerance test curves presented in 
Figures 4.2 and 4.3, being representative o f 8 animals per sex per genotype, t-tests were performed 
comparing all genotypes to their wild-type controls; ** , p< 0.01, ***, p  < 0.001, **** p  < 0.0001.
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4.3 Fasting blood glucose levels of offspring from the Irs-2+Adb+A intercross at 4
and 8 weeks of age
Consistent wiith Irs-2'Aob'A double knockout mice, Irs-2~Adb~A double knockout 
mice were also hyperglycaemic at four weeks of age (Fig 4.5a). This was particularly 
evident in male mice (p < 0.05). Whilst female mice tended to have elevated fasting 
blood glucose levels relative to wild-type controls, these levels were not significantly 
different (Fig 4.5a). However, the lower numbers of female double knockout mice 
studied may have contributed to this statistical outcome. Interestingly, male Irs-2'Adb+A 
mice also demonstrated significantly elevated fasting blood glucose levels relative to 
wild-type controls. In contrast, hyperglycaemia was not evident in the genotypic 
equivalent Irs-2'Aob+A mice, at this early stage (Fig 4.1a). This supports the idea that 
there are differences in the effects of reducing receptor expression as opposed to reducing 
leptin expression. In comparison, all other genotypes resulting from the intercross of Irs- 
2+Adb+A mice had normal fasting blood glucose levels below 5mmol/L at four weeks of 
age (Fig 4.5a).
Analysis of fasting blood glucose levels taken at eight weeks of age showed the 
double knockout mice to have fasting blood glucose exceeding 20mmol/L (Fig 4.5b). In 
addition, Irs-2'Adb+A, Irs-2+Adb'A, Irs-2'A, and db/db now had high fasting blood glucose 
levels when compared to wild-type animals. It was difficult to assess the fasting blood 
glucose in male Irs-2'A mice at 8 weeks of age, as only three were weaned from the 
intercross of Irs-2+Adb+Armce. Compound heterozygous Irs-2+/'db+/mice had fasting 
blood glucose levels comparable to wild-type littermates (Fig 4.5b).
4.4 Glucose tolerance tests of off spring from the Irs-2+Adb+A intercross at 4 and 8 weeks 
of age
The elevated fasting blood glucose levels demonstrated by double knockout 
mice at 4 weeks of age suggested these mice were also glucose intolerant. Glucose 
tolerance tests were therefore performed to address the glucose tolerance of all genotypes 
resulting from the Irs-2+Adb+Aintercross.
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Figure 4.5 Fasting blood glucose o f offspring from  Irs-2+/~db+/ intercross at a) 4weeks 
and b) 8 weeks o f age.
Results are expressed as mean fasting blood glucose ±_ s.e.m and are representative o f at least 4 animals 
per sex per genotype (except where indicated, * n=3 *, p  < 0.05, **, p  < 0.01, ***, p  < 0.001, **** p  <
0.0001.
101
Glucose tolerance testing of four-week-old mice confirmed that male lrs-ZAdb'A 
double knockout mice were significantly glucose intolerant compared to wild-type 
controls (Figs 4.6 and 4.8a, p < 0.05 for area under the curve versus wild-type controls). 
In contrast all other genotypes at this age were shown to have normal glucose tolerance 
(Fig 4.6 and 4.8a).
Glucose tolerance testing at eight weeks of age indicated that double knockout 
mice were now severely glucose intolerant, regardless of gender (Fig 4.7 and 4.8b). 
Moreover, as with the double knockout mice derived from the intercross of Irs-2+/'ob+/ 
mice, lrs-2'Adb'A double knockout mice were also unable to return into the glucose range 
of the glucometer following a glucose dose (Fig 4.8b, p < 0.0001 for area under the curve 
versus wild-type controls). Glucose intolerance was also observed at eight weeks of age 
in Irs-2+Adb'A and db/db mice. Once again analysis of area under the curve indicated that 
female Irs-2+Adb'A and db/db mice were more significantly glucose intolerant relative to 
sex matched wild-type controls, than were male mice of the same genotype (Fig 4.8b, p < 
0.0001 for female Irs-2+Adb'A and db/db mice versus wild-types, compared to p < 0.001 
for male Irs-2+Adb'A and p < 0.05 for male db/db mice versus wild-types). Irs-2'Adb+A 
mice also displayed glucose intolerance at eight weeks of age (Fig 4.7), being more 
pronounced in males than females (Fig 4.8b). In contrast, Irs-2+Adb+A and female lrs-2'A 
mice appeared to be glucose tolerant at eight weeks of age (Fig 4.8b).
4 .5  S u m m a r y  a n d  d isc u ss io n
The global deletion of IRS-2 in mice is known to lead to the manifestation of 
type-2 diabetes as early as eight weeks of age in male mice. The growth retardation and 
failure to thrive exhibited by double knockout mice suggested that these mice were 
suffering from a more severe metabolic phenotype at an earlier age. Indeed four-week- 
old lrs-ZAob'A mice were diabetic as indicated by fasting blood glucose levels in excess 
of 12-17mmol/l. Glucose tolerance testing carried out on double knockout mice at four 
and eight weeks, highlighted their severe glucose intolerance. It was evident that despite 
having similar fasting blood glucose levels to Irs-2'Aob'A mice at four weeks of age (Fig 
4.4a AUC = -4000), Irs-2'Adb'A mice (Fig 4.8a AUC -  2000) exhibited only mild glucose 
intolerance.
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Figure 4.6 Glucose tolerance tests o f offspring from  the Irs-2+/~db+/' intercross at 4 
weeks o f age.
Results are expressed as mean blood glucose ±_s.e.m and are representative of at least 8 animals per sex 
per genotype (except where indicated, *n= at least 3).
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Figure 4.7 Glucose tolerance tests o f offspring from  the Irs-2+Adb+A intercross at 8 
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Figure 4.8 Statistical anaylsis o f glucose tolerance tests carried out at a) 4 and b) 8 
weeks o f age on offspring from the Irs-2+/'ob+/' intercross.
Results are expressed as mean area under the curve + s. e.m from glucose tolerance test curves presented in 
Figures 4.6 and 4.7, being representative o f at least 4 animals per sex per genotype (except where 
indicated, ’n 3 ) .  t-tests were performed comparing all genotypes to their wild-type controls; *, p  < 0.05,
**, p  < 0.01, ***, p  < 0.001, ****, p  < 0.0001.
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As discussed in chapter 3 this may been a consequence of the db+A mice being derived 
from a different genetic background. However it is clear that wild-type, Irs-2~A, db/db 
and Irs-2+Adb+/ mice resulting from the intercross of Irs-2+Adb+A mice, are similar to the 
equivalent mice from the Irs-2+Aob+A intercross. This would indicate that differences 
observed between other equivalent genotypes, are a true consequence of differences 
between loss of leptin or leptin receptor function. Previous reports have demonstrated 
that adult mice heterozygous for either the ob or db gene function have equivalent fat 
mass and percentage body fat. Interestingly mice heterozygous for both the ob/ob or 
db/db genes, demonstrate further increases in fat mass and percentage body fat (157). 
This additive effect would support the idea that there are subtle differences in the effects 
of deleting either leptin or leptin long-form receptor function.
Considering all other genotypes at four weeks of age, only male and female Irs- 
2+Aob'A mice exhibited significantly elevated fasting blood glucose levels relative to wild- 
type controls, with only males proving to be mildly glucose intolerant. This finding of 
sexual dimorphism is consistent with previous reports of glucose metabolism in Irs-2'A 
mice (83, 84). In the context of Irs-2+Aob'A mice, the presence of Irs-2 expression 
probably facilitates a mild (3-cell response to insulin resistance. The increased glucose 
intolerance reported in males, may occur as a result of increased peripheral insulin 
resistance compared to that present in female mice. Increased insulin resistance could 
arise either from the systemic reduction in Irs-2 expression or due to differences between 
male and female mice lacking leptin (ob) gene function, or through a combination of 
these factors. Glucose-stimulated insulin release was not assessed in the double knockout 
mice, as the small size and frailty of these animals made this technically too difficult. 
Moreover previous studies had shown glucose-stimulated insulin release to be normal in 
Irs-2'A mice. However assessment of glucose-stimulated insulin release in male and 
female Irs-2+Aob'A mice may provide further insight into the metabolic differences 
described for this genotype. Interestingly, both female and male Irs-2+Adb~A mice, were 
glucose tolerant at four weeks of age.
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The observation that lrs-2~Aob+A mice exhibit normal glucose tolerance at four 
weeks of age, illustrates that a single allele of leptin is sufficient to avoid the onset of the 
dramatic metabolic phenotype seen in double knockout mice. The presence of a single 
allele of leptin upon an Irs-2'1' background was also sufficient in preventing the growth 
retardation seen in double knockout mice. Taken together these findings emphasize the 
importance of leptin sensitivity and in particular how leptin action is essential for the 
maintenance of insulin sensitivity. The observation that eight-week-old lrs-2Aob+A 
female mice were more glucose intolerant than Irs-2'A female mice but less so than 
female double knockout mice, further illustrates the importance of leptin sensitivity in 
regulating peripheral glucose metabolim.
Considering Irs-2'Adb+A mice, only males were glucose intolerant at eight 
weeks, with female mice remaining relatively glucose tolerant. This finding supports the 
idea that subtle differences exist between the loss of leptin and leptin long-form receptor 
function, when on an Irs-2'A background. In this context it would appear that, the loss of 
leptin (ob) gene expression induces a slightly more severe metabolic phenotype than 
observed when leptin long-form receptor (db) gene expression is lost. Indeed if leptin 
signalling does converge at IRS-2, these observations could be explained by shorter- 
isoforms of the leptin receptor mediating some leptin action upon IRS-2 in db/db mice. 
In contrast ob/ob mice are unable to mediate any leptin action as they lack leptin 
expression.
Elevated fasting blood glucose levels present in Irs-2'Aob+A, Irs-2+Aob'A, ob/ob 
and lrs-2'A mice at eight weeks of age, indicated that they were now also glucose 
intolerant. As described above Irs-2'A mice displayed sexual dimorphism, with males 
being more glucose intolerant than females. Glucose tolerance testing of eight-week-old 
Irs-2+Aob'A mice, showed female mice were now as glucose intolerant as males. 
Similarly, Irs-2+Adb'A and db/db mice resulting from the Irs-2+Adb+A intercross were also 
glucose intolerant at eight weeks of age. Interestingly both compound heterozygous mice 
(Irs-2+Aob+A and Irs-2+Adb+Amice) showed normal glucose tolerance at eight weeks of 
age.
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In summary assessment of glucose metabolism in offspring resulting from the 
intercross of either Irs-2+/'ob+/' or Irs-2+/'db+/'mice, has demonstrated that both double 
knockout mice are extremely diabetic, characterised by, elevated fasting blood glucose 
levels and glucose intolerance at four weeks of age. However glucose tolerance was 
more impaired in Irs-2'Aob~A mice compared to Irs-2v'db'A mice. Similar differences were 
also evident in other equivalent genotypes resulting from the two intercrosses. Such 
findings suggest that in combination with Irs-2 deficiency, insults to leptin gene 
expression are more detrimental to glucose homeostasis, than insults to leptin receptor 
gene expression. The fact that female Irs-2~Aob+/~ mice are glucose intolerant at eight 
weeks of age but female Irs-2'Adb+/' mice are glucose tolerant at this age, further 
highlights this point. Possibly of more importance is that either a single allele of leptin or 
leptin receptor gene expression was sufficient to delay the marked glucose intolerance 
exhibited by double knockout mice. Taken together these findings exemplify the 
importance of leptin sensitivity to regulate whole-body glucose homeostasis. The wide 
range of glucose tolerance presented by the various genotypes, would suggest differences 
in peripheral insulin sensitivity. Leptin has also been shown to influence (3-cell function 
directly (90, 91, 127). Therefore assessment of pancreatic islet function will provide 
useful insights into the peripheral insulin sensitivity of these animals.
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CHAPTER 5
Pancreatic P-cell function in offspring from lrs-2+/'ob+/' and Irs-
2 db+/' intercrosses.
Pancreatic P-cell function
In view of the impaired glucose tolerance seen in the double knockout mice at 
four weeks of age and the markedly diabetic phenotype seen in these animals by eight 
weeks of age, pancreatic (3-cell function was assessed. Initially fasting serum insulin 
levels were assayed at four and eight weeks of age. This measurement gives indication of 
insulin resistance as hyperinsulinaemia suggests the presence of insulin resistance. The 
markedly impaired glucose intolerance seen in the double knockout mice at eight weeks 
of age in male and female animals also suggests that by this age the mice have an 
inadequate insulin production and could therefore be relatively insulinopaenic.
In addition, pancreatic morphology was assessed. In rodent models, the P-cell 
compensatory response to insulin resistance includes both an increase in insulin 
production and also an increase in P-cell mass. Assessment of islet size was therefore 
performed by histological examination, staining of islets for insulin and morphometric 
analysis.
5.1 Fasting insulin levels of offspring from the Irs-2+/'ob+/' intercross
Fasting insulin levels were measured in male and female animals at four and 
eight weeks of age. At four weeks of age, both male and female double knockout mice 
display elevated fasting insulin levels compared to wild-type mice suggesting the 
presence of insulin resistance (Fig 5.1a, p < 0.01 for both males and females). Similarly 
ob/ob, Irs-2A, Irs-2v'ob+/' and Irs-2+/'obv' mice also displayed elevated fasting insulin 
levels compared to wild-type littermates (Fig 5.1a). Consistent with previous reports (83), 
Irs-2'A mice exhibit sexual dimorphism, with males having significantly higher fasting 
insulin levels compared to wild-types (p < 0.01) and females showing a non-significant 
increase in fasting insulin levels.
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Figure 5.1 Fasting insulin levels o f offspring from  the Irs-2+/'ob+/' intercross at a) four 
and b) eight weeks o f age.
Cardiac puncture was performed on terminally anaesthetized, 15 hr fasted mice. Blood samples were 
clarified by centrifugation (13,000rpm for 20 mins at 4°C) and the resulting serum was quantified for 
insulin concentration by a commercially available rat insulin ELISA assay (using a mouse insulin 
standard). All assays were assayed in duplicate and results are presented as average plasma insulin ±  
s.e.m, being representative o f 5 animals per sex per genotype.
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It is well documented that male lrs-2~A mice are more insulin resistant at this age 
compared to female lrs-2A mice. Hence the it follows that male Irs-2A mice would 
display a more significant increase in fasting insulin levels.
In contrast, by eight weeks of age both male and female double knockout mice 
display relative hypoinsulinaemia compared to wild-type mice suggesting p-cell failure 
(Fig 5.1b). Considering other genotypes at eight weeks, male Irs-21' mice now displayed 
reduced fasting insulin levels while the female mice were hyperinsulinaemic. This again 
demonstrates the sexual dimorphism seen in the metabolic phenotype of Irs-2'A mice. The 
leptin deficient ob/ob and Irs-2+Aob'A mice displayed marked hyperinsulinaemia (Fig 
5.1b,p < 0.0001 for males and females), suggesting insulin resistance. Interestingly, mice 
with a single allele of ob in an Irs-2'A background appeared to have fasting insulin levels 
that were comparable or higher than wild-type mice suggesting that a single allele of ob 
may ameliorate the P-cell defect or insulin resistance seen in the double knockout mouse.
5.2 Fasting insulin levels of offspring from the Irs-2+Adb+A intercross
Fasting insulin levels were also analysed for genotypes resulting from the 
intercross of Irs-2+Adb+A mice at eight weeks of age (Fig 5.2). In contrast to double 
knockout mice from the Irs-2+Aob+A intercross, Irs-2'Adb'A double knockout mice exhibit 
relatively comparable fasting insulin levels to wild-type mice at eight weeks of age. 
Mice deficient for the leptin long-form receptor, db/db and Irs-2+Adb'A also displayed 
elevated fasting insulin levels at eight weeks of age. This hyperinsulinaemia would 
suggest that these mice were also insulin resistant. Unfortunately due to the low numbers 
of male lrs-2'A mice derived from the intercross of Irs-2+Adb+Amice, none were analysed 
for fasting insulin levels. However, female Irs-2'Amice were shown to have significantly 
elevated fasting insulin levels (Fig 5.2, p < 0.01). This was consistent with age matched 
female Irs-2'A mice from the Irs-2+Aob+A intercross. Consistency between the two 
intercrosses was further highlighted by the finding that Irs-2'Adb+Amice of both sexes had 
comparable fasting insulin levels to wild-type controls at eight weeks of age (Fig 5.2).
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Figure 5.2 Fasting insulin levels o f offspring from the Irs-2+/'db+/‘ intercross at eight 
weeks o f age.
Cardiac puncture was performed on terminally anaesthetized, 15 hr fasted mice. Bloods were clarified by 
centrifugation (13,000rpm for 20 mins at 4°C) and the resulting serum was quantified for insulin 
concentration by a commercially available mouse insulin ELISA assay. All assays were assayed in 
duplicate and results are presented as average plasma insulin ±  s.e.m, being representative of at least 5 
animals per sex per genotype (except where indicated, un=3).
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5.3 Pancreatic islet morphology and quantification o f relative islet density and
area in wild-type, Irs-2'1', ob/ob and double knockout mice
Given the relative hypoinsulinaemia of Irs-2~Aob~/\  double knockout mice, 
pancreatic islet morphology was analysed both by haematoxylin & eosin staining of 
pancreatic sections and by immunofluorescence analysis of islets for insulin. In addition 
relative islet density and area were quantified by morphometric analysis of pancreatic 
sections immunostained for insulin.
5.3.1 Haematoxylin and eosin staining
Haematoxylin and eosin staining of pancreas sections from eight-week-old mice 
revealed that the pancreases of the double knockout mice contained fewer islets and those 
that were present were reduced in size (Fig 5.3), when compared to wild-type mice. The 
ob/ob mice show increased p-cell mass suggesting a robust islet compensatory response 
to insulin resistance consistent with the presence of fasting hyperinsulinaemia. Analysis 
of lrs-2'/' mice pancreas showed an approximately 50% reduction in P-cell mass 
compared to wild-type animals consistent with previous reports.
5.3.2 Immunostaining of insulin in /3-cells
Insulin staining of pancreatic sections from eight-week-old mice revealed that 
the p-cells of the double knockout mice were almost void of insulin (Fig 5.4). These 
findings are consistent with the relative hypoinsulinaemia seen in these animals and 
would explain provisionally their rapid development of diabetes. In the case of the Irs-2' 
A mice, their islets although generally smaller than wild-type were still able to produce 
insulin (Fig 5.4). This is likely to be why diabetes does not ensue so rapidly in these 
animals, as it does in the double knockout mice.
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Figure 5.3 Islet morphology o f double knockout (d) compared to wild-type (a), ob/ob 
(b) and Irs-ZA (c) mice at eight weeks o f age.
Pancreas sections (5pm) were stained with haematoxylin and eosin to analyse islet morphology. Images 
were captured at 200 x  magnification. Representative islets are pictured and are typical o f three 
independent experiments.
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Figure 5.4 Immunostaining o f insulin in /3-cells o f Pancreas sections from eight week 
old; wild-type (a), ob/ob (b), Irs-TA(c) and double knockout (d) mice.
Pancreas sections (5pm) were mounted onto poly-lysine coated slides, deparaffinised and probed with an 
anti-insulin monoclonal antibody (1:1,000) (sigma 1-2018) with Subsequent detection by Alexa-Fluor 
594os secondary antibody (molecular probes). Fluorescent images were captured at 200 x  magnification. 
Representative islets are pictured and are typical o f three independent experiments.
5.3.3 Quantification o f relative islet density and relative islet area in wild-type,
ob/oby Irs-2'/m, Irs-2'Aob+A, double knockout mice
Relative islet density and relative islet area of four and eight-week-old; wild- 
type, ob/ob, lrs-2'A, Irs-2'Aob+A, and double knockout mice was determined by quantative 
analysis of four whole pancreatic sections, from four animals, immunostained for insulin. 
At four weeks of age, ob/ob, Irs-2’A, Irs-2'Aob+A, and double knockout mice all showed a 
non-significant increase in relative islet density compared to wild-type mice (Fig 5.5a). 
Analysis of relative islet density at eight weeks of age indicated that both, Irs-2'Amd Irs- 
2'Aob+Amice generally contained fewer islets than wild-type mice (Fig 5.5b). In contrast 
the relative density of islets in double knockout mice was determined to be equal to or 
greater than that observed in wild-type mice. The relative islet density of ob/ob mice was 
significantly increased compared to wild-type controls (p < 0.01). This finding was 
consistent with the hyperinsulinaemia exhibited by these animals at eight weeks of age 
(Fig 5.1b).
The ~50% reduction in relative islet area observed in Irs-2'Armce at four and 
eight weeks of age, was consistent with previous reports (83) (Fig 5.6 a-b). In contrast, 
Irs-2'Aob+A and double knockout mice both contained relative islet areas comparable to 
that of wild-types at four weeks of age (Fig 5.6a). Indeed although not proven to be 
significant, it was noticed that double knockout mice tended to have an increased relative 
islet area compared to wild-type mice. However the relative islet area of Irs-2'Aob+A and 
double knockout mice was dramatically reduced by eight weeks of age (Fig 5.6b). 
Analysis of eight-week-old ob/ob mice showed that not only did they contain 
significantly more islets but those that were present were increased in area (Fig 5.6b, p < 
0.05). These findings are summarised in Table 5.1 as a percentage increase or decrease 
in mean relative islet density and area compared to that observed in wild-type controls.
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Figure 5.5 Quantification o f relative islet density in Irs-2'ob+/', double knockout, 
ob/ob, Irs-2y' and wild-type mice, at a), four and b). eight weeks o f age.
The total islet count for a pancreatic section was expressed as islets/mm2. Results are 
representative o f four pancreatic sections o f four animals per genotype.
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Figure 5.6 Quantification o f relative islet area in Irs-ZAob+/', double knockout, ob/ob, 
lrs-Z ' and wild-type mice, at a), four and b). eight weeks o f age.
The total islet area for a pancreatic section was expressed as a percentage of total 
section area. Results are representative o f four pancreatic sections o f four animals per 
genotype.
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4 WEEKS 8 WEEKS
Relative islet 
density
(islets/mm2)
Relative islet 
area
(% of total 
area)
Relative islet 
density
(islets/mm2)
Relative islet 
area
(% of total 
area)
Double
knockout +48 +27 +15 -59
Irs-2 KO +33 -35 -20 -58
ob/ob +44 +364 +285 +375
lrs-2-i-
ob+A +54 -13 +40 -71
Table 5.1 Summary o f differences in mean relative islet density and area in double 
knockout, Irs-Z \ ob/ob and Irs-IAob+/~ mice compared to wild-types at four and eight 
weeks o f age.
Results are expressed as a percentage increase or decrease in mean relative islet density 
or area compared to that observed in wild-type controls.
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5.4 Assessment o f fasting leptin levels in offspring from the Irs-2+Aob+A and Irs-
2+Adb+A intercrosses
The adipocyte-hormone leptin is known to act upon the P-cell to suppress 
insulin secretion. Given the various levels of fasting insulin and adiposity displayed by 
offspring resulting from either Irs-2+Aob+A or Irs-2+Adb+A intercrosses, fasting leptin 
levels were determined at eight weeks of age (Figs 5.7 and 5.8).
As would be expected fasting leptin was not detectable in animals, homozygous 
for the leptin gene (data not shown). Considering other genotypes from the Irs-2+Aob+A 
intercross at eight weeks of age, both male and female Irs-2+Aob+A and Irs-2'Aob+A mice 
had fasting leptin levels comparable to wild-types (Fig 5.7). Similarly male Irs-2'A mice 
had fasting leptin levels comparable to wild-type mice. In contrast, female Irs-2'A mice 
displayed fasting leptin levels that were significantly elevated compared to wild-type 
controls (Fig 5.7b, p < 0.05). It is known that female Irs-2'A mice do not become 
catabolic as quickly as male Irs-2'A mice. The increased fasting leptin levels presented by 
female Irs-2'A mice at eight weeks is presumably a consequence of the increased 
adiposity exhibited by female Irs-2'A at this age.
Consistent with previous reports mice homozygous for the leptin long-form 
receptor{db/db and Irs-2+Adb'A) were hyperleptinemic at eight weeks of age (Fig 5.8, p < 
0.001). Such hyperleptinemia would indicate that these mice were leptin resistant. In 
contrast, lrs-2'Adb'A double knockout mice were not hyperleptinemic but had fasting 
leptin levels comparable to wild-type mice. The observation that loss of functional leptin 
receptor signalling upon an Irs-2'A background did not result in hyperleptinemia, can be 
explained by the markedly reduced adiposity exhibited by these animals. As white 
adipose tissue (WAT) is responsible for the majority of leptin expression, the lack of 
adiposity (particularly WAT) in Irs-2'Adb'A mice would therefore limit leptin synthesis in 
response to peripheral leptin resistance. Due to the low numbers of male Irs-2'A mice 
derived from this intercross, no fasting leptin levels were measured at eight weeks of age. 
However, female Irs-2'A mice displayed a significant increase in fasting leptin levels 
relative to wild-type controls (Fig 5.8b, p < 0.001).
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Figure 5.7 Fasting leptin levels o f offspring from  the Irs~2+/'ob+/~ intercross at eight 
weeks o f age.
Cardiac puncture was performed on terminally anaesthetized, 15 hr fasied mice. Bloods were clarified by 
centrifugation (13,000rpm for 20 mins at 4°C) and the resulting serum was quantified for leptin 
concentration by a commercially available mouse leptin ELISA assay. All assays were assayed in 
duplicate and results are presented as average plasma leptin ±_ s.e.m, being representative o f at least 5 
animals per sex per genotype. As expected leptin was undetectable in the leptin deficient; ob/ob, Irs-2+/'ob' 
A and double knockout mice. *P < 0.05.
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Figure 5.8 Fasting leptin levels o f offspring from  the Irs-2+/~db+/~ intercross at eight 
weeks o f age.
Cardiac puncture was performed on terminally anaesthetized, 15 hr fasted mice. Bloods were clarified by 
centrifugation (13,000rpm for 20 mins at 4°C) and the resulting serum was quantified for leptin 
concentration by a commercially available mouse leptin ELISA assay. All assays were assayed in 
duplicate and results are presented as average plasma leptin ±  s.e.m, being representative o f at least 5 
animals per sex per genotype (except where indicated, un 3 ) .
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IRS-2+/'ob+/‘ X IRS-2+/'ob+/‘
INCREASING <-----------------------------  BODY WEIGHT -----------------------------> DECREASING
ob ob IRS-2*w - IRS-2*Aob*/- Wild**!>• IRS- KO IRS-2 •'ob*'’
4 weeks of age 4.6+/- 0.7 4.0+/-0.7 4.1 +/-0.9 6.6+/-1.1 4.5+/-0.5 5.0+/-1.0 3.8+/-0.7 4.0+/-1.1 44+/-1.0 5.0+/-0.8 4.7+/-0.8 6.1 +/-1.3
8 weeks of age 8.4+/- 0.9 7.3+/-3.1 10.0+/-2.6 11.7+/-2.9 4.7+/-0.6 4.9+/-0.8 4.6 +/-0.9 4.6+/-0.5 9.3 +/-4.0 7.3+/-4.8 14.8+/-8.1 13.4+/-7.4
4 weeks of age 1.7 +/-0.8 2.3+/-1.2 2.8+/-1.2 2.0+/-0.7 NO DATA NO DATA 1.1*/- 04 0.7+/- 0.1 2.1+/-04 1.2+/- 0.4 1.7+/-0.5 1.6+/-0.6
8 weeks of age 7.9+/-1.3 10.6+/-2.4 9.0+/-2.7 16.2+/-2.6 NO DATA NO DATA 1.0+/- 0.4 1.2+/-04 0.6+/-04 4.1 +/-1.2 1.1+/-0.4 2.1 +/-1.0
8 weeks of age NONE NONE NONE NONE 2.1 +/-14 2.9+/-2.2 1.6+/-0.8 2.0+/-1.2 0.9+/-0.8 1.2+/-1.3 L^7+!^ Tj
IRS-2+/'db*y" X IRS-2+/*db+/-
4 weeks of age
INC REA!5ING -f n .. n n n v  UUFIRMT ...........  . . v n c n LEASING
db/db
MALES FEMALES
4.2+/-0.9 3.2+/-0.4
IRS-2*
MALES
3.4+/-0.6
'db-'-
FEMALES
3.8+/-0.9
IRS-2
MALES
3.8+/-0.6
*'db*'-
FEMALES
3.8+/-0.6
Wild-type 
4.1 +/-0.6 I 3.8+/-1.1
IRS-
MALES
3.1+/-0.3
2 KO 
FEMALES
4.4+/-0.8
IRS-2
MALES
5.5+/-1.4
-db*'-
FEMALES
3.8+/-0.7
8 weeks of age 7.7+/-2.8 8.6+/-2.2 11.9+/-3.1 9.1+/-2.4 4.0+/-0.5 3.6+/-0.3 4.9+/- 0.9 4.0+/-0.9 NO DATA 5.3+/-0.6 11.4+/-6.3 4.7+/-1.0
8 weeks of age j 8.6+/-1.3 J 10.8+/-3.0 7.0+/-2.6 8.2+/-2.7 NO DATA NO DATA 0.8+/-0.2 1.1*/- 0.2 NO DATA 2.6+/-0.7 0.8+/-0.4 I 1.3+/-0.6 1
8 weeks of age 77.0+/-13.3 J 77.2+/-18.8 64.2+/-29.7 69.7+/-18.4 4.4+/-4.1 6.8+/-2.5 0.6+/-0.3 2.2+/-1.4 NO DATA 11.2+/. 6.0 4.9+/-3.7 18.0+/-8.8 j
Double knockout
8.3+/- 4.1 8.2+/-5.5
22.7 +/-2.8 26.1 +/-1.7
I+/-0.3 0 .7+ /-0  1
1.5+/-1.1 2.2 +/- 0.'
Table 5.2: Summary offasting blood glucose, insulin and leptin levels of genotypes resulting from both Irs-2+/-ob+/- and Irs-2+/-db+/-intercrosses.
Results are presented as mean values +/- s.e.m and are extracted from earlier figures describing fasting blood glucose levels (Chapter 4: Figures 4.1 and 4.5), 
insulin levels (Chapter 5: Figures 5.1 and 5.2) and leptin levels (Chapter 5: Figures 5.7 and 5.8) levels for each of the intercrosses. Hence, the data is 
representative of the n-numbers described in such figures.
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Similarly, significantly elevated fasting leptin levels were also observed in both male and 
female Irs-2/ db+/ mice (Fig 5.8, p < 0.05 for males and p < 0.001 for females). 
Interestingly Irs-2+/ db+A mice also displayed elevated fasting leptin levels, which was 
significant for female mice (Fig 5.8b, p  < 0.001).
5.5 Insulin treatment o f double knockout mice
The striking growth retardation and apparent absence of an obesity phenotype in 
the double knockout mice compared to either Irs-2'1' or ob/ob mice suggested that either, 
the loss of both genes impaired adipogenesis or that the marked diabetic phenotype 
leading to a state of catabolism contributed to this lack of marked adiposity. The results 
suggested that the predominant effect of the loss of both alleles was upon p-cell function 
and the ability to compensate for insulin resistance. To attempt to determine whether the 
growth retardation was a secondary effect to the dramatic diabetes seen in these mice, 
three double knockout mice were treated with insulin over a 20 day period. In addition 
Irs-2'A and Irs-2'Aob+A mice were also treated with insulin.
Insulin treatment was successful at reducing the glucose and ketone levels in the 
urine of these three double knockout mice (data not shown) and this was paralleled with a 
rescuing of their growth retardation. Following 20 days of insulin treatment double 
knockout mice weighed almost double that of the average, untreated double knockout of 
the same age (Fig 5.9). Further treatment of double knockout mice over a period of 6 
weeks indicated that the rescuing of growth in the double knockout mice was so dramatic 
that they now weighed more than their wild-type littermates and were similar in body 
habitus to ob/ob mice (Figure 5.10).
5.5 Summary and discussion
The dramatic impairment to glucose homeostasis described at four weeks of age 
in Irs-2'Aob'A double knockout mice, suggested that these mice were insulin resistant. 
Fasting insulin levels determined at four weeks of age showed double knockout mice to 
be significantly hyperinsulinaemic relative to wild-type mice, indicating the presence of
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Double Knockout 
IRS-2 KO + Insulin
lrs-2-/-ob+/-
Double Knockout 
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15 200 5 10
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Figure 5.9 Insulin treatment o f Irs-T j Irs -I 'ob+ and double knockout mice.
Three four-week-old Irs-2'A, I rs -2 o b +/ and double knockout mice were administered daily injections of 
Lantus (a long-acting insulin), in accordance with daily measurements o f body weight and urine glucose 
and ketone content. Following 20 days o f treatment double knockout mice weighed significantly more than 
age-matched untreatred double knockout mice (*p < 0.05).
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Figure 5.10 Insulin treatment o f double knockout mice over a forty-day period.
Double knockout mice were administered daily injections o f Lantus (a long-acting insulin), in accordance 
with daily measurements o f body weight and urine glucose and ketone content. Following thirty days of 
treatment double knockout mice weighed more than age-matched wild-type mice. Indeed double knockout 
mice now had the habitus o f ob/ob mice.
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insulin resistance. Interestingly by eight weeks of age Irs-2~Aob~Amice were relatively 
hypoinsulinaemic, suggesting (3-cell failure.
Quantification of relative islet density and area at four and eight weeks of age 
was consistent with this pattern of fasting insulin levels. Relative islet density and area in 
four-week-old double knockout mice was equal to (if not greater) than that of wild-type 
mice. Although the difference did not reach statistical significance, the trend for double 
knockout mice to display an increased relative islet density and area at four weeks of age 
relative to lrs-2'A mice, indicated that initially p-cell compensation was occurring in these 
mice. However despite having a relative islet density comparable to that of wild-type 
controls even at eight weeks of age, the islets present were reduced in relative area. 
Hence the relative islet compensation present in double knockout mice is short-lived. 
Moreover assessment of pancreatic islet morphology in eight-week-old double knockout 
mice by insulin staining, indicated that not only were islets smaller but almost void of 
insulin. It is therefore evident that P-cell failure occurs by eight weeks of age in the lrs-2 
Aob'A double knockout mice, explaining their severe metabolic phenotype.
Interestingly Irs-2Adb'A double knockout mice had fasting insulin levels 
comparable to wild-type controls at eight weeks of age. Although Irs-2’Adb'A double 
knockout mice also exhibit a severe early-onset diabetic phenotype, they appear to be less 
glucose intolerant than their Irs-2'Aob'A equivalents. As discussed in chapter four, this 
was certainly evident when considering glucose tolerance testing of four-week-old mice 
(Figs 4.2 and 4.6). However, if Irs-2'Adb'A mice are more glucose tolerant and insulin 
sensitive than Irs-2'Aob'A mice, it is plausible that Irs-2'Adb'A mice may still mount a mild 
P-cell response at eight weeks of age. The possibility that the shorter isoforms of the 
leptin receptor are capable of mediating some of leptin’s actions in db/db mice, finds 
further support from these findings.
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Similarly to double knockoukout mice, male lrs-2A mice exhibited elevated 
fasting insulin levels at four weeks, followed by relative hypoinsulinaemia at eight weeks 
of age. In contrast female lrs-2'A mice had fasting insulin levels comparable to wild-type 
mice at four weeks of age but displayed hyperinsulinaemia by eight weeks of age. This 
highlighted the sexual dimorphism presented by this genotype and indicated that male 
lrs-2'A mice suffer with increased insulin resistance.
Leptin deficient (ob/ob or Irs-2+/'ob^') or the leptin long-form receptor deficient 
(idb/db or Irs-2+/'db'A) mice were hyperinsulinaemic at eight weeks of age. Analysis of 
islet morphology in ob/ob mice demonstrated the presence of (3-cell hyperplasia, 
consistent with such fasting hyperinsulinaemia. Moreover quantification of relative islet 
density and area in ob/ob mice showed them to have a significant increase in both relative 
density and area compared to wild-type controls (Table 5.1, >300% increased relative 
islet area, relative to that exhibited by wild-type controls). Although not addressed it is 
suspected that the dramatic hyperinsulinaemia reported in Irs-2+/'ob'A, db/db and Irs-2+/' 
db'Amice was also the result of P-cell hyperplasia.
Taken together these findings highlight the importance of both insulin and leptin 
action in maintainance of the P-cell response to insulin resistance. In the absence of 
leptin or its receptor lrs-2 A mice had an increased P-cell response compared to mice just 
lacking IRS-2. These findings suggest that leptin negatively regulates p-cell mass, acting 
either in the periphery or intrinsically to the P-cell. It is also possible that defects in the 
central actions of leptin result in the negative regulation of P-cell mass in response to 
insulin resistance.
Consistent with their improved glucose homeostasis, Irs-2'Aob+A mice displayed 
fasting insulin levels comparable to lrs-2'A mice at eight weeks of age. Interestingly Irs- 
2'Aob+A mice had a reduced relative islet area compared to double knockout mice at eight 
weeks of age. However, immunostaining with insulin reveal that those islets present 
contained more insulin (data not shown). This could account for the increased fasting 
insulin levels seen in lrs-2'1'ob+A mice compared to double knockout mice at this age. 
Hence the expression of a single allele of leptin in lrs-2 / ob+/ mice was sufficient to 
permit increased P-cell compensation compared to that seen in double knockout mice.
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Although not quantified it was presumed that the improved glucose homeostasis reported 
in lrs-2'Adb+A mice was also a result of improved insulin and leptin sensitivty.
It was evident that the various genotypes exhibit differences in both fat mass (as 
% total body weight -  see chapter 3) and insulin sensitivity. Both obesity and relative 
lipodystrophy (lack of white adipose tissue) can lead to severe insulin resistance. It 
follows that adipokines, such as leptin act as regulators of insulin sensitivity. To assess 
the role of leptin in these various genotypes, fasting serum leptin levels were determined 
at eight weeks of age. The lack of leptin expression was confirmed in mice homozygous 
delete for the leptin gene (ob/ob, Irs-2+Aob'A and lrs-2'Aob'A mice). Considering other 
genotypes from the intercross of Irs-2+Aob+/' mice, only female Irs-2'A mice had elevated 
fasting serum leptin levels. This finding suggested the presence of leptin resistance in 
female Irs-2'A mice. In contrast male Irs-2'A mice showed a non significant trend towards 
having reduced fasting serum leptin levels. It is known that female lrs-2'A mice exhibit 
increased adiposity compared to male Irs-2A mice (84). This is exaggerated by the 
increased catabolic nature of male Irs-2'A mice, which leads to a depletion of fat stores. 
Hence despite the presence of leptin resistance, reduced fat mass in eight-week-old male 
Irs-2'A mice may lead to lower circulating leptin levels compared to females. This in turn 
may contribute to the progressive metabolic phenotype.
As discussed in chapter one, dysregulation of the adipo-insular axis is thought to 
be a major contributor to the onset of type 2 diabetes in obese subjects. Female lrs-2'A 
mice are obese and eventually develop type 2 diabetes. The presence of both elevated 
fasting plasma insulin and leptin levels at eight weeks of age could imply these mice may 
have a dysregulated adipo-insular axis. Interestingly lrs-2'Aob+A female mice did not 
display either elevated fasting insulin or leptin levels, indicating that expression of a 
single allele of leptin was sufficient to preserve insulin sensitivity.
Although fasting insulin and leptin levels were not assessed in male Irs-2'A mice 
derived from the Irs-2+Adb+A intercross, female Irs-2’A mice resulting from this cross 
displayed elevated fasting insulin and leptin levels. In contrast to female Irs-2'Aob+/ 
mice, whilst exhibiting normal fasting insulin levels female Irs-2'Adb+A mice had elevated 
fasting leptin levels compared to female Irs-2'A mice. Studies assessing the 
responsiveness of isolated islets and adipocytes from female Irs-2'Aob+A, Irs-2/ db+/, Irs-
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2 / mice to leptin and insulin (or both) may provide useful insights into mechanisms 
responsible for dysregulation of the adipo-insular axis.
In Irs-2+/'db~A and db/db mice the complete loss of leptin receptor function 
resulted in significant hyperleptinaemia at eight weeks of age indicating that these mice 
were highly leptin resistant. In contrast, fasting leptin levels in Irs-2'^db^ double 
knockout mice were comparable with that observed in wild-type animals. This was 
presumably due to the lack of white adipose tissue in these double knockout mice.
The accumulation of lipid deposits in non-adipose tissues, termed “lipotoxicity”, 
is a major cause of insulin resistance (158). Leptin is thought to have a protective effect 
against lipotoxicity by promoting fatty acid oxidation, whilst inhibiting the production of 
triacylglycerides (158). Therefore assessment of serum free fatty acid (FFAs) levels 
would have provided useful insight into the fatty acid metabolism of these animals. 
Unfortunately, the growth retardation exhibited by double knockout mice made it 
impractical to obtain the blood volumes required for analysis of FFAs.
Finally, it is clear that the fat mass is critical for the maintenance of normal 
growth and also peripheral insulin sensitivity. Both in vitro and in vivo studies have 
demonstrated the importance of IRS-signalling in adipogenesis (115). The relative 
lipodystrophy and growth retardation observed in Irs^ 'o b ^ ' double knockout animals 
could have been a consequence of impaired adipogenesis or may simply have been a 
secondary effect of their marked diabetes. Hence four-week-old double knockout mice 
were administered daily injections of insulin. Treatment successfully reduced urine 
glucose and ketone levels in double knockout mice and this was paralleled with a rescue 
of their fat mass and growth retardation. Moreover double knockout mice treated over a 
six week period weighed more than their wild-type littermates and resembled ob/ob mice 
in habitus. This demonstrates that the marked diabetes present in double knockout mice 
promotes a state of catabolism that contributes to the lack of white adipose tissue.
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CHAPTER 6
Analysis of insulin and leptin signal transduction in peripheral 
tissues of double knockout mice.
The marked insulin resistance present in the double knockout mice at four weeks of 
age suggested that there were potentially defects in insulin signalling mechanisms in insulin- 
sensitive tissues. Previously, it has been demonstrated that in IrsZ1' mice, insulin-stimulated 
activation of PI3K (one of the major signalling mediators of the metabolic effects of insulin) 
is dysregulated in both liver and skeletal muscle (83). Likewise in ob/ob mice, PI3K 
activation in liver and muscle, in response to insulin was shown to been reduced (119). In 
contrast, activation of the mitogenic limb of the insulin-signalling pathway including MAPK 
kinase often appears to be unaffected in insulin resistant states characterised by defects in 
glucose homeostasis. However the effects of deletion of lrs-2 upon this limb of the cascade 
have not been reported.
The serine/threonine kinase Akt, and in particular the isoforms Akt-1 and Akt-2, are 
activated by insulin in metabolic tissues in a PI3K-dependent manner and mediate many of 
the metabolic effects of insulin. Global deletion of Akt-2 results in insulin resistance and a 
diabetes-mellitus like syndrome in mice (159). Indeed Akt-2 has also been identified as an 
insulin resistance gene in humans (160).
Therefore both the PI3K/Akt and mitogenic MAP-kinase limbs of the insulin 
signalling cascade were compared in the liver and skeletal muscle of wild-type, lrs-2'/\  ob/ob 
and double knockout mice at four weeks of age. To assess the insulin signalling in these 
peripheral tissues, anaethetised mice were stimulated with either saline or insulin (5IU) for 
five minutes. Muscle and liver samples were then harvested for subsequent protein 
extraction. Initially, to assess the effect of deleting both ob and lrs-2 genes upon insulin 
signalling, PDK-1 and Akt kinase activation in response to insulin stimulation was assessed 
in liver homogenates by western blot analysis, using phospho-specific antibodies to these 
kinase proteins (Fig 6.2).
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6.1 Insulin-stimulated activation of IRS/PI3K signalling in the liver and skeletal 
muscle of wild-type, double knockout, lrs-2'*' and ob/ob mice
Activation of Akt requires phosphorylation of Thr-308 in the activation loop and 
Ser-473 in the C-terminal hydrophobic motif. PDK-1 can only phosphorylate Akt in the 
presence of PIP3 and therefore a model has been proposed in which binding of PIP3 to the 
PH domain of Akt causes a conformational change that relieves autoinhibition of the 
enzyme, allowing PDK-1 access to Thr-308. The kinase responsible for Ser-473 
phosphorylation is poorly characterised, but has been tentatively termed PDK-2 as it is also 
PI3K-dependent. Phosphorylation at Thr-308 is thought to facilitate in the subsequent 
phosphorylation of Ser-473. Hence phosphorylation at Ser-473 is considered a good 
indicator of Akt activity.
Assessment of the expression and phosphorylation of these PI3K-dependent 
proteins was carried out in liver and skeletal muscle lysates obtained from wild-type, lrs-2' 
A, ob/ob and double knockout mice.
Initially it was planned to assess both IRS-1 and IRS-2 expression in all tissue. 
To achieve this I generated and purified GST-fusion proteins for both IRS-1 and IRS-2 
which were subsequently used for the production of polyclonal antibodies in sheep. 
Analysis of the immunised sheep serum indicated that both anti-IRS-1 and anti-IRS-2 
polyclonal antibodies could be used for immunoprecipitation of their respective proteins 
(see chapter 2, for details of antibody generation and function). Indeed the resulting anti- 
IRS-2 polyclonal was used to confirm deletion of IRS-2 in the skeletal muscle of both 
double knockout and Irs-2~A mice (Fig 6.1).
p85 expression in the liver appeared to be comparable between all genotypes (Fig
6.2). Insulin-stimulated activation of PDK-1 was evident in wild-type and ob/ob livers. 
However ob/ob mice demonstrated a slightly higher level of PDK-1 phosphorylation at 
Ser-241 in the basal state (Fig 6.2). Interestingly insulin-stimulated phosphorylation of 
PDK-1 at Ser-241 appeared to be significantly reduced in livers from both Irs-2 A and 
double knockout animals with the effect being more pronounced in the double knockout 
animals (Fig 6.2). Moreover it appeared that whereas Irs-2'Amice displayed basal PDK-1 
phosphorylation at Ser-241 comparable to that seen in wild-type mice, basal 
phosphorylation of PDK-1 at this residue was reduced in the livers of double knockout 
mice (Fig 6.2).
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Figure 6.1 Insulin receptor substrate-2 expression in the skeletal muscle o f wild-type, 
double knockouty lrs-2 'and ob/ob mice.
Muscle lysates were obtained from wild-type, double knockout, lrs-2'1' and ob/ob mice that 
had been stimulated with either saline or insulin (5 i. u. via inferior vena cava injections) 
for 5 minutes. Muscle lysates (2 mg in total) were then immunoprecipitated with 10 pi of  
anti-lRS-2(S919A) serum. Immunoprecipitates were resolved by 6% SDS-PAGE, 
transferred and blotted for IRS-2 using anti-IRS-2 antibody (Upstate, cat# 06-508 
(1:1,000)).
IRS-2
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Figure 6.2 Insulin signalling analysis o f the livers o f wild-type, Irs-T', ob/ob and double­
knockout mice.
Insulin stimulated liver was compared with basal liver for the activation o f downstream 
markers o f the IRS/PI3K limb o f the insulin signalling cascade; p85, PDK-1 and Akt in 
wild-type, lrs-2'f\  ob/ob and double knockout mice by western blotting with phopho- 
specific and total antibodies to these proteins. Results are representative of three 
independent experiments.
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The increased phosphorylation of PDK-1 in insulin-stimulated livers of wild-type 
and ob/ob mice resulted in activation of Akt as evidenced by an increased phosphorylation 
at Ser-473 (Fig 6.2). Increased Akt phosphorylation was also noted in insulin-stimulated 
livers from Irs-2/ and double knockout mice. However, consistent with impairment to 
PDK-1 activity, levels of Akt phosphorylation in these animals was significantly reduced 
compared to those seen in insulin-stimulated livers of wild-type mice (Fig 6.2).
In contrast to the observations made in liver assessment of the PI3K limb of 
insulin signalling in skeletal muscle surprisingly revealed little difference between 
genotypes (Fig 6.3). Consistent with liver p85 expression in skeletal muscle was 
comparable between all four genotypes (Fig 6.3). Insulin-stimulation led to an increase in 
Akt phosphorylation in skeletal muscle of all genotypes, suggesting increased activity (Fig
6.3).
6.2 Insulin-stimulated activation of MAP-Kinase signalling in the liver and skeletal
muscle of wild-type, double knockout, Irs-2'/m and ob/ob mice
The mitogenic limb of insulin signalling was also assessed in the liver and 
skeletal muscle of wild-type, double knockout, lrs-2'A and ob/ob mice. The expression of 
MAP-kinase was comparable between basal and insulin-stimulated states and similar levels 
were seen for all genotypes (Fig 6.4). Insulin-stimulated activation of MAP-kinase was 
assessed by comparing basal and insulin-stimulated phosphorylation at Thr202/Tyr204 
residues. Phosphorylation at these residues was almost undetectable in the liver lysates 
obtained from wild-type, double knockout and ob/ob mice during the basal state. In 
contrast basal phosphorylation of MAP-kinase was dramatically increased in the livers of 
Irs-2'A mice (Fig 6.4), this finding has not been reported previously and was reproducible. 
A dramatic increase in phosphorylation at Thr202/Tyr204 was seen in the livers of insulin- 
stimulated wild-type mice, suggesting an increased MAP-kinase activity. This increased 
phosphorylation in response to insulin was not evident in the livers of double knockout or 
ob/ob mice (Fig 6.4).
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Figure 6.3 Insulin signalling analysis in skeletal muscle o f wild-type, Irs-T ', ob/ob and 
double-knockout mice.
Insulin stimulated skeletal muscle was compared with basal skeletal muscle for the 
activation of downstream markers o f the IRS/PI3K limb o f the insulin signalling cascade; 
p85, PDK-1, Akt and in wild-type, lrs-2~/', ob/ob and double knockout mice by western 
blotting with phopho-specific and total antibodies to these proteins. Results are 
representative o f three independent experiments.
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Figure 6.4 Insulin signalling analysis o f livers o f wild-type, Irs-IA, ob/ob and double­
knockout mice.
MAP Kinase phosphorylation in response to insulin stimulation was assessed in the livers 
of wild-type, lrs-2", ob/ob and double knockout mice at 4 weeks of age. Results are 
representative o f three independent experiments.
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Interestingly, levels of MAP-kinase phosphorylation were similar in the livers of insulin- 
stimulated wild-type and Irs-2'A animals. However in Irs-2'A mice insulin-stimulated 
MAP-kinase phosphorylation was surprisingly reduced compared to basal levels of 
phosphorylation in Irs-2'A livers (Fig 6.4).
Basal MAP-kinase expression was comparable in the skeletal muscle of all 
genotypes and was not affected by insulin-stimulation (Fig 6.5). In comparison to liver, 
basal levels of MAP-kinase phosphorylation were reduced in Irs-2~A mice. However 
insulin-stimulated MAP-kinase phosphorylation in the skeletal muscle of Irs-2'A mice was 
similar to that in skeletal muscle of insulin-stimulated wild-type animals (Fig 6.5). 
Consistent with observations made in liver, the skeletal muscle of leptin-deficient double 
knockout and ob/ob mice did not display an increase in MAP-kinase phosphorylation at 
Thr202/Tyr204 in response to insulin stimulation (Fig 6.5). Such findings suggested that 
functional leptin signalling is critical for insulin-stimulated MAP-kinase activation.
6.3 Insulin-stimulated inactivation of GSK-3 odft and activation of p7(f6k in the liver
and skeletal muscle of wild-type, double knockout, lrs-2'A and ob/ob mice
Given the impaired phosphorylation of Akt in the livers of lrs-2 deficient animals, 
GSK-3a/$ and p70s6k phosphorylation was assessed in the livers and skeletal muscle of 
mice. These are two key downstream mediators of insulin signalling.
Glycogen synthase kinase-3 (GSK-3a/p) inhibits the conversion of glucose into 
glycogen by phosphorylating the glycogen synthase enzyme. Therefore its activity in cells 
is reduced by insulin stimulation. Inhibition is achieved by insulin inducing 
phosphorylation of GSK-3a on Ser-21 and GSK-3P on Ser-9 (46).
p70 ribosomal s6  protein kinase (p70s6k) controls the translation of several 
hundred mRNAs required for the assembly of the translational machinery (53). Its deletion 
in mice results in growth retardation and the development of a metabolic phenotype similar 
to that displayed by Irs-2'A mice (161).
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Figure 6.5 Insulin signalling analysis o f skeletal muscle o f wild-type, Irs-I', ob/ob and 
double-knockout mice.
MAP Kinase phosphorylation in response to insulin stimulation was assessed in the 
skeletal muscle o f  wild-type, lrs-2*A, ob/ob and double knockout mice at 4 weeks of age. 
Results are representative of three independent experiments.
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The more recent finding that p70s6k~A mice are resistant to age- and diet-induced 
obesity but have enhanced insulin sensitivity (162), suggests that p70s6k may act as an 
important mediator of insulin and leptin action.
Total GSK-3a/|3 expression in liver was determined to be comparable between 
wild-type, double knockout and ob/ob mice. However expression appeared to be reduced 
in the livers of Irs-2'A mice compared to other genotypes (Fig 6 .6 ). Consistent with insulin- 
stimulated Akt-activation (Fig 6.2), wild-type and ob/ob mice both exhibited increased 
phosphorylation of Ser-9 and Ser-21 residues of GSK-3a/p upon insulin-stimulation. This 
increased phosphorylation of GSK-3oc/|3 was not seen in the livers of insulin-stimulated 
double knockout and lrs-2'/' mice (Fig 6 .6 ). However this finding would be consistent with 
the reduced insulin-stimulated Akt-phosphorylation observed in the livers of these animals 
(Fig 6.2). Similar to GSK-3a/p, expression of total p70s6k protein in the liver was 
comparable between all genotypes. Surprisingly insulin-stimulation led to a decreased 
phosphorylation of p70s6k on Thr-389 in all genotypes. This was particularly evident in 
double knockout and ob/ob mice (Fig 6 .6 ). Interestingly, basal phosphorylation of p70s6k 
was reduced in the livers of ob/ob mice relative to that seen in the other genotypes (Fig 
6.6).
The expression of both GSK-3oc/p and p70s6k in skeletal muscle was comparable 
for all genotypes (Fig 6.7). Insulin-stimulated phosphorylation of GSK-3a/p at Ser-9 and 
Ser-21 was evident in the skeletal muscle of all genotypes. This finding was expected, as 
activation of both the PI3K and MAP-kinase limbs of insulin signalling appeared to be 
comparable in the skeletal muscle of Irs-2'A and wild-type mice (Figs 6.3 and 6.5). Insulin- 
stimulation in skeletal muscle resulted in an increase in phosphorylation of p70s6k in wild- 
type, double knockout, Irs-2'A and ob/ob mice (Fig 6.7).
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Figure 6.6 Insulin signalling analysis o f the livers o f wild-type, Irs-I ', ob/ob and double­
knockout mice.
Insulin stimulated liver was compared with basal liver for the activation of downstream 
markers of the Akt signalling; GSK-3a//3 and p70S6K in wild-type, Irs-T/', ob/ob and double 
knockout mice by western blotting with phopho-specific and total antibodies to these 
proteins. Results are representative o f three independent experiments.
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Figure 6.7 Insulin signalling analysis in skeletal muscle o f wild-type, lrs-2/', ob/ob and 
double-knockout mice.
Insulin stimulated muscle was compared with basal muscle for the activation of  
downstream markers o f the Akt signalling cascade; GSK-3a/j3 and p7(f6K in wild-type, Irs- 
2'7', ob/ob and double knockout mice by western blotting with phopho-specific and total 
antibodies to these proteins. Results are representative o f three independent experiments.
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6.4 Assessment of D-type cyclin expression in the liver and skeletal muscle of wild- 
type, double knockout, Irs-2'A and ob/ob mice
The decision for cells to divide occurs at a restriction point late in Gl, after which 
they become refractory to extracellular growth regulatory signals and are commited to an 
autonomous program that carries them through to division (163). Passage through this 
restriction point is controlled by the D-type cyclins (Dl, D2 and D3), whose expression is 
modulated by extracellular growth-stimulatory signals (164, 165). These cyclins associate 
with the closely related Cyclin-dependent protein kinases 4 and 6  (Cdk4 and Cdk6 ), 
resulting in their catalytic activation and substrate recognition (166). Activated Cdk4 and 
Cdk6  phosphorylate the retinoblastoma (Rb) family of proteins, relieving negative 
regulation of transcription factors critical for Gl/S transition and cell cycle progression 
(167, 168). The deletion of Cdk4 in mice results in a similar phenotype to Irs-2~Amice, 
with Cdk4'A mice also being growth retarded, infertile and developing insulin-deficient 
diabetes due to a reduction in P-cell mass (169).
Consistent with the notion that p70s6k controls cell size, growth and proliferation, 
its deletion in mice also resulted in a small mouse phenotype (170). Remarkably later 
studies revealed that like both Irs-2'A and Cdk4'A mice, p70s6k/" mice were also 
hypoinsulinaemic, glucose intolerant and had a reduced P-cell mass (161).
In view of these strikingly similar phenotypes and the surprising insulin- 
stimulated decrease in p70s6k phosphorylation, observed in the livers of wild-type, double 
knockout, Irs-2'A and ob/ob mice, the basal expression levels of D-type cyclins (Dl, D2 
and D3), was assessed in the livers and skeletal muscle of these four genotypes.
The expression of cyclin Dl appeared to be similar in the livers of wild-type, Irs- 
2'a and ob/ob mice. However cyclin Dl expression was reduced in the livers of double 
knockout animals (Fig 6 .8 ). In contrast the expression of cyclins D2 and D3 was 
comparable in the livers of all genotypes (Fig 6 .8 ).
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Assessment of cyclin expression in skeletal muscle indicated that there was no 
obvious change in basal expression of any of the D-type cyclins between the different 
genotypes (Fig 6.9).
6.5 Summary and discussion
Assessment of the PI3K limb of the insulin signalling cascade in the liver and 
skeletal muscle of wild-type, double knockout, Irs-2'A and ob/ob mice, indicated that 
insulin resistance was more prevalent in the livers of these animals. In particular, insulin- 
stimulated phosphorylation of Akt was reduced in the livers of double knockout, Irs-2'A and 
ob/ob mice. This reduced Akt phosphorylation implied a reduction in the activity of this 
critical intermediate of insulin action. Indeed consistent with a reduced Akt activity, livers 
from lrs-2 deficient animals also displayed decreased GSK-3a/p phosphorylation, in 
response to insulin. As GSK-3a/(3 is a downstream effector of Akt signalling this finding 
would also suggest a reduction in Akt activity.
In physiological terms it is likely that lrs-2 deficient animals have impaired 
glycogen metabolism with their livers being unable to convert glucose into glycogen. 
Insulin resistance in the livers of these mice would be a contributor to the elevated fasting 
blood glucose levels observed in these animals. It was also evident that the livers of ob/ob 
mice displayed a slight decrease in insulin-stimulated Akt phosphorylation. This is 
consistent with previous findings in these animals, where it was shown that the livers of 
ob/ob mice exhibit a 29% and 72% decrease in IRS-1 and IRS-2 expression, respectively 
(119). In addition ob/ob livers showed a change in expression of the alternatively spliced 
isoforms of the regulatory subunits for PI3K. However it should be noted that these studies 
were carried out in eight-ten week-old ob/ob mice. In contrast current studies were earned 
out in four-week-old ob/ob mice, an age when ob/ob mice were determined to have normal 
glucose tolerance. It would be important to assess whether these changes in IRS expression 
are a genetic consequence of the loss of leptin expression in ob/ob mice or if they occur due 
to secondary effects associated with the onset of obesity and glucose intolerance in ob/ob 
mice.
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Figure 6.8 Insulin signalling analysis o f livers o f wild-type, Irs-I ', ob/ob and double­
knockout mice.
Expression of Cyclins Dl, D2 and D3 was assessed in the livers o f wild-type, double 
knockout, lrs-2'^and ob/ob mice at 4 weeks o f age. Results are representative o f three 
experiments.
Figure 6.9 Insulin signalling analysis o f skeletal muscle o f wild-type, Irs-T ', ob/ob and 
double-knockout mice.
Expression of Cyclins D l, D2 and D3 was assessed in the skeletal muscle of wild-type, 
double knockout, Irs^ 'an d  ob/ob mice at 4 weeks o f age. Results are representative of 
three experiments.
146
In contrast assessment of the same downstream mediators of IRS/PI3K signalling 
in skeletal muscle revealed normal responses to insulin for all genotypes.
Interestingly analysis of the mitogenic limb of insulin signalling in the liver and 
skeletal muscle of these animals highlighted the importance of leptin in mediating insulin- 
stimulated MAP-kinase phosphorylation. This was demonstrated by the fact that insulin- 
stimulated MAP-kinase phosphorylation was reduced in both the liver and skeletal muscle 
of double knockout and ob/ob mice. Insulin-mediated responses on MAP-kinase signalling 
in skeletal muscle have previously been reported to be impaired in ob/ob mice (171, 172). 
In contrast insulin-stimulated MAP-kinase phosphorylation varied dramatically between 
the liver and skeletal muscle of Irs-2'A mice. Whereas insulin-stimulated MAP-kinase 
phosphorylation appeared to be comparable to that observed in the skeletal muscle of wild- 
type animals, basal levels of MAP-kinase phosphorylation were increased in the livers of 
lrs-2'/' animals. Moreover levels of MAP-kinase phosphorylation were decreased in the 
livers of lrs-2~f' mice upon insulin-stimulation. Such dephosphorylation in response to 
insulin is difficult to explain but may result because of increased phosphatase activity 
towards MAP-kinase, in response to insulin. However the increased basal phosphorylation 
of MAP-kinase in insulin target tissues would indicate that MAP-kinase may play a pivotal 
role in the pathogenesis of insulin resistance in type 2  diabetes.
As p70s6k controls cell size, growth and proliferation some focus was given to the 
cell cycle machinery. Similar to lrs-2/' mice, both p7Cf6k/' and Cdk~4'A mice also display 
glucose intolerance and a reduced P-cell mass. The D-type cyclins are the regulatory 
partners of Cdk-4 and are required to mediate the initiation of cell cycle progression. Hence 
the expression of D-type cyclins was assessed in the liver and skeletal muscle of wild-type, 
double knockout, Irs-2'A and ob/ob mice. Overall expression of the D-type cyclins was 
comparable in both liver and skeletal muscle for all genotypes. However there appeared to 
be a dramatic decrease in cyclin Dl levels in the livers of double knockout mice. This 
finding could be indicative of defects to the cell cycle machinery in the hepatocytes of 
double knockout mice. Assessment hepatocyte morphology in liver sections stained with 
haemotoxylin and eosin would provide insight into the effectiveness of cell division. It 
would be interesting to determine whether the lower cyclin Dl levels were a result of 
decreased expression or increased degradation. Indeed GSK-3a/p has been proposed to
147
phosphorylate cyclin Dl on Thr-286 (173), an event which prepares cyclin-Dl for 26S 
proteosome degradation. Interestingly, insulin-stimulated GSK-3 oc/p phosphorylation was 
impaired in the livers of double knockout mice. As insulin-stimulation is proposed to 
inhibit GSK-3 a/p activity it is possible that insulin resistance in the livers of double 
knockout mice manifests an increased GSK-3 a/p activity. This increased GSK-3 a/p 
activity results in an increased phosphorylation of cyclin Dl on Thr-286 and subsequent 
26S proteosome-mediated degradation.
In summary PI3K and MAP-kinase couple insulin signalling to metabolic and 
mitogenic events, respectively. It is evident that the liver is a major site of insulin 
resistance in these diabetic murine models, with impairment to both the PI3K and MAP- 
kinase limbs of the insulin signalling cascade. However, although IRS/PI3K-mediated 
signalling appear to be normal in the skeletal muscle of these four genotypes, double 
knockout and ob/ob mice exhibit impaired insulin-stimulated MAP-kinase phosphorylation. 
This impairment to insulin-stimulated MAP-kinase phosphorylation seen both in the liver 
and skeletal muscle of leptin-deficient mice, suggests that MAP-kinase may act as a point 
of convergence for insulin and leptin signalling.
Further assessment of insulin and leptin signalling action in these peripheral 
tissues and others may provide greater insights into the differences in peripheral insulin 
resistance observed in these animals. Indeed similar signalling analysis of peripheral 
tissues obtained from; Irs-2'Adb'A double knockout, db/db, Irs-2'Adb+A and Irs-2'Aob+A mice 
would hopefully further our understanding of how leptin deficiency leads to impaired 
insulin-stimulated MAP-kinase phosphorylation. However, these initial findings 
demonstrate the complex overlap of insulin and leptin action in the periphery.
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CHAPTER 7
Generation and metabolic analysis of 
|3-HypIRS2+STAT3KO mice.
The striking growth impairment and dramatic diabetes seen in both Irs-2'Aob'A 
and lrs-2AdbA double knockout mice, highlights the importance of lrs-2 signalling in the 
p-cell compensatory response. The complex interplay between leptin and insulin 
sensitivity, is also highlighted by the other genotypes resulting from these intercrosses. 
For example, the presence of a single allele of the leptin gene upon an Irs-2'A background 
was sufficient in preventing the early-onset diabetes seen in double knockout mice. This 
was achieved by preservation of P-cell function in these animals. This effect was also 
noted in the Irs-2+Adb+A intercross, where the expression of a single allele of the leptin 
long-form receptor upon an lrs-2'1' background, also rescued the dramatic phenotype 
displayed by Irs-2'Adb'A double knockout mice. These findings suggest that either 
directly in the P-cell or indirectly via altering insulin sensitivity restoration of leptin 
function permitted an appropriate P-cell compensatory response.
The marked growth retardation and ketoacidosis displayed by four-week-old 
double knockout mice was rescued by daily administration of insulin. Indeed insulin 
treatment of double knockout mice over a period of forty days, rescued catabolism and 
permited an anabolic state that encouraged fat deposition. Similarly, Irs-2+Aob'A mice 
also exhibit an obese phenotype, suggesting that restoration of just a single allele of lrs-2, 
is sufficient for mounting a P-cell compensatory response to peripheral insulin resistance. 
It is therefore likely that deletion of lrs-2 gene function is largely responsible for the 
metabolic phenotype seen in double knockout mice. However it is also evident that the 
early-onset diabetes observed in double knockout mice is not solely attributable to the 
loss of lrs-2 gene function. As described, lrs-2’A mice do not develop a diabetic 
phenotype until approximately eight weeks of age (83). Hence loss of leptin gene 
function or leptin long-form receptor gene function, in addition to lrs-2 gene function, 
must have an additive effect with regards to insulin sensitivity. It is possible that
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deficiency of leptin or leptin long-form receptor in these mice leads to an increased 
resistance to the actions of insulin.
The metabolic phenotype of lrs-2~f~ob'*' and lrs-Z/~db~/~ double knockout mice is 
complex and it is difficult to fully dissect the specific contribution of signalling and 
pathophysiology to the phenotype. However it is evident that the restoration of a single 
allele of leptin or its long-form receptor, results in improved glucose tolerance and insulin 
sensitivity. The impairment to energy homeostasis described in P-HypIRS2KO (8 8 , 89) 
and p-HypSTAT3KO (81, 82) mice demonstrates a critical role for both intrinsic IRS-2 
and STAT-3 signalling pathways in the P-cell and hypothalamus. Hence P-HypIRS2KO 
mice were inter-crossed with P-HypSTAT3KO mice to produce P-HypIRS2+STAT3KO 
mice. These mice lack Irs-2 and stat-3 expression in the P-cell and hypothalamus. This 
tissue-specific approach would hopefully address the roles of insulin and leptin signalling 
pathways in relation to islet and hypothalamic function and provide some clues as to 
whether these intrinsic pathways converge to effect whole-body energy homeostasis. By 
deleting both these genes in two of the major sites (P-cell and hypothalamus) where 
leptin and IRS-2 are thought to act in energy homeostasis, we envisaged that we would 
recapitulate the double knockout phenotype.
7.1 Generation of 0-HypIRS2+STAT3KO mice
Both P-HypIRS2KO and P-HypSTAT3KO mice had previously been generated 
within the laboratory, by intercrossing IRS21ox and STAT31ox mice with mice 
expressing Cre-recombinase under the control of the rat insulin II promoter (RIP-Cre 
mice). Initially mice heterozygous (with regards to floxed alleles) and positive for the 
RIP-cre transgene (ie.both P-HypIRS21ox+/’ and P-HypSTAT31ox+/ mice) were 
intercrossed. These matings yielded compound heterozygotes that were positive for the 
RIP-cre transgene (ie.RIP-cre+veP-HypIRS21ox+/'STAT31ox+/'mice). These mice were 
then inter-crossed to generate wild-type, P-HypIRS2KO, P-HypSTAT3KO and P- 
HypIRS2+STAT3KO mice. PCR genotyping carried out at three weeks of age revealed 
that P-HypIRS2+STAT3KO mice were viable.
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Figure 7.1 Analysis o f body weights o f wild-type and fl-HypIRS2+STA T3KO mice at 
four weeks o f age.
Results are representative as mean weights ±  s. e.m of 5 animals per genotype.
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7.2 Analysis o f  /3-HypIRS2 +STA T3KO mice body weight
Body weights measured at four weeks of age indicated that p- 
HypIRS2+STAT3KO mice were comparable in weight to wild-types (Fig 7 .1). In 
contrast, body weight data obtained at eight weeks of age, showed (3- 
HypIRS2+STAT3KO mice now weighed significantly more than wild-type controls (Fig 
7.2, p < 0.0001). A significant increase in body weight relative to wild-type controls was 
also evident in the (3-HypIRS2KO mice (Fig 7.2, p < 0.05). However, this increase was 
less dramatic than observed in the P-HypIRS2+STAT3KO mice. Indeed p- 
HypIRS2+STAT3KO mice were significantly heavier than P-HypIRS2KO mice (Fig 7.2, 
****p < o .O O O l). Consistent with previous reports P-HypSTAT3KO mice were increased 
in body weight compared to wild-type mice. These findings suggested that there was an 
additive effect of deleting both Irs-2 and stat-3 gene function at the same time, in p-cells 
and hypothalamic neurons.
7,3 Assessment of glucose homeostasis in 0-HypIRS2+STAT3KO mice
Fasting blood glucose levels at eight weeks of age indicated that P- 
HypIRS2+STAT3KO mice had elevated fasting blood glucose relative to wild-type 
controls. Moreover the hyperglycemia in these animals was significantly increased 
compared to P-HypIRS2KO mice (Fig 7.3, ** p < 0.01). p-HypIRS2KO mice also 
exhibited elevated fasting blood glucose levels relative to controls (Fig 7.3, *p < 0.05) 
but P-HypSTAT3KO mice displayed normal fasting blood glucose levels. The 
hyperglycaemia observed in P-HypIRS2+STAT3KO mice suggested the presence of 
glucose intolerance and possibly diabetes.
Glucose tolerance testing carried out on P-HypIRS2+STAT3KO mice at eight 
weeks of age, confirmed them to be glucose intolerant (Fig 7.4). Analysis of area under 
the curve (AUC) showed P-HypIRS2+STAT3KO mice to have a highly significant 
increase in AUC relative to wild-type controls (Fig 7.5, p < 0.001). Interestingly both p- 
HypIRS2KO and P-HypSTAT3KO mice appeared to be relatively glucose tolerant (Fig 
7 .4 ) and although demonstrating a trend towards being glucose intolerant relative to 
control mice, this was not significant (Fig 7.5).
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Figure 7.2 Analysis o f body weights o f wild-type, p-HypSTAT3KO, /3-HypIRS2KO and 
J3-HypIRS2+STAT3KO mice at eight weeks o f  age.
Results are representative as mean weights ±  s.e.m o f 5 animals per genotype. Statistical 
analysis was carried out by means o f t-tests comparing all genotypes to their wild-type 
controls; * p  < 0.05, **, p  < 0.01, ***, p  < 0.001, * * * *  p  < 0.0001 and j3-HypIRS2KO 
mice vs p-HyplRS2+STAT3KO mice, * * * *  p  < 0.0001.
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Figure 7.3 Fasting blood glucose o f  wild-type, /3-HypSTAT3KO, /3-HypIRS2KO and f3- 
HypIRS2+STAT3KO mice at eight weeks o f  age.
Results are expressed as mean fasting blood glucose j_s.e.m and are representative of at 
least 7 animals per genotype, except for /3-HyplRS2+STAT3KO mice n=4.
*p < 0.05 and ****p < 0.0001 for genotypes vs wild-type mice and J3-HypIRS2KO mice 
vs P-HypIRS2+STAT3KO mice, **, p  < 0.01.
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Figure 7.4 Glucose tolerance tests o f wild-type, /3-HypSTA T3K0, fi-HypIRS2K0 and 
fl-HypIRS2+S TA T3KO mice at eight weeks o f age.
Results are expressed as mean blood glucose ±_ s.e.m and are representative o f at least 7 
animals per genotype, except for f}-HypIRS2+STAT3KO mice n=4.
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Figure 7.5 Statistical anaylsis o f glucose tolerance tests carried out at eight weeks o f  
age on wild-type, P-HypSTAT3KO, /3-HypIRS2KO and fi-HypIRS2+STAT3KO mice.
Results are expressed as mean area under the curve ±  s. e.m and are representative o f at 
least 7 animals per genotype, except for f3-HyplRS2+ST A T3K0 mice n=4. t-tests were 
performed comparing all genotypes to their wild-type controls; * **  p  < 0.001.
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This finding supports the idea that combined deletion of Irs-2 and stat-3 gene 
function in the P-cell and hypothalamus, leads to an additive effect upon glucose 
homeostasis.
To address the glucose intolerance displayed by p-HypIRS2+STAT3KO mice, 
pancreatic p-cell function was assessed. Initially fasting insulin and leptin levels were 
determined at eight weeks of age. Relative islet density and relative islet area were then 
determined by morphometric analysis of pancreatic sections immunostained for insulin.
7,4 Determination of fasting serum insulin and leptin levels in wild-type, f3- 
HypSTAT3KO, fiHypIRS2KO and fiHypIRS2+STAT3KO mice
Since P~HypIRS2+STAT3KO mice exhibit both an increase in body weight and 
glucose intolerance relative to p-HypSTAT3KO and P-HypIRS2KO mice, pancreatic 
islet function was assessed.
Initially fasting insulin levels were assessed for wild-type, P-HypSTAT3KO, p- 
HypIRS2KO and P-HypIRS2+STAT3KO mice at eight weeks of age. Both p- 
HypSTAT3KO and P-HypIRS2KO mice had elevated fasting insulin levels compared to 
wild-type mice, being significant in P-HypSTAT3KO mice (Fig 7.6, *p < 0.05). 
However P-HypIRS2+STAT3KO mice also exhibited significantly elevated fasting 
insulin levels compared to wild-type mice (Fig 7.6, **p < 0.01). Moreover the 
hyperinsulinaemia displayed by P-HypIRS2+STAT3KO mice was significantly elevated 
relative to the hyperinsulinaemia in P-HypIRS2KO mice (Fig 7.6, *p < 0.05).
Although not quantified it was noticed that P-HypSTAT3KO, P-HypIRS2KO 
and P-HypIRS2+STAT3KO mice all exhibited an increased adiposity. Indeed 
assessment of fasting leptin levels showed that P-HypSTAT3KO, P-HypIRS2KO and P- 
HypIRS2+STAT3KO mice all displayed relative hyperleptinemia compared to wild-type 
controls at eight weeks of age (Fig 7.7). However, this was only shown to be significant 
for p-HypIRS2+STAT3KO mice (Fig 7.7, *p < 0.05). Elevated fasting leptin levels 
would be indicative of increase body fat mass.
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Figure 7.6 Fasting serum insulin levels o f wild-type, J3-HypSTA T3KO, fi-HyplRS2KO 
and fi-HypIRS2+STA T3KO mice at eight weeks o f age.
Cardiac puncture was performed on anaesthetized, IS hr fasted mice. Bloods were clarified by 
centrifugation (13,000rpm fo r  20 mins at 4°Q and the resulting serum was quantified for insulin 
concentration by a commercially available rat ultrasensitive insulin ELISA assay, using a mouse 
standard fo r  calibration. All assays were assayed in duplicate and results are presented as average 
serum insulin ± s . e.m, being representative o f  at least 4 animals per genotype. * p  < 0.05, **, p  < 0.01, 
and *, p  < 0.05, fo r 0-HypIRS2KO mice vs /3-HypIRS2+STA T3KO mice.
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Figure 7.7 Fasting serum leptin levels o f wild-type, fi-HypSTAT3KO, fi-HypIRS2KO 
and 0-HypIRS2+STA T3KO mice at eight weeks o f age.
Cardiac puncture was performed on anaesthetized, IS hr fasted mice. Bloods were clarified by 
centrifugation (13,000rpm fo r  20 mins at 4°Q and the resulting serum was quantified for leptin 
concentration, by a commercially available mouse leptin ELISA assay (CrystalChem Inc.) All assays 
were assayed in duplicate and results are presented as average serum insulin ± s.e.m, being 
representative o f  at least 7 animals per genotype. * p  < 0.05 for (3-HyplRS2KO and fi-HypSTA T3K0 mice 
vs wild-type. **, p  < 0.0J for fi-HypIRS2+STA T3K0 vs wild-type mice.
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7.5 Quantification o f  relative islet density and relative islet area in wild-type,
ffHypSTAT3KO, fi-HypIRS2KO and fi-HypIRS2+STAT3KO mice
Relative islet density and relative islet area of eight-week-old; wild-type, |3- 
HypSTAT3KO, P-HypIRS2KO and P-HypIRS2+STAT3KO mice was determined by 
morphometric analysis of four whole pancreatic sections (5|nm), from four animals, 
immunostained for insulin. Consistent with previous findings P-HypIRS2KO mice 
showed an ~40% reduction in both relative islet density and relative islet area compared 
to wild-type controls (Figs 7.8 and 7.9). In contrast P-HypSTAT3KO mice showed a 
non-significant trend towards a reduction in relative islet density (Fig 7.8) but were 
determined to have a relative islet area comparable to wild-type controls (Fig 7.9). 
Interestingly relative islet density in P-HypIRS2+STAT3KO mice appeared to be 
comparable with that seen in wild-type animals (Fig 7.8). Moreover islets present in P- 
HypIRS2+STAT3KO mice were significantly increased in area compared to those 
displayed by P-HypIRS2KO mice (Fig 7.9, ***p < 0.001). It was also evident that P- 
HypIRS2+STAT3KO mice also showed an non-significant increase in relative islet area 
compared to P-HypSTAT3KO and wild-type mice (Fig 7.9).
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Figure 7.8 Quantification o f relative islet density in wild-type, fi-HypSTA T3KO, 
P-HypIRS2KO and fi-HypIRS2+STAT3KO mice at eight weeks o f age.
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Figure 7.9 Quantification o f relative islet area in wild-type, fi-HypSTA T3KO, 
0-HypIRS2KO and /3-HypIRS2+STA T3KO mice at eight weeks o f age.
7.6 Summary and discussion
In contrast to the growth retardation and diabetes observed in both lrs-2/'ob'/' 
and Irs-2'Adb~A double knockout mice, P-HypIRS-2+STAT-3KO mice exhibited a 
significant increase in body weight and were not diagnosed diabetic. This demonstrates 
that deletion of IRS-2 and STAT-3 signalling in the (3-cell and hypothalamus is not 
sufficient to manifest the full double knockout phenotype. Moreover it highlights the 
importance of IRS-2 and STAT-3 signalling in other tissues, in preventing the 
development of the double knockout phenotype.
However, P-HypIRS2+STAT3KO mice were significantly more glucose 
intolerant than P-HypIRS2KO and P-HypSTAT3KO mice, at eight weeks of age. 
Moreover P-HypIRS2+STAT3KO mice also tended to display elevated fasting insulin 
and leptin levels compared to both P-HypIRS2KO and p-HypSTAT3KO mice. 
Hyperinsulinaemia was attributable to an improved P-cell compensatory response in P- 
HypIRS2+STAT3KO mice, as evidenced by an increased relative islet area. Although 
not quantified, it was evident that similar to P-HypIRS2KO and P-HypSTAT3KO mice, 
P-HypIRS2+STAT3KO mice displayed increased body adiposity. Consistent with this 
idea p-HypIRS2+STAT3KO mice exhibited a significant increase in body weight and 
non-significant trend towards increased hyperleptinaemia compared to p-HypIRS2KO 
and P~HypSTAT3KO mice. Such additive effects on whole-body physiology and glucose 
metabolism were more consistent with original expectations of what Irs-2'^ob ^  double 
knockout mice might exhibit.
Although P-HypIRS2+STAT3KO mice did not display the same phenotype 
described for global double knockout animals, there were some common features 
between these animals. In particular was their ability to increase P-cell mass in response 
to insulin resistance. As discussed in chapter five, four-week-old Irs^ 'ob^ ' double 
knockout mice displayed an improved preservation of P-cell mass and function in 
response to insulin resistance, compared to age-matched Irs-2'A mice. Indeed it is also 
reported that both ob/ob and db/db mice exhibit P-cell hyperplasia, suggesting leptin 
deficiency promotes an increased P-cell response even in the absence of IRS-2 function.
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Consistent with this idea P-HypIRS2+STAT3KO mice had a significantly increased 
relative islet density and area compared to P-HypIRS2KO mice. Interestingly the relative 
islet area of p-HypIRS2+STAT3KO mice was also increased compared to that seen in P- 
HypSTAT3KO mice, indicating that such tissue-specific deletion of IRS-2 and STAT-3 
resulted in an additive effect with regards to islet function.
The fact that deletion of IRS-2 and STAT-3 in the P-cell and hypothalamus did 
not recapitulate the global double knockout phenotype, suggests that dysregulation of 
IRS-2 and leptin action in other tissues is critical for the manifestation of their severe 
diabetic phenotype. In view of the results obtained in chapter six, insulin resistance in 
the liver is likely to play a key role in the manifestation of the double knockout 
phenotype. However it will be essential to determine whether insulin resistance arises in 
the liver through direct effects or via the indirect actions of other insulin target tissues (ie. 
adipose and muscle tissues).
In summary, global deletion of IRS-2 in combination with either leptin or its 
functional receptor in mice resulted in growth retardation and early-onset diabetes. 
Additive effects were also observed with regards to body weight, insulin resistance and 
glucose homeostasis in p-HypIRS2+STAT3KO mice. These observations provide 
further genetic evidence that IRS-2 and STAT-3 signalling intrinsic to the P-cell and 
hypothalamus are important for mediating the effects of insulin and leptin in these target 
tissues. Moreover the additive effects of their deletion suggest that IRS-2 and STAT-3 
mediate these effects by acting in separate signalling pathways, as opposed to converging 
upon a linear pathway.
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CHAPTER 8
Discussion
Insulin and leptin have complex and convergent physiological roles in the 
regulation of whole body energy homeostasis (19). Leptin is thought to predominantly 
work in the central nervous system to regulate adiposity through the control of food 
intake and energy expenditure. Insulin is primarily considered to act in insulin-sensitive 
peripheral tissues such as skeletal muscle, adipose tissue and liver, regulating glucose and 
lipid metabolism. Both hormones have also been implicated in regulating additional 
physiological processes. For example, insulin also serves as an adiposity signal acting 
upon the same CNS mechanisms as leptin (16). In addition both leptin and insulin have 
been implicated in regulating P-cell function. Leptin has also been shown to modulate 
insulin secretion reducing its release (90, 91). Insulin signalling mechanisms have been 
shown to regulate insulin production and secretion and regulate P-cell development and 
growth (85, 92).
Recent evidence has also suggested that insulin and leptin utilise common signal 
transduction processes to mediate their physiological effects. For example, in mice with 
targeted disruption of Irs2> leptin-stimulated STAT-3 phosphorylation is impaired (84). 
Similarly, both insulin and leptin have been shown to activate PI3K in a number of 
cellular systems and it has been suggested that leptin-induced anorexia requires PI3K 
activation in hypothalamic neurons (132).
The work described in this thesis was undertaken to further understand the 
interaction between leptin and insulin signalling mechanisms and their contribution to 
energy homeostasis using a genetic approach. In particular, it was hoped that this would 
help address the role of IRS-2, as a potential convergence point for insulin and leptin 
signalling.
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Initially mice lacking Irs-2, a key insulin signalling intermediate were 
intercrossed with ob/ob mice lacking leptin and also with db/db mice, which lack the 
functional leptin long-form receptor. The various genetic offspring resulting from these 
two intercrosses were then phenotyped with respect to growth, glucose homeostasis, (3- 
cell function and preliminary insights were gained into insulin signalling events in their 
peripheral metabolic tissues.
As lrs-2 'A, ob/ob and db/db mice are hyperphagic, leading to obesity and 
eventually the development of insulin resistance and type 2  diabetes, it was hypothesised 
that the combined deletion of these genes in mice was likely to produce an exaggerated 
adiposity phenotype prior to the development of diabetes. In contrast both Irs-2'Aob'A and 
Irs-2'Adb'A double knockout mice were markedly growth retarded and exhibited 
significantly reduced fat mass. Moreover, assessment of glucose homeostasis in double 
knockout animals showed that they were severely diabetic as indicated by glucose 
intolerance as early as four weeks of age. These mice also exhibited fasting 
hyperinsulinaemia at four weeks of age, demonstrating their insulin resistance.
Interestingly despite having similar fasting blood glucose levels to Irs-2'Aob'A 
mice at four weeks of age, Irs-2'Adb’A mice exhibited only mild glucose intolerance. 
Although the original db+A mice were derived from a slightly different genetic 
background, it was evident that glucose homeostasis in wild-type, Irs-2'A and db/db mice 
derived from the Irs-2+Adb+A intercross, was consistent with previous reports on these 
animals (21, 92). Hence the observation that Irs-2'Adb'A have improved glucose 
homeostasis at four weeks of age implies that subtle differences exist between these 
double knockout mice, as a result of the loss of either ob/ob or db/db gene function. This 
idea finds further support from the observation that Irs-2+Aob'A mice weighed 
significantly more than Irs-2+Adb'A mice at eight weeks of age.
Despite exhibiting similar phenotypes, ob/ob and db/db mice are not exactly 
identical. As db/db mice are deleted for the expression of the leptin long-form receptor, 
they are highly leptin resistant, resulting in an increase in circulating leptin levels. Whilst 
the leptin long-form receptor has been shown to be the major mediator of leptin action, 
the shorter isoforms may also facilitate some of leptin’s effects (56-58). If the leptin
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short-isoform receptors do mediate some leptin signalling in the hyperleptinemic db/db 
mice, then these mice would exhibit some degree of leptin sensitivity. In contrast, leptin 
signalling is completely obliterated in ob/ob mice, as these mice do not express leptin. 
Previous reports have demonstrated that adult mice heterozygous for either the ob or db 
gene function have equivalent fat mass and percentage body fat. Interestingly mice 
heterozygous for both the ob or db genes (ob+Adb+A), demonstrate further increases in fat 
mass and percentage body fat (157). Therefore it is reasonable to assume that differences 
exist between mice deleted for either leptin or leptin receptor function upon an Irs-2 null 
background.
In contrast to double knockouts, lrs-2'Aob+A and Irs-2'Adb+A mice displayed 
normal growth and glucose homeostasis at four weeks of age. This indicates that a single 
allele of leptin or leptin long-form receptor expression was sufficient to rescue mice from 
the severe metabolic phenotype seen in double knockout mice. These findings emphasize 
the importance of leptin sensitivity and in particular how leptin action is essential for the 
maintenance of glucose homeostasis. The observation that eight-week-old Irs-2'Aob+A 
female mice were more glucose intolerant than lrs-2'A female mice but less so than 
female double knockout mice, further illustrates the importance of leptin sensitivity in 
regulating peripheral glucose metabolism.
In view of the marked glucose intolerance displayed by double knockout mice 
their pancreatic islet function was assessed, to gain insights into the peripheral insulin 
sensitivity of these animals. Fasting insulin levels determined at four weeks of age 
showed lrs-2'Aob'Amice to be significantly hyperinsulinaemic relative to wild-type mice, 
indicating the presence of insulin resistance. However by eight weeks of age these 
double knockout mice were relatively hypoinsulinaemic, suggesting p-cell failure.
Quantification of relative islet density and area at four and eight weeks of age 
was consistent with this pattern of fasting insulin levels. At four weeks of age double 
knockout mice displayed a relative islet density and area comparable to that seen in wild- 
type animals. However by eight weeks of age despite exhibiting a slight increase in 
relative islet density, the relative islet area of double knockout mice was reduced 
compared to that seen in wild-type mice, this suggested that this relative islet
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compensation is short-lived and p-cell failure soon follows. Although not proven to be 
significant the trend for double knockout mice to display an increased relative islet 
density and area at four weeks of age compared to lrs-2'A mice, would indicate the loss of 
leptin function in combination with lrs-2 deletion, permits an initial P-cell compensatory 
response in double knockout mice. Indeed ob/ob mice display P-cell hyperplasia in the 
presence of peripheral insulin resistance well beyond eight weeks of age.
Interestingly Irs-2'Adb'A double knockout mice had fasting insulin levels 
comparable to wild-type controls even at eight weeks of age. This was consistent with 
the milder impairment to glucose homeostasis seen in these mice compared to age- 
matched Irs-2'Aob'A double knockout mice. The improved fasting insulin levels noted in 
lrs-2'Adb'A mice, suggests that they are able to preserve some P-cell response to insulin 
resistance. The possibility that the shorter isoforms of the leptin receptor are capable of 
mediating some of leptin’s actions in db/db mice, finds further support from this finding.
Consistent with their improved glucose homeostasis, Irs-2'Aob+A mice displayed 
fasting insulin levels comparable to lrs-2'A mice at eight weeks of age. Furthermore, 
despite showing a percentage decrease in relative islet area at four weeks of age 
compared to wild-type mice, a greater percentage decrease was observed for lrs-2'A mice. 
This would further suggest that relative leptin deficiency can promote a greater p-cell 
response. Interestingly Irs-2'Aob+A mice had a reduced relative islet area compared to 
double knockout mice at eight weeks of age. However, immunostaining with insulin 
reveal that those islets present contained more insulin. This would account for the 
increased fasting insulin levels seen in Irs-2'Aob+A mice compared to double knockout 
mice at this age.
Dysregulation of the adipo-insular axis is thought to be a major contributor to 
the onset of type 2 diabetes, in obese subjects (113). Interestingly the lack of adipose 
tissue (lipodystrophy) can also lead to severe insulin resistance and the development of 
type 2 diabetes (14, 106). It follows that adipokines, such as leptin, act as regulators of 
insulin sensitivity. To assess the role of leptin in these various genotypes, fasting plasma 
leptin levels were determined at eight weeks of age. The lack of leptin expression was 
confirmed in mice homozygous delete for the leptin gene (ob/ob, Irs-2+Aob'A and Irs-2'A
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ob'A mice -  data not shown). Elevated fasting leptin levels were only reported in female 
Irs-2V~ mice resulting from the Irs-2+Aob+A intercross. In contrast male Irs-2'A mice 
showed a non significant trend towards having reduced fasting leptin levels. It is known 
that female Irs-2'A mice exhibit increased adiposity compared to male Irs-2'A mice (84), 
and this is exaggerated by the increased catabolic nature of male Irs-2'A mice, which 
leads to a depletion of fat stores. Hence despite the presence of leptin resistance, reduced 
fat mass in eight-week-old male Irs-2'A mice may lead to lower circulating leptin levels 
compared to females.
In Irs-2+Adb'A and db/db mice the complete loss of leptin receptor function 
resulted in leptin resistance, as indicated by significant hyperleptinemia at eight weeks of 
age. In contrast fasting leptin levels in Irs-2'Adb'A double knockout mice were 
comparable with that observed in wild-type animals. This was presumably due to the 
lack of white adipose tissue in these double knockout mice.
Taken together these observations highlight the importance of both insulin and 
leptin action in maintenance of the p-cell response to insulin resistance. Moreover, they 
provide evidence that leptin deficiency promotes an increased p-cell response even in the 
absence of IRS-2 function. These findings perhaps indicate that leptin has the ability to 
negatively regulate P-cell mass, acting either in the periphery or intrinsically to the P-cell. 
It is also possible that defects in the central actions of leptin result in the negative 
regulation of P-cell mass in response to insulin resistance.
The marked growth retardation and ketoacidosis displayed by four-week-old 
double knockout mice was rescued by daily administration of insulin. Insulin treatment 
of double knockout mice rescued catabolism and permited an anabolic state that 
encouraged fat deposition. Similarly, Irs-2+Aob'A mice also exhibit an obese phenotype, 
suggesting that restoration of just a single allele of Irs-2, is sufficient for mounting a P- 
cell compensatory response to insulin resistance. However the systemic loss of gene 
function in the double knockout mice makes it difficult to assess the contribution of their 
loss in various cell types, to the development of insulin resistance.
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Analysis of insulin signalling pathways in the liver and skeletal muscle of wild- 
type, double knockout, Irs-2'A and ob/ob mice indicated that the liver is a major site of 
insulin resistance in these diabetic murine models. However, although IRS/PI3K- 
mediated signalling appear to be normal in the skeletal muscle of these four genotypes, 
double knockout and ob/ob mice exhibit impaired insulin-stimulated MAP-kinase 
phosphorylation. Insulin-mediated responses on MAP-kinase signalling in skeletal 
muscle have previously been reported to be impaired in ob/ob mice (171, 172). This 
impairment to insulin-stimulated MAP-kinase phosphorylation seen both in the liver and 
skeletal muscle of leptin-deficient mice, suggests that MAP-kinase may act as a point of 
convergence for insulin and leptin signalling. Indeed the finding that basal MAP-kinase 
phosphorylation was increased in the livers of Irs-2'Amice, would also indicate that MAP- 
kinase plays an important role in the pathogenesis of insulin resistance in type 2  diabetes. 
Further assessment of insulin and leptin signalling action in the periphery of these 
genotypes and others, may provide greater insights into the differences in peripheral 
insulin resistance, observed in these animals.
These genetic studies have therefore provided new insights into the role of 
leptin in the regulation of insulin sensitivity. The molecular basis for leptin’s insulin 
sensitising effect is not clear but two basic mechanisms have been suggested to operate 
(8 ). Firstly, the effects of leptin may mainly occur via the CNS with the central effects 
being transmitted to the periphery through neural or neuroendocrine mechanisms 
including the hypothalamo-pituitary adrenal axis and the autonomic nervous system 
(134). The other mechanism that has been suggested to operate involves the direct effects 
of leptin upon peripheral insulin sensitive tissues such as liver, muscle and fat. Neuronal- 
specific deletion of the leptin receptor largely recapitulates the phenotype of the ob/ob 
mice suggesting that most of the effects of leptin are initiated in the CNS (174). More 
recently it has been proposed that leptin action is critical for the development of 
hypothalamic projection pathways, involved in the control of food intake and energy 
homeostasis (175, 176). Leptin has also been shown to acutely regulate the 
responsiveness of these projection pathways (177). Whilst the above observations 
suggest that deletion of lrs-2 is perhaps the major factor in the metabolic phenotype 
exhibited by double knockout mice, it is also evident that the early-onset diabetes 
observed in double knockout mice is not solely attributable to the loss of lrs-2 gene 
function. As described above, lrs-2'A mice do not develop a diabetic phenotype until
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approximately eight weeks of age (83), whereas double knockout mice have a marked 
phenotype at 3-4 weeks of age. Hence the finding that leptin and IRS-2 action is critical 
for the development as well as the function of neuronal networks involved in the 
regulation of energy homeostasis, may in part account for the more severe metabolic 
phenotype exhibited by double knockout mice. Indeed, shortly following the 
physiological assessment of lrs-2'/'ob'*' double knockout mice, Schubert et al reported 
that disruption of the Irs2 gene reduced neuronal proliferation during development by 
50% (145). Such findings highlight the importance of IRS-2 signalling in the 
development of the CNS and further suggest that a component of the phenotype observed 
in double knockout mice may result from developmental defects.
The impairment of energy homeostasis regulation described in P-HypIRS2KO 
(8 8 , 89) and P-HypSTAT3KO mice (81, 82) demonstrates a critical role for both intrinsic 
IRS-2 and STAT-3 signalling pathways in P-cell and hypothalamic function. Hence to 
address the roles of these insulin and leptin signalling intermediates in relation to islet 
and hypothalamic function, P-HypIRS2KO mice were inter-crossed with P- 
HypSTAT3KO mice to produce P-HypIRS2+STAT3KO mice. The study of these mice 
would hopefully increase our understanding of whether these intrinsic pathways converge 
to effect whole-body energy homeostasis. Such a tissue-specific approach would 
hopefully provide some insight into the contribution of developmental defects in the CNS 
to the systemic double knockout metabolic phenotype.
In contrast to systemic double knockout mice, p-HypIRS2+STAT3KO mice were 
not growth retarded, exhibiting a significant increase in body weight. Similarly they did 
not develop early-onset diabetes. This demonstrates that deletion of lrs-2 and stat-3 in the 
P-cell and hypothalamus is not sufficient to manifest the systemic double knockout 
phenotype. Moreover it highlights the importance of IRS-2 and leptin signalling in other 
tissues, in preventing the development of the double knockout phenotype.
However, it was evident P-HypIRS2+STAT3KO mice weighed significantly 
more than p-HypIRS2KO and P-HypSTAT3KO mice, at eight weeks of age. Moreover, 
consistent with an increased impairment to glucose homeostasis, P-HypIRS2+STAT3KO 
mice also tended to display elevated fasting insulin and leptin levels compared to both p-
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HypIRS2KO and (3-HypSTAT3KO mice. This hyperinsulinemia was attributable to an 
improved P-cell compensatory response in the (3-HypIRS2+STAT3KO mice, as 
evidenced by an increased relative islet area.
Although (3-HypIRS2+STAT3KO mice did not display the same phenotype 
described for global double knockout animals, there were some common features 
between these animals. In particular was their ability to increase p-cell mass in response 
to insulin resistance. As discussed in chapter five, four-week-old Irs-2'^ob^ double 
knockout mice displayed an improved preservation of P-cell mass and function in 
response to insulin resistance, compared to age-matched Irs-2'A mice. Indeed it is also 
reported that both ob/ob and db/db mice exhibit P-cell hyperplasia. These findings 
suggest that leptin deficiency promotes an increased P-cell response even in the absence 
of IRS-2 function. Consistent with this idea P-HypIRS2+STAT3KO mice had a 
significantly increased relative islet density and area compared to P-HypIRS2KO mice. 
Interestingly, the relative islet area of P-HypIRS2+STAT3KO mice was also increased 
compared to that seen in P-HypSTAT3KO mice, indicating that the combined tissue- 
specific deletion of IRS-2 and STAT-3 resulted in an additive effect with regards to islet 
function.
Considering either systemic or tissue-specific approaches, it is evident that 
insults to leptin signalling in combination with lrs-2 deletion results in additive effects 
upon growth, adiposity, glucose homeostasis and islet function. These additive effects 
would indicate that IRS-2 and STAT-3 mediate these effects by acting in separate 
signalling pathways, as opposed to converging upon a linear pathway (Fig 8.1). However 
cross-talk between these pathways is likely to be critical for the maintenance of insulin 
and leptin sensitivity in target tissues.
The generation of P-HypIRS2+STAT3KO mice provides further evidence that 
IRS-2 and STAT-3 signalling, intrinsic to the P-cell and hypothalamus are important for 
mediating the effects of insulin and leptin upon energy homeostasis. However, previous 
murine studies have demonstrated that defective signalling in one tissue can affect actions 
of insulin and other hormones in the next. An example is the muscle and liver insulin 
resistance exhibited by mice with selective deletion of GLUT-4 in adipose tissue (178).
172
The liver is known to play a central role in the control of glucose homeostasis 
and is subject to complex regulation by insulin and other hormones (118, 179). The liver- 
specific deletion of the insulin receptor in mice showed that insulin receptor signalling is 
critical for regulating glucose homeostasis, facilitating insulin clearance, and maintaining 
normal hepatic function (118). In contrast, conditional deletion of hepatic leptin long- 
form receptor function did not lead to a discemable phenotype in terms of energy balance 
(174), suggesting that leptin signalling is redundant in the liver.
However considering the signalling data presented in chapter six, it was 
evident that the liver was a major site of insulin resistance. Moreover, leptin deficiency 
led to a major impairment of insulin-stimulated MAP-kinase phosphorylation in liver. 
The presence of hepatic insulin resistance in these animals might be explained by indirect 
effects, owing to leptin dysfunction in other metabolic tissues, like muscle and adipose 
tissue. Indeed similar defects in insulin-stimulated MAP-kinase phosphorylation were 
observed in skeletal muscle of ob/ob mice (see chapter 6 ). Such defects could lead to an 
altered transcriptional program in the skeletal muscle of ob/ob mice. Alterations in 
transcription could promote the secretion of metabolic precursors that have insulin 
desensitizing effects in neighbouring tissues like the liver. Interestingly the deletion of 
STAT-3 in the liver of mice, suggests an important role for STAT-3 signalling in the 
regulation of hepatic gluconeogenic genes (64).
The accumulation of free fatty acids (FFAs) in non-adipose tissue like the 
pancreatic p-cell, muscle and liver, often precedes the onset of hyperglycaemia and 
insulin resistance (180). An emerging body of evidence suggests that AMP-activated 
protein kinase (AMPK) may play a critical role in the pathogenesis of P-cell 
glucolipotoxicity and type 2 diabetes (181). Interest in AMPK has heightened since the 
demonstration that leptin can stimulate its activity acting either in the periphery or 
centrally (34). It has also been implicated as mediating leptin’s effects in the CNS to 
regulate food intake (182, 183). Moreover, it is known that AMPK can regulate the 
expression of a number of transcription factors, including peroxisome proliferative- 
activated receptor a  (PPARa), the uncoupling proteins UCP2 and UCP3 and the Sterol- 
regulatory-element-binding protein-lc (SREBP-lc). Alterations in the expression of
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these transcription factors in mice, has been shown to manifest various metabolic 
phenotypes (106, 184-186).
The SREBPs transcription factors are of particular interest as they have been 
shown to suppress IRS-2-mediated insulin signalling in the liver (14, 120). Interestingly 
microarray analysis has indicated that the livers of lrs-2'/’ mice exhibit increased SREBP- 
1 gene expression (121). In addition systemic deletion of SREBP-1 in ob/ob mice 
ameliorated their fatty livers but had no effect upon obesity and insulin resistance, 
highlighting their importance in the regulation of lipogenesis. This is further evidenced 
by the lipodystrophy exhibited by mice expressing a constitutively active form of 
SREBP-1 c (103). Furthermore, leptin treatment reverses the insulin resistance and fatty 
livers displayed by these lipodystrophic mice, indicating that SREBP-1 c may be a critical 
mediator of insulin and leptin action (106).
In summary the genetic studies described in this thesis have provided some 
useful insight into the complex interplay that exists between insulin and leptin action, in 
the regulation of energy homeostasis. In particular they have shown that;
1). Global deletion of IRS-2 in combination with either leptin production (ob/ob) or 
function (db/db) in mice, results in the development of growth retardation and severe 
diabetes at an earlier age than Irs-2’A mice. Such additive effects and the finding that a 
single allele of leptin or leptin receptor gene function was sufficient to prevent this severe 
metabolic phenotype, highlight the importance of leptin function in the maintenance of 
insulin sensitivity.
2). Assessment of pancreatic p-cell function indicated that double knockout 
animals had an increased p-cell area compared to Irs-2'A at four weeks of age. As both 
ob/ob and db/db mice display P-cell hyperplasia, it is proposed that leptin may have an 
inhibitory effect upon P-cell mass.
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3). Generation of (3-HypIRS2+STAT3KO mice demonstrated the importance of 
both IRS-2 and STAT-3 signalling pathways in P-cell and hypothalamic function. 
Furthermore these mice exhibited additive effects with regards to body weight and 
impairment of glucose homeostasis, compared to P-HypIRS2KO and P-HypSTAT3KO 
mice. This would indicate that IRS-2 and STAT-3 do not act within a linear pathway to 
mediate the effects of insulin and leptin on energy homeostasis. Instead it is proposed 
that these proteins mediate these effects in parallel pathways, potentially interacting with 
similar cytoplasmic enzymes or by initiating overlapping transcriptional programs (Fig 
8.1).
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Figure 8.1 Schematic o f how IRS-2 and STAT-3 potentially mediate the effects o f 
insulin and leptin upon gene transcription
In view o f the observations from both systemic and tissue-specific gene knockout studies, 
it is unlikely that IRS-2 acts upstream of STAT-3 to mediate the effects o f insulin and 
leptin upon energy homeostasis. Instead, IRS-2 may regulate the activation o f other 
proteins that interact with STATS directly or activate a transcriptional program that has 
implication for STATS activity, mediating the effects o f insulin and leptin upon energy 
homeostasis
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FUTURE WORK:
In order to utilise these models further and understand how insulin and leptin 
action regulates energy homeostasis, the following lines of investigation would be carried 
out;
1). Morphological analysis:
Histological analysis of the peripheral tissues including liver, skeletal muscle, 
adipose tissue would be carried out to determine morphology. In addition the use of Oil- 
Red staining would provide some indication of the accumulation of fat droplets in non­
adipose tissues.
2). Investigation of Lipotoxicitv:
Early signalling studies have demonstrated the insulin resistance present in the 
livers of double knockout mice. Given the fact that both ob/ob and db/db mice display 
enlarged fatty livers, it is plausible that lipotoxicity is a major contributor to the 
development of insulin resistance seen in the livers of double knockout animals. It would 
therefore be important to measure serum free fatty acids (FFA) levels in these mice. As 
discussed previously, the volumes of blood serum required for these assays were not 
obtainable from double knockout animals. However assessment of FFA levels in other 
genotypes resulting from the global intercrosses may provide some insight into relative 
gene dosage effects upon FFA metabolism.
31. Analysis of peripheral signal transduction:
Further analysis of insulin signalling pathways would be carried out in the 
offspring resulting from both global intercrosses. This would provide further insight into 
the differences in peripheral insulin resistance seen in the various insulin target tissues of 
these mice. It may also provide insight into the improved glucose homeostasis seen in 
Irs-2'^db ^  double knockout mice compared to Irs-2V~ob A. It would also be interesting to 
analyse these signalling mechanisms in the tissue-specific knockouts, to address how 
peripheral insulin resistance is affected by deleting IRS-2 and STAT-3 specifically in the 
(3-cell and hypothalamus.
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4). Assessment of gene expression in hepatic and adipose tissue:
Quantification of mRNA species would be carried out by use of 
semiquantitative real-time PCR (TaqMan). In particular it would be interesting to 
measure the levels of expression of proteins involved in the regulation of fatty acid 
metabolism in the livers of these animals.
5). Studies in isolated islets:
In view of the dramatic impairment to islet function reported in P-HypIRS2KO 
and (3-HypSTAT3KO mice and the fact that P-HypIRS2+STAT3KO mice had an 
increased relative islet area compared to these mice at eight weeks of age, it would be 
important to carry out islet function assays on these animals. For example isolated islets 
could be stimulated with glucose to assess glucose-stimulated insulin release. 
Interestingly, it has been shown that P-HypSTAT3KO mice exhibit a major loss of acute 
1st phase insulin release (82). Indeed quantification of mRNA levels in isolated islets 
from P-HypSTAT3KO mice, showed VEGF-1, GLUT-2 and SUR-1 expression to be 
significantly lower compared to control islets (82). Assessment of these RNA species in 
P-HypIRS2+STAT3KO mice may prove useful insight into the relative contribution of 
IRS-2 and STAT-3 to their expression.
6 ). Role of AMP-Activated Protein Kinase (AMPK):
AMPK is an important mediator of leptin’s effects upon energy homeostasis and 
appetite control, highlighting it as a potential convergence point for insulin and leptin
action (117, 182, 183). It would therefore be interesting to assess the activity of AMPK
in the various peripheral tissues in these genotypes.
7). Overcoming developmental defects:
Since the undertaking of this project, developmental defects have been reported 
in the CNS of ob/ob, db/db and lrs-2 null mice (145, 175-177). Axonal labelling of ARC 
axons with the anterograde tracer Dil revealed that ARC projection pathways are severely 
reduced in ob/ob and db/db mice (Fig 8.2) and that leptin deficiency (ob/ob) or leptin 
resistance (db/db) causes a significant delay in the formation of projections from the 
ARC to each major target nucleus (176). Indeed that all three of these mouse mutants 
exhibit reduced brain weight and morphological defects, supports this notion (84, 145,
178
187-191). Hence, the combination of such defects as would be presented in the systemic 
double knockout mice, presumably contributes significantly to the observed dramatic 
phenotype of growth retardation and marked type 2 diabetes. Histological assessment of 
hypothalamus obtained from wild-type, ob/ob, Irs-2'A and double knockout animals by in 
situ hybridisation or Immunocytochemistry, would provide some insight into any 
morphological defects present in the double knockout mice.
Further investigation of the roles of IRS-2 and STAT-3 could be achieved by 
more sophisticated conditional deletion. In particular the development transgenic murine 
models capable of mediating post-natal, deletion of genes, has already been reported 
(192, 193). In addition more restricted deletion of either IRS-2 and STAT-3 in POMC 
and AgRP neurons may not be associated with developmental abnormalities. Applying 
such transgenic systems to both the IRS21ox and STAT-31ox mice would facilitate the 
deletion of these genes following the normal development of the CNS. This would 
provide a more defined understanding of the relative contributions of these genes to the 
central actions of both insulin and leptin.
179
APPENDIX I.
ABBREVIATIONS
AgRP Agouti-related protein
AMPK AMP-activated protein kinase
AMP Adenosine monophosphate
ARC Arcuate nucleus
ATP Adenosine triphosphate
CART Cocaine-amphetamine-regulated transcript
CDK4 Cyclin-dependent kinase 4
CDK6 Cyclin-dependent kinase 6
CNS Central nervous system
db Diabetes gene
DMH Dorsomedial hypothalamus
DMV Dorso-motor nucleus of the vagus
DTT Dithiothreitol
ELISA Enzyme-linked immunoabsorbance assay
FA Fatty acid
FFAs Free Fatty Acids
FIRKO mice Fat insulin receptor knockout mice
GLUT-4 glucose transporter protein-4
Grb2 Growth factor receptor-bound protein-2
GSK-3 Glycogen synthase kinase-3
GST Glutathione
Hyp Hypothalamus
I.U. International units
lgf-1 Insulin growth factor-1
lgf-1 r Insulin growth factor-1 receptor
IR Insulin receptor
IRS-1 Insulin receptor substrate-1
IRS-2 Insulin receptor substrate-2
IRS-3 Insulin receptor substrate-3
IRS-4 Insulin receptor substrate-4
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JAK2 Janus-kinase 2
K+ Potassium+
KO Knockout
LHA Lateral hypothalamus
LIRKO mice Liver insulin receptor knockout mice
MAPK Mitogen-activated protein kinase
MIRKO mice Muscle insulin receptor knockout mice
NPY Neuropeptide Y
NTS Nucleus of the solitary tract
ob O bese gene
ObRb Leptin long-form receptor
p70s6k p70 ribosomal s6 protein kinase
PCR Polymerase chain reaction
PDK-1 Phosphoinositide-dependent kinase-1
PH-domain Pleckstrin-homology domain
PI 3-K Phosphoinositol 3-kinase
PIP3 Phosphatidylinositol 3,4,5-tris-phosphate
PKB Protein kinase B
POMC Proopiomelanocortin
PVN Paraventricular nucleus
Rb Retinoblastoma protein
RIP Rat insulin II promoter
Ser Serine
SH2-domain Src-homology 2 domain
SOCS Suppressor of cytokine signalling
SOS Son of sevenless
SREBP-lc Sterol regulatory element binding protein
STAT-3 Signal transducer and activators of transcription 3
TAG Triacylglycerides
Thr Threonine
T2DM Type 2 diabetes
Tyr Tyrosine
VMH Ventromedial hypothalamus
WAT White adipose tissue
WT Wild-type
181
APPENDIX II
Genotyping primers for global deletions.
lrs-2 genotyping
lrs-2 upper ctt ggc tac cat gtt gtt att gtc
lrs-2 lower age tct gga ggt tta ctt tcc tag
lrs-2 neo get acc cgt gat att get gaa gag
ob genotyping
APC-Fow ccg gag taa gca gag aca caa gc
APC-Rev cca ata cct ege tct etc tcc a
OB-Fow ttg gac ttc att cct ggg ctt c
OB-WT cag cag atg gag gag gtc teg
OB-MUT cag cag atg gag gag gtc tea
db genotyping
db-F atg acc act aca gat gaa ccc agt eta
db-R cat tea aac cat agt tta ggt ttg tct
Genotyping primers for tissue-specific deletions.
RIP-Cre genotyping
CRE 1084 geg gtc tgg cag taa aaa eta tc
CRE 1085 gtg aaa cag cat tgc tgt cac tt
IL2F eta ggc cac aga att gaa aga tct
IL2R gta ggt gga aat tct age ate ate c
STAT3lox genotyping
APRF-11 UP cac caa cac atg eta ttt gta gg
APR F-11 DOWN cct gtc tct gac agg cca tc
APRF-14 DOWN gca gca gaa tac tct aca get c
IRS2lox genotyping
LoxPF act tga agg aag cca cag teg
LoxPR agt cca ctt tcc tga caa gc
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APPENDIX III
SUPPLIERS
SUPPLIER
AB-gene
Amersham Pharmacia
Anachem
Bayer Diagnostics
BD Biosciences:Pharmingen
BDH
Becton Dickinson 
CAMLAB
Fisher Scientific UK 
Guilbert
ICN Pharmaceuticals
Immuno-diagnostic systems Ltd
Insight Direct Ltd
Invitrogen
Jencons
Merck Biosciences
New England Biolabs (UK) Ltd
Promega
Qiagen
Roche Diagnostics 
Santa Cruz
Scientific Lab Supplies 
Sigma-aldrich company Ltd 
Stratagene Ltd 
ThermoLife Sciences
ADDRESS
Epsom, Surrey KT19 9AP, UK 
Little Chalfont, Buckinghamshire, UK 
Luton, Bedfordshire LU2 OEB, UK. 
Bury St. Edmunds, UK 
San Diego, CA 92121, USA 
Poole, Dorset, UK 
NJ, 07417, USA 
Cambridge, CB4 5WE, UK 
Loughborough, Leicestershire, UK 
Andover, UK 
Thame, Oxfordshire, UK 
Tyne and Wear, NE35 9PD, UK. 
Sheffield, S9 2BU England 
Paisley, PA4 9RF, UK 
Bedfordshire, LU7 4UA, UK 
Lutterworth, Leicestershire, UK 
Hitchin, Hertfordshire, UK 
Southampton, UK 
Crawley, West Sussex, UK 
East Sussex, BN7 1LG, UK 
Santa Cruz, California 95060, U.S.A. 
Nottingham NG11 7EP, UK 
Poole, Dorset, UK 
La Jolla, CA, USA
Basingstoke, Hampshire, RG21 6YH
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SUPPLIER ADDRESS
VWR International 
Eppendorf
Gibco BRL (LifeTechnologies Ltd)
CrystalChem Inc
Millipore
National Diagnostics 
GraphPad Software Inc 
Helena Biosciences 
Sartorius Instrument Ltd 
Upstate Ltd
East Sussex BN7 1LG, United Kingdom 
Hamburg, Germany 
Paisley, UK
suite A, Downers grove, IL 60515 USA 
Watford, UK
Aylesbury, Buckinghamshire, UK 
San Diego, USA 
Sunderland, Tyne and Wear, UK 
Gottingen, Germany 
Milton Keynes, UK
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